<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36043493</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1470-8728</ISSN><JournalIssue CitedMedium="Internet"><Volume>479</Volume><Issue>16</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>31</Day></PubDate></JournalIssue><Title>The Biochemical journal</Title><ISOAbbreviation>Biochem J</ISOAbbreviation></Journal><ArticleTitle>The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.</ArticleTitle><Pagination><StartPage>1653</StartPage><EndPage>1708</EndPage><MedlinePgn>1653-1708</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1042/BCJ20220154</ELocationID><Abstract><AbstractText>Ischaemia-reperfusion (I-R) injury, initiated via bursts of reactive oxygen species produced during the reoxygenation phase following hypoxia, is well known in a variety of acute circumstances. We argue here that I-R injury also underpins elements of the pathology of a variety of chronic, inflammatory diseases, including rheumatoid arthritis, ME/CFS and, our chief focus and most proximally, Long COVID. Ischaemia may be initiated via fibrin amyloid microclot blockage of capillaries, for instance as exercise is started; reperfusion is a necessary corollary when it finishes. We rehearse the mechanistic evidence for these occurrences here, in terms of their manifestation as oxidative stress, hyperinflammation, mast cell activation, the production of marker metabolites and related activities. Such microclot-based phenomena can explain both the breathlessness/fatigue and the post-exertional malaise that may be observed in these conditions, as well as many other observables. The recognition of these processes implies, mechanistically, that therapeutic benefit is potentially to be had from antioxidants, from anti-inflammatories, from iron chelators, and via suitable, safe fibrinolytics, and/or anti-clotting agents. We review the considerable existing evidence that is consistent with this, and with the biochemical mechanisms involved.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0001-5838-7963</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZB, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Kemitorvet 200, 2800 Kgs Lyngby, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Private Bag X1 Matieland 7602, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9108-2384</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool L69 7ZB, U.K.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, Private Bag X1 Matieland 7602, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem J</MedlineTA><NlmUniqueID>2984726R</NlmUniqueID><ISSNLinking>0264-6021</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015427" MajorTopicYN="Y">Reperfusion Injury</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">amyloid microclots</Keyword><Keyword MajorTopicYN="N">ischaemia&#x2013;reperfusion injury</Keyword></KeywordList><CoiStatement>E.P. is the managing director of BioCODE Technologies. D.B.K. holds shares in PhenUTest Ltd. These companies are developing or contemplating developing diagnostics for Long COVID.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36043493</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pii">231696</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu, M.Y., Yiang, G.T., Liao, W.T., Tsai, A.P., Cheng, Y.L., Cheng, P.W.et al. (2018) Current mechanistic concepts in ischemia and reperfusion injury. Cell. Physiol. Biochem. 46, 1650&#x2013;1667 10.1159/000489241</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000489241</ArticleId><ArticleId IdType="pubmed">29694958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausenloy, D.J. and Yellon, D.M. (2013) Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 123, 92&#x2013;100 10.1172/JCI62874</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI62874</ArticleId><ArticleId IdType="pmc">PMC3533275</ArticleId><ArticleId IdType="pubmed">23281415</ArticleId></ArticleIdList></Reference><Reference><Citation>Daiber, A., Andreadou, I., Oelze, M., Davidson, S.M. and Hausenloy, D.J. (2021) Discovery of new therapeutic redox targets for cardioprotection against ischemia/reperfusion injury and heart failure. Free Rad. Biol. Med. 163, 325&#x2013;343 10.1016/j.freeradbiomed.2020.12.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.12.026</ArticleId><ArticleId IdType="pubmed">33359685</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy, E. and Steenbergen, C. (2008) Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88, 581&#x2013;609 10.1152/physrev.00024.2007</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00024.2007</ArticleId><ArticleId IdType="pmc">PMC3199571</ArticleId><ArticleId IdType="pubmed">18391174</ArticleId></ArticleIdList></Reference><Reference><Citation>Enzmann, G., Kargaran, S. and Engelhardt, B. (2018) Ischemia-reperfusion injury in stroke: impact of the brain barriers and brain immune privilege on neutrophil function. Ther. Adv. Neurol. Disord. 11, 1756286418794184 10.1177/1756286418794184</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286418794184</ArticleId><ArticleId IdType="pmc">PMC6111395</ArticleId><ArticleId IdType="pubmed">30181779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, M., Gu, X. and Ma, Z. (2021) Mitochondrial quality control in cerebral ischemia-reperfusion injury. Mol. Neurobiol. 58, 5253&#x2013;5271 10.1007/s12035-021-02494-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02494-8</ArticleId><ArticleId IdType="pubmed">34275087</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito, H., Nojima, T., Fujisaki, N., Tsukahara, K., Yamamoto, H., Yamada, T.et al. (2020) Therapeutic strategies for ischemia reperfusion injury in emergency medicine. Acute Med. Surg. 7, e501 10.1002/ams2.501</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ams2.501</ArticleId><ArticleId IdType="pmc">PMC7231568</ArticleId><ArticleId IdType="pubmed">32431842</ArticleId></ArticleIdList></Reference><Reference><Citation>Aigner, F., Maier, H.T., Schwelberger, H.G., Wallnofer, E.A., Amberger, A., Obrist, P.et al. (2007) Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart. Am. J. Transplant. 7, 779&#x2013;788 10.1111/j.1600-6143.2006.01723.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-6143.2006.01723.x</ArticleId><ArticleId IdType="pubmed">17391123</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeschke, H. and Woolbright, B.L. (2012) Current strategies to minimize hepatic ischemia-reperfusion injury by targeting reactive oxygen species. Transplant. Rev. 26, 103&#x2013;114 10.1016/j.trre.2011.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trre.2011.10.006</ArticleId><ArticleId IdType="pmc">PMC3575198</ArticleId><ArticleId IdType="pubmed">22459037</ArticleId></ArticleIdList></Reference><Reference><Citation>Situmorang, G.R. and Sheerin, N.S. (2019) Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction. Pediatr. Nephrol. 34, 951&#x2013;963 10.1007/s00467-018-3940-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-018-3940-4</ArticleId><ArticleId IdType="pmc">PMC6477994</ArticleId><ArticleId IdType="pubmed">29603016</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai, Y., Petrowsky, H., Hong, J.C., Busuttil, R.W. and Kupiec-Weglinski, J.W. (2013) Ischaemia&#x2013;reperfusion injury in liver transplantation--from bench to bedside. Nat. Rev. Gastroenterol. Hepatol. 10, 79&#x2013;89 10.1038/nrgastro.2012.225</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2012.225</ArticleId><ArticleId IdType="pmc">PMC3577927</ArticleId><ArticleId IdType="pubmed">23229329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chouchani, E.T., Pell, V.R., Gaude, E., Aksentijevic, D., Sundier, S.Y., Robb, E.L.et al. (2014) Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431&#x2013;435 10.1038/nature13909</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13909</ArticleId><ArticleId IdType="pmc">PMC4255242</ArticleId><ArticleId IdType="pubmed">25383517</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger, D.N. and Kvietys, P.R. (2015) Reperfusion injury and reactive oxygen species: the evolution of a concept. Redox Biol. 6, 524&#x2013;551 10.1016/j.redox.2015.08.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2015.08.020</ArticleId><ArticleId IdType="pmc">PMC4625011</ArticleId><ArticleId IdType="pubmed">26484802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Akeredolu, O.-O., Soma, P. and Kell, D.B. (2017) Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability. Exp. Biol. Med. 242, 355&#x2013;373 10.1177/1535370216681549</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1535370216681549</ArticleId><ArticleId IdType="pmc">PMC5298544</ArticleId><ArticleId IdType="pubmed">27889698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2018) No effects without causes. The iron dysregulation and dormant microbes hypothesis for chronic, inflammatory diseases. Biol. Rev. 93, 1518&#x2013;1557 10.1111/brv.12407</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12407</ArticleId><ArticleId IdType="pmc">PMC6055827</ArticleId><ArticleId IdType="pubmed">29575574</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa, S., Nora-Krukle, Z., Henning, N., Eliassen, E., Shikova, E., Harrer, T.et al. (2018) Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J. Transl. Med. 16, 268 10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian, A., Sehgal, K., Gupta, A., Madhavan, M.V., McGroder, C., Stevens, J.S.et al. (2021) Post-acute COVID-19 syndrome. Nat. Med. 27, 601&#x2013;615 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff, A.L. and Lipkin, W.I. (2021) Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 27, 895&#x2013;906 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal, A.D. and VanElzakker, M.B. (2021) Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 12, 698169 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukocheva, O.A., Maksoud, R., Beeraka, N.M., Madhunapantula, S.V., Sinelnikov, M., Nikolenko, V.N.et al. (2022) Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome. J. Adv. Res. Still in press. 10.1016/j.jare.2021.11.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2021.11.013</ArticleId><ArticleId IdType="pmc">PMC8619886</ArticleId><ArticleId IdType="pubmed">36100326</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen, C.L.M.C., Rowe, P.C. and Visser, F.C. (2021) Orthostatic symptoms and reductions in cerebral blood flow in long-Haul COVID-19 patients: similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina (Kaunas) 58, 28 10.3390/medicina58010028</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, T.L. and Weitzer, D.J. (2021) Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-a systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas) 57, 418 10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapkota, H.R. and Nune, A. (2022) Long COVID from rheumatology perspective - a narrative review. Clin. Rheumatol. 41, 337&#x2013;348 10.1007/s10067-021-06001-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-06001-1</ArticleId><ArticleId IdType="pmc">PMC8629735</ArticleId><ArticleId IdType="pubmed">34845562</ArticleId></ArticleIdList></Reference><Reference><Citation>Agergaard, J., Leth, S., Pedersen, T.H., Harbo, T., Blicher, J.U., Karlsson, P.et al. (2021) Myopathic changes in patients with long-term fatigue after COVID-19. Clin. Neurophysiol. 132, 1974&#x2013;1981 10.1016/j.clinph.2021.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.04.009</ArticleId><ArticleId IdType="pmc">PMC8102077</ArticleId><ArticleId IdType="pubmed">34020890</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbarialiabad, H., Taghrir, M.H., Abdollahi, A., Ghahramani, N., Kumar, M., Paydar, S.et al. (2021) Long COVID, a comprehensive systematic scoping review. Infection 49, 1163&#x2013;1186 10.1007/s15010-021-01666-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01666-x</ArticleId><ArticleId IdType="pmc">PMC8317481</ArticleId><ArticleId IdType="pubmed">34319569</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H.E., Assaf, G.S., McCorkell, L., Wei, H., Low, R.J., Re'em, Y.et al. (2021) Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 38, 101019 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshee, S., Vatti, N. and Chang, C. (2022) Long-term effects of COVID-19. Mayo Clin. Proc. 97, 579&#x2013;599 10.1016/j.mayocp.2021.12.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.12.017</ArticleId><ArticleId IdType="pmc">PMC8752286</ArticleId><ArticleId IdType="pubmed">35246288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds, E., Rushforth, A., Wieringa, S., Taylor, S., Rayner, C., Husain, L.et al. (2020) Persistent symptoms after COVID-19: qualitative study of 114 "long COVID" patients and draft quality principles for services. BMC Health Serv. Res. 20, 1144 10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul, L., O'Boyle, S., Palla, L., Nacul, F.E., Mudie, K., Kingdon, C.C.et al. (2020) How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front. Neurol. 11, 826 10.3389/fneur.2020.00826</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran, A.V., Jayadevan, R. and Sashidharan, S. (2021) Long COVID: an overview. Diabetes Metab. Syndr. 15, 869&#x2013;875 10.1016/j.dsx.2021.04.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Twomey, R., DeMars, J., Franklin, K., Culos-Reed, S.N., Weatherald, J. and Wrightson, J.G. (2021) Chronic fatigue and post-exertional malaise in people living with long COVID. medRxiv 2021.2006.2011.21258564</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehar, S., Boushra, M., Ntiamoah, P. and Biehl, M. (2021) Post-acute sequelae of SARS-CoV-2 infection: caring for the 'long-haulers'. Cleve Clin. J. Med. 88, 267&#x2013;272 10.3949/ccjm.88a.21010</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.88a.21010</ArticleId><ArticleId IdType="pubmed">33941600</ArticleId></ArticleIdList></Reference><Reference><Citation>Walitt, B. and Bartrum, E. (2021) A clinical primer for the expected and potential post-COVID-19 syndromes. Pain Rep. 6, e887 10.1097/PR9.0000000000000887</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PR9.0000000000000887</ArticleId><ArticleId IdType="pmc">PMC7889402</ArticleId><ArticleId IdType="pubmed">33615088</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong, S.J. and Liu, S. (2021) Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 32, e2315 10.1002/rmv.2315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban, F., Ling, S., Lui, L.M.W., Lee, Y., Gill, H., Teopiz, K.M.et al. (2022) Fatigue and cognitive impairment in post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav. Immun. 101, 93&#x2013;135 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, D.A. and O'Brien, K.K. (2021) Conceptualising long COVID as an episodic health condition. BMJ Glob. Health 6, e007004 10.1136/bmjgh-2021-007004</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-007004</ArticleId><ArticleId IdType="pmc">PMC8460526</ArticleId><ArticleId IdType="pubmed">34551971</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Brien, K.K., Brown, D.A., Bergin, C., Erlandson, K.M., Vera, J.H., Avery, L.et al. (2022) Long COVID and episodic disability: advancing the conceptualisation, measurement and knowledge of episodic disability among people living with long COVID - protocol for a mixed-methods study. BMJ Open 12, e060826 10.1136/bmjopen-2022-060826</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-060826</ArticleId><ArticleId IdType="pmc">PMC8905414</ArticleId><ArticleId IdType="pubmed">35256450</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune, A., Durkowski, V., Titman, A., Gupta, L., Hadzhiivanov, M., Ahmed, A.et al. (2021) Incidence and risk factors of long COVID in the UK: a single-centre observational study. J. R. Coll. Physicians Edinb. 51, 338&#x2013;343 10.4997/jrcpe.2021.405</Citation><ArticleIdList><ArticleId IdType="doi">10.4997/jrcpe.2021.405</ArticleId><ArticleId IdType="pubmed">34882130</ArticleId></ArticleIdList></Reference><Reference><Citation>Salmon-Ceron, D., Slama, D., De Broucker, T., Karmochkine, M., Pavie, J., Sorbets, E.et al. (2021) Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: a cross-sectional study. J. Infect. 82, e1&#x2013;e4 10.1016/j.jinf.2020.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.002</ArticleId><ArticleId IdType="pmc">PMC7833274</ArticleId><ArticleId IdType="pubmed">33285216</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart, S., Newson, L., Briggs, T.A., Grammatopoulos, D., Young, L. and Gill, P. (2021) Long COVID risk - a signal to address sex hormones and women's health. Lancet Reg. Health Eur. 11, 100242 10.1016/j.lanepe.2021.100242</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona, E., Buonsenso, D., Carfi, A., Malorni, W. and Long COVID kids study group (2021) Long COVID: an estrogen-associated autoimmune disease? Cell Death Discov. 7, 77 10.1038/s41420-021-00464-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00464-6</ArticleId><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona, E. and Malorni, W. (2022) Long COVID: to investigate immunological mechanisms and sex/gender related aspects as fundamental steps for tailored therapy. Eur. Respir. J. 59, 2102245 10.1183/13993003.02245-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02245-2021</ArticleId><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman, L., Bested, A.C., Bonilla, H.F., Chheda, B.V., Chu, L., Curtin, J.M.et al. (2021) Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin. Proc. 96, 2861&#x2013;2878 10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers, B.M., van de Sande, M.I., De Meirleir, K.L., Klimas, N.G., Broderick, G., Mitchell, T.et al. (2011) Myalgic encephalomyelitis: international consensus criteria. J. Internsive Med. 270, 327&#x2013;338 10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Green, M.A. and Shearman, C.P. (1994) Reperfusion injury in peripheral vascular disease. Vasc. Med. Rev. 5, 97&#x2013;106 10.1177/1358863X9400500202</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1358863X9400500202</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C., Haupert, S.R., Zimmermann, L., Shi, X., Fritsche, L.G. and Mukherjee, B. (2021) Global prevalence of post-acute sequelae of COVID-19 (PASC) or long COVID: a meta-analysis and systematic review. medRxiv 2021.2011.2015.21266377</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold, J.E., Okyay, R.A., Licht, W.E. and Hurley, D.J. (2021) Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens 10, 763 10.3390/pathogens10060763</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10060763</ArticleId><ArticleId IdType="pmc">PMC8233978</ArticleId><ArticleId IdType="pubmed">34204243</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall, M. (2021) The four most urgent questions about long COVID. Nature 594, 168&#x2013;170 10.1038/d41586-021-01511-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01511-z</ArticleId><ArticleId IdType="pubmed">34108700</ArticleId></ArticleIdList></Reference><Reference><Citation>Arjun, M.C., Singh, A.K., Pal, D., Das, K., Gajjala, A., Venkateshan, M.et al. (2022) Prevalence, characteristics, and predictors of long COVID among diagnosed cases of COVID-19. medRxiv 2022.2001.2004.21268536</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9767341</ArticleId><ArticleId IdType="pubmed">36538532</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet, M., Dercon, Q., Luciano, S., Geddes, J.R., Husain, M. and Harrison, P.J. (2021) Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 18, e1003773 10.1371/journal.pmed.1003773</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Yomogida, K., Zhu, S., Rubino, F., Figueroa, W., Balanji, N. and Holman, E. (2021) Post-acute sequelae of SARS-CoV-2 infection among adults aged &#x2265;8 years - long beach, California, April 1-December 10, 2020. MMWR Morb. Mortal. Wkly Rep. 70, 1274&#x2013;1277 10.15585/mmwr.mm7037a2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7037a2</ArticleId><ArticleId IdType="pmc">PMC8445372</ArticleId><ArticleId IdType="pubmed">34529639</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker, M., Elliott, J., Chadeau-Hyam, M., Riley, S., Darzi, A., Cooke, G.et al. (2022) Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 13, 1957 10.1038/s41467-022-29521-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, C., Haupert, S.R., Zimmermann, L., Shi, X., Fritsche, L.G. and Mukherjee, B. (2022) Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. jiac136 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie, T., Hittle, M. and Goodman, S.N. (2021) Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw. Open. 4, e2111417 10.1001/jamanetworkopen.2021.11417</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese, J., Blau, H., Bergquist, T., Loomba, J.J., Callahan, T., Laraway, B.et al. (2022) Generalizable long COVID subtypes: findings from the NIH N3C and RECOVER programs. medRxiv 2022.2005.2024.22275398</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D., Bermingham, C., Pouwels, K.B., Glickman, M., Nafilyan, V., Zaccardi, F.et al. (2021) Changes in the trajectory of long COVID symptoms following COVID-19 vaccination: community-based cohort study. medRxiv 2021.2012.2009.21267516</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Caspersen, I.H., Magnus, P. and Trogstad, L. (2021) Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort. medRxiv 2021.2010.2015.21265038</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8872922</ArticleId><ArticleId IdType="pubmed">35211871</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit, D., Nicholson, T.R., Needham, D.M., Seylanova, N., Parr, C., Chen, J.et al. (2022) Studying the post-COVID-19 condition: research challenges, strategies, and importance of core outcome Set development. BMC Med. 20, 50 10.1186/s12916-021-02222-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai, A.D., Lavelle, M., Boursiquot, B.C. and Wan, E.Y. (2022) Long-term complications of COVID-19. Am. J. Physiol. Cell Physiol. 322, C1&#x2013;C11 10.1152/ajpcell.00375.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y. and Al-Aly, Z. (2022) Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 10, 311&#x2013;321 10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie, Y., Xu, E., Bowe, B. and Al-Aly, Z. (2022) Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28, 583&#x2013;590 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Salazar, B., Holwerda, M., Studle, C., Piragyte, I., Mercader, N., Engelhardt, B.et al. (2022) COVID-19 and the vasculature: current aspects and long-term consequences. Front. Cell Dev. Biol. 10, 824851 10.3389/fcell.2022.824851</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.824851</ArticleId><ArticleId IdType="pmc">PMC8887620</ArticleId><ArticleId IdType="pubmed">35242762</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham, E.L., Clark, J.R., Orban, Z.S., Lim, P.H., Szymanski, A.L., Taylor, C.et al. (2021) Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 "long haulers". Ann. Clin. Transl. Neurol. 8, 1073&#x2013;1085 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer, R.R., Rock, M.A., Vasilevsky, N., Carmody, L., Rando, H., Anzalone, A.J.et al. (2021) Characterizing long COVID: deep phenotype of a complex condition. EBioMedicine 74, 103722 10.1016/j.ebiom.2021.103722</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen, M., Manoharan, L., Elkheir, N., Cheng, V., Dagens, A., Hastie, C.et al. (2021) Characterising long COVID: a living systematic review. BMJ Glob. Health 6, e005427 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell, M.L., Catalfamo, C.J., Farland, L.V., Ernst, K.C., Jacobs, E.T., Klimentidis, Y.C.et al. (2021) Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One 16, e0254347 10.1371/journal.pone.0254347</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg, B., Mohn, K.G., Brokstad, K.A., Zhou, F., Linchausen, D.W., Hansen, B.A.et al. (2021) Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 27, 1607&#x2013;1613 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue, J.K., Franko, N.M., McCulloch, D.J., McDonald, D., Magedson, A., Wolf, C.R.et al. (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw. Open. 4, e210830 10.1001/jamanetworkopen.2021.0830</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.0830</ArticleId><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre, C.H., Murray, B., Varsavsky, T., Graham, M.S., Penfold, R.S., Bowyer, R.C.et al. (2021) Attributes and predictors of long COVID. Nat. Med. 27, 626&#x2013;631 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal, S., Barnett, J., Brill, S.E., Brown, J.S., Denneny, E.K., Hare, S.S.et al. (2021) 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 76, 396&#x2013;398 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Nurek, M., Rayner, C., Freyer, A., Taylor, S., Jarte, L., MacDermott, N.et al. (2021) Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br. J. Gen. Pract. 71, e815&#x2013;e825 10.3399/BJGP.2021.0265</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0265</ArticleId><ArticleId IdType="pmc">PMC8510689</ArticleId><ArticleId IdType="pubmed">34607799</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid, L., Drake, T.M., Pauley, E., Jesudason, E.C., Olliaro, P., Lim, W.S.et al. (2021) Long COVID in adults discharged from UK hospitals after COVID-19: a prospective, multicentre cohort study using the ISARIC WHO clinical characterisation protocol. Lancet Reg. Health Eur. 8, 100186 10.1016/j.lanepe.2021.100186</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh, T., Knight, M., A'Court, C., Buxton, M. and Husain, L. (2020) Management of post-acute COVID-19 in primary care. BMJ 370, m3026 10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando, H.M., Bennett, T.D., Byrd, J.B., Bramante, C., Callahan, T.J., Chute, C.G.et al. (2021) Challenges in defining Long COVID: striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv 10.1101/2021.1103.1120.21253896</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.1103.1120.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tereshchenko, L.G., Bishop, A., Fisher-Campbell, N., Levene, J., Morris, C.C., Patel, H.et al. (2021) Risk of cardiovascular events after COVID-19: a double-cohort study. medRxiv 2021.2012.2027.21268448</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya, A.A., Akbari, A., Emami, A., Lotfi, M., Rostamihosseinkhani, M., Nemati, H.et al. (2021) Long COVID syndrome-associated brain fog. J. Med. Virol. 94, 979&#x2013;984 10.1002/jmv.27404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanou, M.I., Palaiodimou, L., Bakola, E., Smyrnis, N., Papadopoulou, M., Paraskevas, G.P.et al. (2022) Neurological manifestations of long-COVID syndrome: a narrative review. Ther. Adv. Chronic. Disord. 13, 20406223221076890 10.1177/20406223221076890</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pmc">PMC8859684</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire, A., Trender, W., Chamberlain, S.R., Jolly, A.E., Grant, J.E., Patrick, F.et al. (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39, 101044 10.1016/j.eclinm.2021.101044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall, M. (2021) COVID and the brain: researchers zero in on how damage occurs. Nature 595, 484&#x2013;485 10.1038/d41586-021-01693-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-01693-6</ArticleId><ArticleId IdType="pubmed">34234323</ArticleId></ArticleIdList></Reference><Reference><Citation>Glynne, P., Tahmasebi, N., Gant, V. and Gupta, R. (2021) Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines. J. Investig. Med. 70, 61&#x2013;67 10.1136/jim-2021-002051</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-002051</ArticleId><ArticleId IdType="pmc">PMC8494538</ArticleId><ArticleId IdType="pubmed">34611034</ArticleId></ArticleIdList></Reference><Reference><Citation>Montes, N., Dom&#xe8;nech, &#xc8;, Guerrero, S., Oliv&#xe1;n-Bl&#xe1;zquez, B. and Magall&#xf3;n-Botaya, R. (2021) Analysis of cell-mediated immunity in people with long COVID. medRxiv 2021.2006.2009.21258553</Citation></Reference><Reference><Citation>Grobler, C., Maphumulo, S.C., Grobbelaar, L.M., Bredenkamp, J., Laubscher, J., Lourens, P.J.et al. (2020) COVID-19: the rollercoaster of fibrin(ogen), D-dimer, von willebrand factor, P-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int. J. Mol. Sci. 21, 5168 10.3390/ijms21145168</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21145168</ArticleId><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis, I., Fonseca-Rodr&#xed;guez, O., Farrington, P., Lindmark, K. and Fors Connolly, A.M. (2021) Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet 398, 599&#x2013;607 10.1016/S0140-6736(21)00896-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar, L.M., Venter, C., Vlok, M., Ngoepe, M., Laubscher, G.J., Lourens, P.J.et al. (2021) SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. 41, BSR20210611 10.1042/BSR20210611</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B., Laubscher, G.J. and Pretorius, E. (2022) A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem. J. 479, 537&#x2013;559 10.1042/BCJ20220016</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubscher, G.J., Lourens, P.J., Venter, C., Kell, D.B. and Pretorius, E. (2021) TEG&#xae;, microclot and platelet mapping for guiding early management of severe COVID-19 coagulopathy. J. Clin. Med. 10, 5381 10.3390/jcm10225381</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225381</ArticleId><ArticleId IdType="pmc">PMC8621180</ArticleId><ArticleId IdType="pubmed">34830660</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Venter, C., Laubscher, G.J., Lourens, P.J., Steenkamp, J. and Kell, D.B. (2020) Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; type 2 diabetes mellitus and COVID-19 plasma: a preliminary report. Cardiovasc. Diabetol. 19, 193 10.1186/s12933-020-01165-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Vlok, M., Venter, C., Bezuidenhout, J.A., Laubscher, G.J., Steenkamp, J.et al. (2021) Persistent clotting protein pathology in long COVID/ post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 20, 172 10.1186/s12933-021-01359-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Venter, C., Laubscher, G.J., Kotze, M.J., Oladejo, S., Watson, L.R.et al. (2022) Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) Research Square 10.21203/rs.21203.rs-1205453/v1205452</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.21203.rs-1205453/v1205452</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavi, L. (2022) Postural tachycardia syndrome and long COVID: an update. Br. J. Gen. Pract. 72, 8&#x2013;9 10.3399/bjgp22X718037</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp22X718037</ArticleId><ArticleId IdType="pmc">PMC8714530</ArticleId><ArticleId IdType="pubmed">34972793</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak, P., Mukerji, S.S., Alabsi, H.S., Systrom, D., Marciano, S.P., Felsenstein, D.et al. (2022) Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann. Neurol. 91, 367&#x2013;379 10.1002/ana.26286</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, I., Joseph, P., Heerdt, P.M., Cullinan, M., Lutchmansingh, D.D., Gulati, M.et al. (2022) Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest 161, 54&#x2013;63 10.1016/j.chest.2021.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>Afari, N. and Buchwald, D. (2003) Chronic fatigue syndrome: a review. Am. J. Psychiatry 160, 221&#x2013;236 10.1176/appi.ajp.160.2.221</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ajp.160.2.221</ArticleId><ArticleId IdType="pubmed">12562565</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J.S., Kim, H.G., Lee, D.S. and Son, C.G. (2018) Oxidative stress is a convincing contributor to idiopathic chronic fatigue. Sci. Rep. 8, 12890 10.1038/s41598-018-31270-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-31270-3</ArticleId><ArticleId IdType="pmc">PMC6110864</ArticleId><ArticleId IdType="pubmed">30150620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani, E., Mariotto, S., Gabbiani, D., Dorelli, G., Bozzetti, S., Federico, A.et al. (2021) Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? J. Neurovirol. 27, 631&#x2013;637 10.1007/s13365-021-01002-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-021-01002-x</ArticleId><ArticleId IdType="pmc">PMC8328351</ArticleId><ArticleId IdType="pubmed">34341960</ArticleId></ArticleIdList></Reference><Reference><Citation>Joseph, P., Arevalo, C., Oliveira, R.K.F., Faria-Urbina, M., Felsenstein, D., Oaklander, A.L.et al. (2021) Insights from invasive cardiopulmonary exercise testing of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Chest 160, 642&#x2013;651 10.1016/j.chest.2021.01.082</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.01.082</ArticleId><ArticleId IdType="pmc">PMC8727854</ArticleId><ArticleId IdType="pubmed">33577778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe, P.C., Underhill, R.A., Friedman, K.J., Gurwitt, A., Medow, M.S., Schwartz, M.S.et al. (2017) Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Front. Pediatr. 5, 121 10.3389/fped.2017.00121</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00121</ArticleId><ArticleId IdType="pmc">PMC5474682</ArticleId><ArticleId IdType="pubmed">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Deumer, U.S., Varesi, A., Floris, V., Savioli, G., Mantovani, E., Lopez-Carrasco, P.et al. (2021) Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): an overview. J. Clin. Med 10, 4786 10.3390/jcm10204786</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10204786</ArticleId><ArticleId IdType="pmc">PMC8538807</ArticleId><ArticleId IdType="pubmed">34682909</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaarslan, F., Demircio&#x11f;lu Guneri, F. and Karde&#x15f;, S. (2022) long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin. Rheumatol. 41, 289&#x2013;296 10.1007/s10067-021-05942-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05942-x</ArticleId><ArticleId IdType="pmc">PMC8553494</ArticleId><ArticleId IdType="pubmed">34713356</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A., Khalafpour, S. and Wilson, C. (1989) Rheumatoid arthritis and Proteus: a possible aetiological association. Rheumatol. Int. 9, 223&#x2013;228 10.1007/BF00271885</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00271885</ArticleId><ArticleId IdType="pubmed">2692130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A. and Wilson, C. (2000) HLA molecules, bacteria and autoimmunity. J. Med. Microbiol. 49, 305&#x2013;311 10.1099/0022-1317-49-4-305</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-49-4-305</ArticleId><ArticleId IdType="pubmed">10755623</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A. and Rashid, T. (2009) Rheumatoid arthritis is caused by Proteus: the molecular mimicry theory and Karl Popper. Front. Biosci. (Elite Ed.) 1, 577&#x2013;586 10.2741/e56</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/e56</ArticleId><ArticleId IdType="pubmed">19482674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A., Rashid, T. and Wilson, C. (2010) Rheumatoid arthritis, proteus, anti-CCP antibodies and Karl Popper. Autoimmun. Rev. 9, 216&#x2013;223 10.1016/j.autrev.2009.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2009.10.006</ArticleId><ArticleId IdType="pubmed">19895906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A. (2012) Rheumatoid arthritis and Proteus, Springer, London</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebringer, A. and Rashid, T. (2014) Rheumatoid arthritis is caused by a Proteus urinary tract infection. APMIS 122, 363&#x2013;368 10.1111/apm.12154</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apm.12154</ArticleId><ArticleId IdType="pubmed">23992372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. (2009) Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genom. 2, 2 10.1186/1755-8794-2-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1755-8794-2-2</ArticleId><ArticleId IdType="pmc">PMC2672098</ArticleId><ArticleId IdType="pubmed">19133145</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung, T.H., Skepper, J.N. and Burton, G.J. (2001) In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am. J. Pathol. 159, 1031&#x2013;1043 10.1016/S0002-9440(10)61778-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)61778-6</ArticleId><ArticleId IdType="pmc">PMC1850466</ArticleId><ArticleId IdType="pubmed">11549595</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung, T.H., Charnock-Jones, D.S., Skepper, J.N. and Burton, G.J. (2004) Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am. J. Pathol. 164, 1049&#x2013;1061 10.1016/S0002-9440(10)63192-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)63192-6</ArticleId><ArticleId IdType="pmc">PMC1614718</ArticleId><ArticleId IdType="pubmed">14982858</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Kenny, L.C. (2016) A dormant microbial component in the development of pre-eclampsia. Front. Med. Obs. Gynecol. 3, 60 10.3389/fmed.2016.00060</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2016.00060</ArticleId><ArticleId IdType="pmc">PMC5126693</ArticleId><ArticleId IdType="pubmed">27965958</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenny, L.C. and Kell, D.B. (2018) Immunological tolerance, pregnancy and pre-eclampsia: the roles of semen microbes and the father. Front. Med. Obs. Gynecol. 4, 239 10.3389/fmed.2017.00239</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2017.00239</ArticleId><ArticleId IdType="pmc">PMC5758600</ArticleId><ArticleId IdType="pubmed">29354635</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayaram, A., Buhimschi, I.A., Aldasoqi, H., Hartwig, J., Owens, T., Elam, G.L.et al. (2021) Who said differentiating preeclampsia from COVID-19 infection was easy? Pregnancy Hypertens. 26, 8&#x2013;10 10.1016/j.preghy.2021.07.248</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preghy.2021.07.248</ArticleId><ArticleId IdType="pmc">PMC8302825</ArticleId><ArticleId IdType="pubmed">34392167</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza, M., Garcia-Ruiz, I., Maiz, N., Rodo, C., Garcia-Manau, P., Serrano, B.et al. (2020) Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG 127, 1374&#x2013;1380 10.1111/1471-0528.16339</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1471-0528.16339</ArticleId><ArticleId IdType="pmc">PMC7300912</ArticleId><ArticleId IdType="pubmed">32479682</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanz, T.V., Brewer, R.C., Ho, P.P., Moon, J.S., Jude, K.M., Fernandez, D.et al. (2022) Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321&#x2013;327 10.1038/s41586-022-04432-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04432-7</ArticleId><ArticleId IdType="pmc">PMC9382663</ArticleId><ArticleId IdType="pubmed">35073561</ArticleId></ArticleIdList></Reference><Reference><Citation>Wekerle, H. (2022) Epstein-Barr virus sparks brain autoimmunity in multiple sclerosis. Nature 603, 230&#x2013;232 10.1038/d41586-022-00382-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00382-2</ArticleId><ArticleId IdType="pubmed">35169323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullard, A. (2022) The quest to prevent MS - and understand other post-viral diseases. Nature 603, 784&#x2013;786 10.1038/d41586-022-00808-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00808-x</ArticleId><ArticleId IdType="pubmed">35354995</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Hagan, S., Wright Muelas, M., Day, P.J., Lundberg, E. and Kell, D.B. (2018) Genegini: assessment via the Gini coefficient of reference &#x2018;&#x2018;housekeeping&#x2019;&#x2019; genes and diverse human transporter expression profiles. Cell Syst. 6, 230&#x2013;244 10.1016/j.cels.2018.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2018.01.003</ArticleId><ArticleId IdType="pmc">PMC5840522</ArticleId><ArticleId IdType="pubmed">29428416</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright Muelas, M., Mughal, F., O'Hagan, S., Day, P.J. and Kell, D.B. (2019) The role and robustness of the Gini coefficient as an unbiased tool for the selection of Gini genes for normalising expression profiling data scientific reports. Sci. Rep. 9, 17960 10.1038/s41598-019-54288-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-54288-7</ArticleId><ArticleId IdType="pmc">PMC6884504</ArticleId><ArticleId IdType="pubmed">31784565</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinhardt-Emmer, S., Wittschieber, D., Sanft, J., Kleemann, S., Elschner, S., Haupt, K.F.et al. (2021) Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage. eLife 10, e60361 10.7554/eLife.60361</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.60361</ArticleId><ArticleId IdType="pmc">PMC8009677</ArticleId><ArticleId IdType="pubmed">33781385</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson, C.B., Farzan, M., Chen, B. and Choe, H. (2022) Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3&#x2013;20 10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig, A.M., Khaleeq, A., Ali, U. and Syeda, H. (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 11, 995&#x2013;998 10.1021/acschemneuro.0c00122</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00122</ArticleId><ArticleId IdType="pubmed">32167747</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, X.R., Geng, R., Li, Q., Chen, Y., Li, S.F., Wang, Q.et al. (2022) ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal. Transduct. Target. Ther. 7, 83 10.1038/s41392-022-00919-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00919-x</ArticleId><ArticleId IdType="pmc">PMC8914143</ArticleId><ArticleId IdType="pubmed">35277473</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung, C.C.L., Goh, D., Lim, X., Tien, T.Z., Lim, J.C.T., Lee, J.N.et al. (2022) Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 71, 226&#x2013;229 10.1136/gutjnl-2021-324280</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Palsson, B&#xd8;. (2006) Systems biology: properties of reconstructed networks, Cambridge University Press, Cambridge</Citation></Reference><Reference><Citation>Klipp, E., Herwig, R., Kowald, A., Wierling, C. and Lehrach, H. (2005) Systems biology in practice: concepts, implementation and clinical application, Wiley/VCH, Berlin</Citation></Reference><Reference><Citation>Kell, D.B. and Knowles, J.D. (2006) The role of modeling in systems biology. In System Modeling In Cellular Biology: From Concepts to Nuts And Bolts (Szallasi, Z., Stelling, J. and Periwal, V., eds), pp. 3&#x2013;18, MIT Press, Cambridge</Citation></Reference><Reference><Citation>Alon, U. (2006) An introduction to systems biology: design principles of biological circuits, Chapman and Hall/CRC, London</Citation></Reference><Reference><Citation>Babior, B.M. (2000) Phagocytes and oxidative stress. Am. J. Med. 109, 33&#x2013;44 10.1016/S0002-9343(00)00481-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(00)00481-2</ArticleId><ArticleId IdType="pubmed">10936476</ArticleId></ArticleIdList></Reference><Reference><Citation>Cave, A.C., Brewer, A.C., Narayanapanicker, A., Ray, R., Grieve, D.J., Walker, S.et al. (2006) NADPH oxidases in cardiovascular health and disease. Antioxid. Redox Signal. 8, 691&#x2013;728 10.1089/ars.2006.8.691</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2006.8.691</ArticleId><ArticleId IdType="pubmed">16771662</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedard, K. and Krause, K.H. (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245&#x2013;313 10.1152/physrev.00044.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00044.2005</ArticleId><ArticleId IdType="pubmed">17237347</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, J.M., Terada, L.S., Grosso, M.A., Whitmann, G.J., Velasco, S.E., Patt, A.et al. (1988) Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J. Clin. Invest. 81, 1297&#x2013;1301 10.1172/JCI113448</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI113448</ArticleId><ArticleId IdType="pmc">PMC329662</ArticleId><ArticleId IdType="pubmed">3127425</ArticleId></ArticleIdList></Reference><Reference><Citation>Granger, D.N. (1988) Role of xanthine oxidase and granulocytes in ischemia reperfusion injury. Am. J. Physiol. 255, H1269&#x2013;H1275 10.1152/ajpheart.1988.255.6.H1269</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1988.255.6.H1269</ArticleId><ArticleId IdType="pubmed">3059826</ArticleId></ArticleIdList></Reference><Reference><Citation>Linas, S.L., Whittenburg, D. and Repine, J.E. (1990) Role of xanthine oxidase in ischemia reperfusion injury. Am. J. Physiol. 258, F711&#x2013;F716 10.1152/ajpcell.1990.258.5.C849</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1990.258.5.C849</ArticleId><ArticleId IdType="pubmed">2316673</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson-Gorman, S.L. and Zweier, J.L. (1990) Evaluation of the role of xanthine oxidase in myocardial reperfusion injury. J. Biol. Chem. 265, 6656&#x2013;6663 10.1016/S0021-9258(19)39200-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)39200-2</ArticleId><ArticleId IdType="pubmed">2157706</ArticleId></ArticleIdList></Reference><Reference><Citation>Adkins, W.K. and Taylor, A.E. (1990) Role of xanthine oxidase and neutrophils in ischemia-reperfusion injury in rabbit lung. J. Appl. Physiol. 69, 2012&#x2013;2018 10.1152/jappl.1990.69.6.2012</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1990.69.6.2012</ArticleId><ArticleId IdType="pubmed">2076995</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller, M.J., Vollmar, B., Friedl, H.P. and Menger, M.D. (1996) Xanthine oxidase and superoxide radicals in portal triad crossclamping-induced microvascular reperfusion injury of the liver. Free Rad. Biol. Med. 21, 189&#x2013;197 10.1016/0891-5849(96)00028-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0891-5849(96)00028-7</ArticleId><ArticleId IdType="pubmed">8818634</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridovich, I. (1995) Superoxide radical and superoxide dismutases. Annu. Rev. Biochem. 64, 97&#x2013;112 10.1146/annurev.bi.64.070195.000525</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bi.64.070195.000525</ArticleId><ArticleId IdType="pubmed">7574505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wardman, P. and Candeias, L.P. (1996) Fenton chemistry: an introduction. Rad. Res. 145, 523&#x2013;531 10.2307/3579270</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/3579270</ArticleId><ArticleId IdType="pubmed">8619017</ArticleId></ArticleIdList></Reference><Reference><Citation>Kehrer, J.P. (2000) The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 149, 43&#x2013;50 10.1016/S0300-483X(00)00231-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-483X(00)00231-6</ArticleId><ArticleId IdType="pubmed">10963860</ArticleId></ArticleIdList></Reference><Reference><Citation>Koppenol, W.H. (2001) The Haber-Weiss cycle--70 years later. Redox Rep. 6, 229&#x2013;234 10.1179/135100001101536373</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/135100001101536373</ArticleId><ArticleId IdType="pubmed">11642713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hershko, C. and Weatherall, D.J. (1988) Iron-chelating therapy. Crit. Rev. Clin. Lab. Sci. 26, 303&#x2013;345 10.3109/10408368809105894</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10408368809105894</ArticleId><ArticleId IdType="pubmed">3077034</ArticleId></ArticleIdList></Reference><Reference><Citation>Hininger, I., Waters, R., Osman, M., Garrel, C., Fernholz, K., Roussel, A.M.et al. (2005) Acute prooxidant effects of vitamin C in EDTA chelation therapy and long-term antioxidant benefits of therapy. Free Rad. Biol. Med. 38, 1565&#x2013;1570 10.1016/j.freeradbiomed.2005.02.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.02.016</ArticleId><ArticleId IdType="pubmed">15917185</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, III, E.R., Pastor-Barriuso, R., Dalal, D., Riemersma, R.A., Appel, L.J. and Guallar, E. (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142, 37&#x2013;46 10.7326/0003-4819-142-1-200501040-00110</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-142-1-200501040-00110</ArticleId><ArticleId IdType="pubmed">15537682</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G. and Gluud, C. (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst. Rev. 2008, CD007176 10.1002/14651858.CD007176</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD007176</ArticleId><ArticleId IdType="pubmed">18425980</ArticleId></ArticleIdList></Reference><Reference><Citation>Feierman, D.E. and Cederbaum, A.I. (1983) The effect of EDTA and iron on the oxidation of hydroxyl radical scavenging agents and ethanol by rat liver microsomes. Biochem. Biophys. Res. Commun. 116, 765&#x2013;770 10.1016/0006-291X(83)90590-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(83)90590-9</ArticleId><ArticleId IdType="pubmed">6418168</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf, E., Mahoney, J.R., Bryant, R.G. and Eaton, J.W. (1984) Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site. J. Biol. Chem. 259, 3620&#x2013;3624 10.1016/S0021-9258(17)43139-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(17)43139-5</ArticleId><ArticleId IdType="pubmed">6323433</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida, K., Enomoto, N., Itakura, K. and Kawakishi, S. (1989) The hydroxyl radical generated by an iron(II)/EDTA/ascorbate system preferentially attacks tryptophan residues of the protein. Agr. Biol. Chem. 53, 3285&#x2013;3292 10.1080/00021369.1989.10869852</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00021369.1989.10869852</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller, C.J., Rose, A.L. and Waite, T.D. (2016) Importance of iron complexation for fenton-mediated hydroxyl radical production at circumneutral pH. Front. Mar. Sci. 3, 134 10.3389/fmars.2016.00134</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmars.2016.00134</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, J.K., Carden, D.L., Grisham, M.B., Granger, D.N. and Korthuis, R.J. (1989) Role of iron in postischemic microvascular injury. Am. J. Physiol. 256, H1472&#x2013;H1477 10.1152/ajpheart.1989.256.5.h1472</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1989.256.5.h1472</ArticleId><ArticleId IdType="pubmed">2719141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2014) Serum ferritin is an important disease marker, and is mainly a leakage product from damaged cells. Metallomics 6, 748&#x2013;773 10.1039/C3MT00347G</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C3MT00347G</ArticleId><ArticleId IdType="pubmed">24549403</ArticleId></ArticleIdList></Reference><Reference><Citation>Matin, A., Auger, E.A., Blum, P.H. and Schultz, J.E. (1989) Genetic basis of starvation survival in nondifferentiating bacteria. Annu. Rev. Microbiol. 43, 293&#x2013;316 10.1146/annurev.mi.43.100189.001453</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.43.100189.001453</ArticleId><ArticleId IdType="pubmed">2478072</ArticleId></ArticleIdList></Reference><Reference><Citation>Morita, R.Y. (1988) Bioavailability of energy and its relationship to growth and starvation survival in nature. Can. J. Microbiol. 34, 346&#x2013;441 10.1139/m88-076</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/m88-076</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorsen, B.K., Enger, &#xd8;, Norland, S. and Hoff, K.A. (1992) Long-term starvation survival of Yersinia ruckeri at different salinities studied by microscopical and flow cytometric methods. Appl. Environ. Microbiol. 58, 1624&#x2013;1628 10.1128/aem.58.5.1624-1628.1992</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/aem.58.5.1624-1628.1992</ArticleId><ArticleId IdType="pmc">PMC195649</ArticleId><ArticleId IdType="pubmed">1622232</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergkessel, M. and Delavaine, L. (2021) Diversity in starvation survival strategies and outcomes among heterotrophic proteobacteria. Microb. Physiol. 31, 146&#x2013;162 10.1159/000516215</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516215</ArticleId><ArticleId IdType="pubmed">34058747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaprelyants, A.S., Gottschal, J.C. and Kell, D.B. (1993) Dormancy in non-sporulating bacteria. FEMS Microbiol. Rev. 10, 271&#x2013;286 10.1111/j.1574-6968.1993.tb05871.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6968.1993.tb05871.x</ArticleId><ArticleId IdType="pubmed">8318260</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B., Kaprelyants, A.S., Weichart, D.H., Harwood, C.L. and Barer, M.R. (1998) Viability and activity in readily culturable bacteria: a review and discussion of the practical issues. Antonie Leeuwenhoek 73, 169&#x2013;187 10.1023/A:1000664013047</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1000664013047</ArticleId><ArticleId IdType="pubmed">9717575</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamolova, G.V., Kaprelyants, A.S., Young, D.I., Young, M. and Kell, D.B. (1998) A bacterial cytokine. Proc. Natl Acad. Sci. U.S.A. 95, 8916&#x2013;8921 10.1073/pnas.95.15.8916</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.15.8916</ArticleId><ArticleId IdType="pmc">PMC21177</ArticleId><ArticleId IdType="pubmed">9671779</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukamolova, G.V., Yanopolskaya, N.D., Kell, D.B. and Kaprelyants, A.S. (1998) On resuscitation from the dormant state of Micrococcus luteus. Antonie Leeuwenhoek 73, 237&#x2013;243 10.1023/A:1000881918216</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/A:1000881918216</ArticleId><ArticleId IdType="pubmed">9801768</ArticleId></ArticleIdList></Reference><Reference><Citation>Shleeva, M., Goncharenko, A., Kudykina, Y., Young, D., Young, M. and Kaprelyants, A. (2013) Cyclic AMP-dependent resuscitation of dormant mycobacteria by exogenous free fatty acids. PLoS One 8, e82914 10.1371/journal.pone.0082914</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082914</ArticleId><ArticleId IdType="pmc">PMC3871856</ArticleId><ArticleId IdType="pubmed">24376605</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikitushkin, V.D., Demina, G.R., Shleeva, M.O., Guryanova, S.V., Ruggiero, A., Berisio, R.et al. (2015) A product of RpfB and RipA joint enzymatic action promotes the resuscitation of dormant mycobacteria. FEBS J. 282, 2500&#x2013;2511 10.1111/febs.13292</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13292</ArticleId><ArticleId IdType="pubmed">25846449</ArticleId></ArticleIdList></Reference><Reference><Citation>Houben, R.M.G.J. and Dodd, P.J. (2016) The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLoS Med. 13, e1002152 10.1371/journal.pmed.1002152</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002152</ArticleId><ArticleId IdType="pmc">PMC5079585</ArticleId><ArticleId IdType="pubmed">27780211</ArticleId></ArticleIdList></Reference><Reference><Citation>Knight, G.M., McQuaid, C.F., Dodd, P.J. and Houben, R. (2019) Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Lancet Infect. Dis. 19, 903&#x2013;912 10.1016/S1473-3099(19)30307-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(19)30307-X</ArticleId><ArticleId IdType="pmc">PMC6656782</ArticleId><ArticleId IdType="pubmed">31281059</ArticleId></ArticleIdList></Reference><Reference><Citation>Reshetnyak, V.I. and Reshetnyak, T.M. (2017) Significance of dormant forms of Helicobacter pylori in ulcerogenesis. World J. Gastroenterol. 23, 4867&#x2013;4878 10.3748/wjg.v23.i27.4867</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v23.i27.4867</ArticleId><ArticleId IdType="pmc">PMC5526757</ArticleId><ArticleId IdType="pubmed">28785141</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, J. and Perez-Perez, G.I. (2018) Helicobacter pylori the latent human pathogen or an ancestral commensal organism. Front. Microbiol. 9, 609 10.3389/fmicb.2018.00609</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00609</ArticleId><ArticleId IdType="pmc">PMC5891615</ArticleId><ArticleId IdType="pubmed">29666614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis, K. (2010) Persister cells. Annu. Rev. Microbiol. 64, 357&#x2013;372 10.1146/annurev.micro.112408.134306</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.112408.134306</ArticleId><ArticleId IdType="pubmed">20528688</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Yew, W.W. and Barer, M.R. (2012) Targeting persisters for tuberculosis control. Antimicrob. Agents Chemother. 56, 2223&#x2013;2230 10.1128/AAC.06288-11</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.06288-11</ArticleId><ArticleId IdType="pmc">PMC3346619</ArticleId><ArticleId IdType="pubmed">22391538</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood, T.K., Knabel, S.J. and Kwan, B.W. (2013) Bacterial persister cell formation and dormancy. Appl. Environ. Microbiol. 79, 7116&#x2013;7121 10.1128/AEM.02636-13</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AEM.02636-13</ArticleId><ArticleId IdType="pmc">PMC3837759</ArticleId><ArticleId IdType="pubmed">24038684</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden, D.W. (2015) Persisters unmasked. Science 347, 30&#x2013;32 10.1126/science.1262033</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1262033</ArticleId><ArticleId IdType="pubmed">25554777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B., Potgieter, M. and Pretorius, E. (2015) Individuality, phenotypic differentiation, dormancy and &#x2018;persistence&#x2019; in culturable bacterial systems: commonalities shared by environmental, laboratory, and clinical microbiology. F1000Research 4, 179 10.12688/f1000research.6709.2</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.6709.2</ArticleId><ArticleId IdType="pmc">PMC4642849</ArticleId><ArticleId IdType="pubmed">26629334</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe, S.E., Conlon, B.P., Keren, I. and Lewis, K. (2016) Persisters: methods for isolation and identifying contributing factors--a review. Methods Mol. Biol. 1333, 17&#x2013;28 10.1007/978-1-4939-2854-5_2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-2854-5_2</ArticleId><ArticleId IdType="pubmed">26468096</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher, R.A., Gollan, B. and Helaine, S. (2017) Persistent bacterial infections and persister cells. Nat. Rev. Microbiol. 15, 453&#x2013;464 10.1038/nrmicro.2017.42</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.42</ArticleId><ArticleId IdType="pubmed">28529326</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bergh, B., Fauvart, M. and and Michiels, J. (2017) Formation, physiology, ecology, evolution and clinical importance of bacterial persisters. FEMS Microbiol. Rev. 41, 219&#x2013;251 10.1093/femsre/fux001</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fux001</ArticleId><ArticleId IdType="pubmed">28333307</ArticleId></ArticleIdList></Reference><Reference><Citation>Salcedo-Sora, J.E. and Kell, D.B. (2020) A quantitative survey of bacterial persistence in the presence of antibiotics: towards antipersister antimicrobial discovery. Antibiotics 9, 508 10.3390/antibiotics9080508</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics9080508</ArticleId><ArticleId IdType="pmc">PMC7460088</ArticleId><ArticleId IdType="pubmed">32823501</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, S. and Wood, T.K. (2020) Persister cells resuscitate via ribosome modification by 23S rRNA pseudouridine synthase RluD. Environ. Microbiol. 22, 850&#x2013;857 10.1111/1462-2920.14828</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1462-2920.14828</ArticleId><ArticleId IdType="pubmed">31608580</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamasaki, R., Song, S., Benedik, M.J. and Wood, T.K. (2020) Persister cells resuscitate using membrane sensors that activate chemotaxis, lower cAMP levels, and revive ribosomes. iScience 23, 100792 10.1016/j.isci.2019.100792</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2019.100792</ArticleId><ArticleId IdType="pmc">PMC6957856</ArticleId><ArticleId IdType="pubmed">31926430</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli, G. and Cutler, S. (2016) Evolution of the Koch postulates: towards a 21st-century understanding of microbial infection. Clin Microbiol Infect. 22, 583&#x2013;584 10.1016/j.cmi.2016.03.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2016.03.030</ArticleId><ArticleId IdType="pubmed">27064135</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd, A.L. and Segre, J.A. (2016) Adapting Koch's postulates. Science 351, 224&#x2013;226 10.1126/science.aad6753</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad6753</ArticleId><ArticleId IdType="pubmed">26816362</ArticleId></ArticleIdList></Reference><Reference><Citation>Falkow, S. (1988) Molecular Koch's postulates applied to microbial pathogenicity. Rev. Infect. Dis. 10, S274&#x2013;S276 10.1093/cid/10.Supplement_2.S274</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/10.Supplement_2.S274</ArticleId><ArticleId IdType="pubmed">3055197</ArticleId></ArticleIdList></Reference><Reference><Citation>Falkow, S. (2004) Molecular Koch's postulates applied to bacterial pathogenicity - a personal recollection 15 years later. Nat. Rev. Microbiol. 2, 67&#x2013;72 10.1038/nrmicro799</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro799</ArticleId><ArticleId IdType="pubmed">15035010</ArticleId></ArticleIdList></Reference><Reference><Citation>Fredricks, D.N. and Relman, D.A. (1996) Sequence-based identification of microbial pathogens - a reconsideration of Koch's postulates. Clin. Micr. Rev. 9, 18&#x2013;33 10.1128/CMR.9.1.18</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.9.1.18</ArticleId><ArticleId IdType="pmc">PMC172879</ArticleId><ArticleId IdType="pubmed">8665474</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe, A.M., Yansouni, C.P. and Behr, M.A. (2008) Causality and gastrointestinal infections: Koch, Hill, and Crohn's. Lancet Infect. Dis. 8, 720&#x2013;726 10.1016/S1473-3099(08)70257-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(08)70257-3</ArticleId><ArticleId IdType="pubmed">18992408</ArticleId></ArticleIdList></Reference><Reference><Citation>Miklossy, J. (2011) Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J. Neuroinflammation 8, 90 10.1186/1742-2094-8-90</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-90</ArticleId><ArticleId IdType="pmc">PMC3171359</ArticleId><ArticleId IdType="pubmed">21816039</ArticleId></ArticleIdList></Reference><Reference><Citation>Segre, J.A. (2013) What does it take to satisfy Koch's postulates two centuries later? Microbial genomics and Propionibacteria acnes. J. Investig. Dermatol. 133, 2141&#x2013;2142 10.1038/jid.2013.260</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2013.260</ArticleId><ArticleId IdType="pmc">PMC3775492</ArticleId><ArticleId IdType="pubmed">23842116</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo, D.J., Rifkin, R.F., Cowan, D.A. and Potgieter, M. (2019) The healthy human blood microbiome: fact or fiction? Front. Cell. Infect. Microbiol. 9, 148 10.3389/fcimb.2019.00148</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00148</ArticleId><ArticleId IdType="pmc">PMC6519389</ArticleId><ArticleId IdType="pubmed">31139578</ArticleId></ArticleIdList></Reference><Reference><Citation>Damgaard, C., Magnussen, K., Enevold, C., Nilsson, M., Tolker-Nielsen, T., Holmstrup, P.et al. (2015) Viable bacteria associated with red blood cells and plasma in freshly drawn blood donations. PLoS One 10, e0120826 10.1371/journal.pone.0120826</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0120826</ArticleId><ArticleId IdType="pmc">PMC4353618</ArticleId><ArticleId IdType="pubmed">25751254</ArticleId></ArticleIdList></Reference><Reference><Citation>Damgaard, C., Saekmose, S.G., Nilsson, M., Kilian, M., Nielsen, C.H. and Holmstrup, P. (2021) Periodontitis increases risk of viable bacteria in freshly drawn blood donations. Blood Transfus. 19, 376&#x2013;383 10.2450/2021.0336-20</Citation><ArticleIdList><ArticleId IdType="doi">10.2450/2021.0336-20</ArticleId><ArticleId IdType="pmc">PMC8486607</ArticleId><ArticleId IdType="pubmed">33539285</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowarsky, M., Camunas-Soler, J., Kertesz, M., De Vlaminck, I., Koh, W., Pan, W.et al. (2017) Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA. Proc. Natl Acad. Sci. U.S.A. 114, 9623&#x2013;9628 10.1073/pnas.1707009114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1707009114</ArticleId><ArticleId IdType="pmc">PMC5594678</ArticleId><ArticleId IdType="pubmed">28830999</ArticleId></ArticleIdList></Reference><Reference><Citation>Panaiotov, S., Filevski, G., Equestre, M., Nikolova, E. and Kalfin, R. (2018) Cultural isolation and characteristics of the blood microbiome of healthy individuals. Adv. Microbiol. 8, 406&#x2013;421 10.4236/aim.2018.85027</Citation><ArticleIdList><ArticleId IdType="doi">10.4236/aim.2018.85027</ArticleId></ArticleIdList></Reference><Reference><Citation>Loohuis, O., Mangul, L.M., Ori, S., Jospin, A.P.S., Koslicki, G., Yang, D.et al. (2018) Transcriptome analysis in whole blood reveals increased microbial diversity in schizophrenia. Transl. Psychiatry 8, 96 10.1038/s41398-018-0107-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-018-0107-9</ArticleId><ArticleId IdType="pmc">PMC5943399</ArticleId><ArticleId IdType="pubmed">29743478</ArticleId></ArticleIdList></Reference><Reference><Citation>Potgieter, M., Bester, J., Kell, D.B. and Pretorius, E. (2015) The dormant blood microbiome in chronic, inflammatory diseases. FEMS Microbiol. Rev. 39, 567&#x2013;591 10.1093/femsre/fuv013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/femsre/fuv013</ArticleId><ArticleId IdType="pmc">PMC4487407</ArticleId><ArticleId IdType="pubmed">25940667</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites, G.E. and Gant, V. (2011) Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus? Nat. Rev. Microbiol. 9, 215&#x2013;222 10.1038/nrmicro2508</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro2508</ArticleId><ArticleId IdType="pubmed">21297670</ArticleId></ArticleIdList></Reference><Reference><Citation>Joura, M.I., Brunner, A., Nemes-Nikod&#xe9;m, &#xc9;, S&#xe1;rdy, M. and Ostorh&#xe1;zi, E. (2021) Interactions between immune system and the microbiome of skin, blood and gut in pathogenesis of rosacea. Acta Microbiol. Immunol. Hung. 68, 1&#x2013;6 10.1556/030.2021.01366</Citation><ArticleIdList><ArticleId IdType="doi">10.1556/030.2021.01366</ArticleId><ArticleId IdType="pubmed">33522984</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Aquila, P., Giacconi, R., Malavolta, M., Piacenza, F., Burkle, A., Villanueva, M.M.et al. (2021) Microbiome in blood samples from the general population recruited in the MARK-AGE project: a pilot study. Front. Microbiol. 12, 707515 10.3389/fmicb.2021.707515</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.707515</ArticleId><ArticleId IdType="pmc">PMC8350766</ArticleId><ArticleId IdType="pubmed">34381434</ArticleId></ArticleIdList></Reference><Reference><Citation>Emery, D.C., Cerajewska, T.L., Seong, J., Davies, M., Paterson, A., Allen-Birt, S.J.et al. (2020) Comparison of blood bacterial communities in periodontal health and periodontal disease. Front. Cell. Infect. Microbiol. 10, 577485 10.3389/fcimb.2020.577485</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.577485</ArticleId><ArticleId IdType="pmc">PMC7813997</ArticleId><ArticleId IdType="pubmed">33469518</ArticleId></ArticleIdList></Reference><Reference><Citation>Aagaard, K., Ma, J., Antony, K.M., Ganu, R., Petrosino, J. and Versalovic, J. (2014) The placenta harbors a unique microbiome. Sci. Transl. Med. 6, 237ra265 10.1126/scitranslmed.3008599</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3008599</ArticleId><ArticleId IdType="pmc">PMC4929217</ArticleId><ArticleId IdType="pubmed">24848255</ArticleId></ArticleIdList></Reference><Reference><Citation>Mysorekar, I.U. and Hultgren, S.J. (2006) Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc. Natl Acad. Sci. U.S.A. 103, 14170&#x2013;14175 10.1073/pnas.0602136103</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602136103</ArticleId><ArticleId IdType="pmc">PMC1564066</ArticleId><ArticleId IdType="pubmed">16968784</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen, D.A., Hooton, T.M., Stamm, W.E., Humphrey, P.A. and Hultgren, S.J. (2007) Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med. 4, e329 10.1371/journal.pmed.0040329</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040329</ArticleId><ArticleId IdType="pmc">PMC2140087</ArticleId><ArticleId IdType="pubmed">18092884</ArticleId></ArticleIdList></Reference><Reference><Citation>Casadevall, A. (2008) Evolution of intracellular pathogens. Annu. Rev. Microbiol. 62, 19&#x2013;33 10.1146/annurev.micro.61.080706.093305</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.61.080706.093305</ArticleId><ArticleId IdType="pubmed">18785836</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin, S. and Roy, C.R. (2008) Host cell processes that influence the intracellular survival of Legionella pneumophila. Cell Microbiol. 10, 1209&#x2013;1220 10.1111/j.1462-5822.2008.01145.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2008.01145.x</ArticleId><ArticleId IdType="pubmed">18363881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunstad, D.A. and Justice, S.S. (2010) Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu. Rev. Microbiol. 64, 203&#x2013;221 10.1146/annurev.micro.112408.134258</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.112408.134258</ArticleId><ArticleId IdType="pubmed">20825346</ArticleId></ArticleIdList></Reference><Reference><Citation>Martirosyan, A., Moreno, E. and Gorvel, J.P. (2011) An evolutionary strategy for a stealthy intracellular Brucella pathogen. Immunol. Rev. 240, 211&#x2013;234 10.1111/j.1600-065X.2010.00982.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-065X.2010.00982.x</ArticleId><ArticleId IdType="pubmed">21349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraunholz, M. and Sinha, B. (2012) Intracellular Staphylococcus aureus: live-in and let die. Front. Cell. Infect. Microbiol. 2, 43 10.3389/fcimb.2012.00043</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2012.00043</ArticleId><ArticleId IdType="pmc">PMC3417557</ArticleId><ArticleId IdType="pubmed">22919634</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva, M.T. (2012) Classical labeling of bacterial pathogens according to their lifestyle in the host: inconsistencies and alternatives. Front. Microbiol. 3, 71 10.3389/fmicb.2012.00071</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2012.00071</ArticleId><ArticleId IdType="pmc">PMC3289908</ArticleId><ArticleId IdType="pubmed">22393329</ArticleId></ArticleIdList></Reference><Reference><Citation>Amano, A. and Furuta, N. (2012) Cell entry and exit by periodontal pathogen Porphyromonas gingivalis. J. Oral Biosci. 54, 54&#x2013;57 10.1016/j.job.2011.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.job.2011.03.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozarov, E. (2012) Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol. 8, 123&#x2013;138 10.2217/fca.11.75</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fca.11.75</ArticleId><ArticleId IdType="pmc">PMC3311919</ArticleId><ArticleId IdType="pubmed">22185451</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulliainen, A.T. and Dehio, C. (2012) Persistence of Bartonella spp. stealth pathogens: from subclinical infections to vasoproliferative tumor formation. FEMS Microbiol. Rev. 36, 563&#x2013;599 10.1111/j.1574-6976.2012.00324.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2012.00324.x</ArticleId><ArticleId IdType="pubmed">22229763</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bargen, K., Gorvel, J.P. and Salcedo, S.P. (2012) Internal affairs: investigating the Brucella intracellular lifestyle. FEMS Microbiol. Rev. 36, 533&#x2013;562 10.1111/j.1574-6976.2012.00334.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2012.00334.x</ArticleId><ArticleId IdType="pubmed">22373010</ArticleId></ArticleIdList></Reference><Reference><Citation>Horsley, H., Malone-Lee, J., Holland, D., Tuz, M., Hibbert, A., Kelsey, M.et al. (2013) Enterococcus faecalis subverts and invades the host urothelium in patients with chronic urinary tract infection. PLoS One 8, e83637 10.1371/journal.pone.0083637</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0083637</ArticleId><ArticleId IdType="pmc">PMC3868479</ArticleId><ArticleId IdType="pubmed">24363814</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva, M.T. and Pestana, N.T. (2013) The in vivo extracellular life of facultative intracellular bacterial parasites: role in pathogenesis. Immunobiology 218, 325&#x2013;337 10.1016/j.imbio.2012.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2012.05.011</ArticleId><ArticleId IdType="pubmed">22795971</ArticleId></ArticleIdList></Reference><Reference><Citation>Blango, M.G., Ott, E.M., Erman, A., Veranic, P. and Mulvey, M.A. (2014) Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLos One 9, e93327 10.1371/journal.pone.0093327</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093327</ArticleId><ArticleId IdType="pmc">PMC3965547</ArticleId><ArticleId IdType="pubmed">24667805</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchacher, T., Wiesinger-Mayr, H., Vierlinger, K., Ruger, B.M., Stanek, G., Fischer, M.B.et al. (2014) Human blood monocytes support persistence, but not replication of the intracellular pathogen C. pneumoniae. BMC Immunol. 15, 60 10.1186/s12865-014-0060-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12865-014-0060-1</ArticleId><ArticleId IdType="pmc">PMC4268907</ArticleId><ArticleId IdType="pubmed">25488836</ArticleId></ArticleIdList></Reference><Reference><Citation>Flores-Mireles, A.L., Walker, J.N., Caparon, M. and Hultgren, S.J. (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 13, 269&#x2013;284 10.1038/nrmicro3432</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3432</ArticleId><ArticleId IdType="pmc">PMC4457377</ArticleId><ArticleId IdType="pubmed">25853778</ArticleId></ArticleIdList></Reference><Reference><Citation>Knodler, L.A. (2015) Salmonella enterica: living a double life in epithelial cells. Curr. Opin. Microbiol. 23C, 23&#x2013;31 10.1016/j.mib.2014.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2014.10.010</ArticleId><ArticleId IdType="pubmed">25461569</ArticleId></ArticleIdList></Reference><Reference><Citation>Reniere, M.L., Whiteley, A.T., Hamilton, K.L., John, S.M., Lauer, P., Brennan, R.G.et al. (2015) Glutathione activates virulence gene expression of an intracellular pathogen. Nature 517, 170&#x2013;173 10.1038/nature14029</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14029</ArticleId><ArticleId IdType="pmc">PMC4305340</ArticleId><ArticleId IdType="pubmed">25567281</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribet, D. and Cossart, P. (2015) How bacterial pathogens colonize their hosts and invade deeper tissues. Microbes Infect. 17, 173&#x2013;183 10.1016/j.micinf.2015.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2015.01.004</ArticleId><ArticleId IdType="pubmed">25637951</ArticleId></ArticleIdList></Reference><Reference><Citation>Leatham-Jensen, M.P., Mokszycki, M.E., Rowley, D.C., Deering, R., Camberg, J.L., Sokurenko, E.V.et al. (2016) Uropathogenic Escherichia coli metabolite-dependent quiescence and persistence may explain antibiotic tolerance during urinary tract infection. mSphere 1, e00055-15 10.1128/mSphere.00055-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSphere.00055-15</ArticleId><ArticleId IdType="pmc">PMC4863606</ArticleId><ArticleId IdType="pubmed">27303698</ArticleId></ArticleIdList></Reference><Reference><Citation>Kortebi, M., Milohanic, E., Mitchell, G., P&#xe9;choux, C., Prevost, M.C., Cossart, P.et al. (2017) Listeria monocytogenes switches from dissemination to persistence by adopting a vacuolar lifestyle in epithelial cells. PLoS Pathog. 13, e1006734 10.1371/journal.ppat.1006734</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006734</ArticleId><ArticleId IdType="pmc">PMC5708623</ArticleId><ArticleId IdType="pubmed">29190284</ArticleId></ArticleIdList></Reference><Reference><Citation>McClure, E.E., Chavez, A.S.O., Shaw, D.K., Carlyon, J.A., Ganta, R.R., Noh, S.M.et al. (2017) Engineering of obligate intracellular bacteria: progress, challenges and paradigms. Nat. Rev. Microbiol. 15, 544&#x2013;558 10.1038/nrmicro.2017.59</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2017.59</ArticleId><ArticleId IdType="pmc">PMC5557331</ArticleId><ArticleId IdType="pubmed">28626230</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucciarelli, M.G. and Garc&#xed;a-Del Portillo, F. (2017) Salmonella Intracellular Lifestyles and Their Impact on Host-to-Host Transmission. Microbiol. Spectr. 5, 1&#x2013;18 10.1128/microbiolspec.MTBP-0009-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/microbiolspec.MTBP-0009-2016</ArticleId><ArticleId IdType="pubmed">28730976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, W.J., Shea, A.E., Kim, J.H. and Daaka, Y. (2018) Uropathogenic Escherichia coli invades bladder epithelial cells by activating kinase networks in host cells. J. Biol. Chem. 293, 16518&#x2013;16527 10.1074/jbc.RA118.003499</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003499</ArticleId><ArticleId IdType="pmc">PMC6200948</ArticleId><ArticleId IdType="pubmed">30166343</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal, A. and Marshall, T. (2018) Myalgic encephalomyelitis/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front. Pediatr. 6, 373 10.3389/fped.2018.00373</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00373</ArticleId><ArticleId IdType="pmc">PMC6288442</ArticleId><ArticleId IdType="pubmed">30564562</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrester, J.V., McMenamin, P.G. and Dando, S.J. (2018) CNS infection and immune privilege. Nat. Rev. Neurosci. 19, 655&#x2013;671 10.1038/s41583-018-0070-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-018-0070-8</ArticleId><ArticleId IdType="pubmed">30310148</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal, A.D. and VanElzakker, M.B. (2021) Pathogens hijack host cell metabolism: intracellular infection as a driver of the Warburg effect in cancer and other chronic inflammatory conditions. Immunometabolism 3, e210003 10.20900/immunometab20210003</Citation><ArticleIdList><ArticleId IdType="doi">10.20900/immunometab20210003</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Neal, A.J. and Hanson, M.R. (2021) The enterovirus theory of disease etiology in myalgic encephalomyelitis/chronic fatigue syndrome: a critical review. Front. Med. (Lausanne) 8, 688486 10.3389/fmed.2021.688486</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.688486</ArticleId><ArticleId IdType="pmc">PMC8253308</ArticleId><ArticleId IdType="pubmed">34222292</ArticleId></ArticleIdList></Reference><Reference><Citation>Speck, S.H. and Ganem, D. (2010) Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8, 100&#x2013;115 10.1016/j.chom.2010.06.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.06.014</ArticleId><ArticleId IdType="pmc">PMC2914632</ArticleId><ArticleId IdType="pubmed">20638646</ArticleId></ArticleIdList></Reference><Reference><Citation>Traylen, C.M., Patel, H.R., Fondaw, W., Mahatme, S., Williams, J.F., Walker, L.R.et al. (2011) Virus reactivation: a panoramic view in human infections. Future Virol. 6, 451&#x2013;463 10.2217/fvl.11.21</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl.11.21</ArticleId><ArticleId IdType="pmc">PMC3142679</ArticleId><ArticleId IdType="pubmed">21799704</ArticleId></ArticleIdList></Reference><Reference><Citation>Grinde, B. (2013) Herpesviruses: latency and reactivation - viral strategies and host response. J. Oral Microbiol. 5. 10.3402/jom.v5i0.22766</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jom.v5i0.22766</ArticleId><ArticleId IdType="pmc">PMC3809354</ArticleId><ArticleId IdType="pubmed">24167660</ArticleId></ArticleIdList></Reference><Reference><Citation>Le, P. and Rothberg, M. (2019) Herpes zoster infection. BMJ 364, k5095 10.1136/bmj.k5095</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.k5095</ArticleId><ArticleId IdType="pubmed">30630827</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki, R.F., Lathe, R., Balin, B.J., Ball, M.J., Braak, H., Bearer, E.L.et al. (2016) Microbes and Alzheimer's disease. J. Alzheimers Dis. 51, 979&#x2013;984 10.3233/JAD-160152</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160152</ArticleId><ArticleId IdType="pmc">PMC5457904</ArticleId><ArticleId IdType="pubmed">26967229</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki, R.F. and Lathe, R. (2018) Herpes viruses and senile dementia: first population evidence for a causal link. J. Alzheimers Dis. 64, 363&#x2013;366 10.3233/JAD-180266</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180266</ArticleId><ArticleId IdType="pubmed">29889070</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki, R.F. (2018) Corroboration of a major role for herpes simplex virus type 1 in Alzheimer's disease. Front. Aging Neurosci. 10, 324 10.3389/fnagi.2018.00324</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00324</ArticleId><ArticleId IdType="pmc">PMC6202583</ArticleId><ArticleId IdType="pubmed">30405395</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhaki, R.F., Golde, T.E., Heneka, M.T. and Readhead, B. (2020) Do infections have a role in the pathogenesis of Alzheimer disease? Nat. Rev. Neurol. 16, 193&#x2013;197 10.1038/s41582-020-0323-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0323-9</ArticleId><ArticleId IdType="pubmed">32152461</ArticleId></ArticleIdList></Reference><Reference><Citation>Manicklal, S., Emery, V.C., Lazzarotto, T., Boppana, S.B. and Gupta, R.K. (2013) The "silent" global burden of congenital cytomegalovirus. Clin. Microbiol. Rev. 26, 86&#x2013;102 10.1128/CMR.00062-12</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00062-12</ArticleId><ArticleId IdType="pmc">PMC3553672</ArticleId><ArticleId IdType="pubmed">23297260</ArticleId></ArticleIdList></Reference><Reference><Citation>Diggins, N.L. and Hancock, M.H. (2018) HCMV miRNA targets reveal important cellular pathways for viral replication, latency, and reactivation. Noncoding RNA 4, 29 10.3390/ncrna404002918</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ncrna404002918</ArticleId><ArticleId IdType="pmc">PMC6315856</ArticleId><ArticleId IdType="pubmed">30360396</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason, L.A., Porter, N., Herrington, J., Sorenson, M. and Kubow, S. (2009) Kindling and oxidative stress as contributors to myalgic encephalomyelitis/chronic fatigue syndrome. J. Behav. Neurosci. Res.
7, 1&#x2013;17
https://pubmed.ncbi.nlm.nih.gov/21253446/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3022475</ArticleId><ArticleId IdType="pubmed">21253446</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapenko, S., Krumina, A., Logina, I., Rasa, S., Chistjakovs, M., Sultanova, A.et al. (2012) Association of active human herpesvirus-6, -7 and parvovirus b19 infection with clinical outcomes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Adv. Virol. 2012, 205085 10.1155/2012/205085</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/205085</ArticleId><ArticleId IdType="pmc">PMC3426163</ArticleId><ArticleId IdType="pubmed">22927850</ArticleId></ArticleIdList></Reference><Reference><Citation>Shikova, E., Reshkova, V., Kumanova, &#x410;., Raleva, S., Alexandrova, D., Capo, N.et al. (2020) Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic small ie, cyrillicncephalomyelitis/chronic fatigue syndrome. J. Med. Virol. 92, 3682&#x2013;3688 10.1002/jmv.25744</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25744</ArticleId><ArticleId IdType="pmc">PMC7687071</ArticleId><ArticleId IdType="pubmed">32129496</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman, K.J., Murovska, M., Pheby, D.F.H. and Zalewski, P. (2021) Our evolving understanding of ME/CFS. Medicina (Kaunas) 57, 200 10.3390/medicina57030200</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030200</ArticleId><ArticleId IdType="pmc">PMC7996879</ArticleId><ArticleId IdType="pubmed">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J.S., Lacerda, E.M., Nacul, L., Kingdon, C.C., Norris, J., O'Boyle, S.et al. (2021) Salivary DNA loads for human herpesviruses 6 and 7 are correlated with disease phenotype in myalgic encephalomyelitis/Chronic fatigue syndrome. Front. Med. (Lausanne) 8, 656692 10.3389/fmed.2021.656692</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.656692</ArticleId><ArticleId IdType="pmc">PMC8378328</ArticleId><ArticleId IdType="pubmed">34422848</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos, M., Paiva, B., Montero-Mateo, R., Garcia, N. and Zabaleta, A. (2021) Epstein-Barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front. Immunol. 12, 656797 10.3389/fimmu.2021.656797</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, T., Khanna, K.M., Carriere, B.N. and Hendricks, R.L. (2001) Gamma interferon can prevent herpes simplex virus type 1 reactivation from latency in sensory neurons. J. Virol. 75, 11178&#x2013;11184 10.1128/JVI.75.22.11178-11184.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.22.11178-11184.2001</ArticleId><ArticleId IdType="pmc">PMC114697</ArticleId><ArticleId IdType="pubmed">11602757</ArticleId></ArticleIdList></Reference><Reference><Citation>Katze, M.G., He, Y. and Gale, Jr., M. (2002) Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2, 675&#x2013;687 10.1038/nri888</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri888</ArticleId><ArticleId IdType="pubmed">12209136</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller, O., Kochs, G. and Weber, F. (2006) The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344, 119&#x2013;130 10.1016/j.virol.2005.09.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2005.09.024</ArticleId><ArticleId IdType="pmc">PMC7125643</ArticleId><ArticleId IdType="pubmed">16364743</ArticleId></ArticleIdList></Reference><Reference><Citation>Decman, V., Kinchington, P.R., Harvey, S.A. and Hendricks, R.L. (2005) Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79, 10339&#x2013;10347 10.1128/JVI.79.16.10339-10347.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.16.10339-10347.2005</ArticleId><ArticleId IdType="pmc">PMC1182646</ArticleId><ArticleId IdType="pubmed">16051826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang, S., Brown, H.M. and Hwang, S. (2018) Direct antiviral mechanisms of interferon-gamma. Immune Netw. 18, e33 10.4110/in.2018.18.e33</Citation><ArticleIdList><ArticleId IdType="doi">10.4110/in.2018.18.e33</ArticleId><ArticleId IdType="pmc">PMC6215902</ArticleId><ArticleId IdType="pubmed">30402328</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Sluis, R.M., Zerbato, J.M., Rhodes, J.W., Pascoe, R.D., Solomon, A., Kumar, N.A.et al. (2020) Diverse effects of interferon alpha on the establishment and reversal of HIV latency. PLoS Pathog. 16, e1008151 10.1371/journal.ppat.1008151</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008151</ArticleId><ArticleId IdType="pmc">PMC7065813</ArticleId><ArticleId IdType="pubmed">32109259</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuhenn, J., Meister, T.L., Todt, D., Bracht, T., Schork, K., Billaud, J.N.et al. (2022) Differential interferon-alpha subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection. Proc. Natl Acad. Sci. U.S.A. 119, e2111600119 10.1073/pnas.2111600119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2111600119</ArticleId><ArticleId IdType="pmc">PMC8872780</ArticleId><ArticleId IdType="pubmed">35131898</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber, F. and Haller, O. (2007) Viral suppression of the interferon system. Biochimie 89, 836&#x2013;842 10.1016/j.biochi.2007.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2007.01.005</ArticleId><ArticleId IdType="pmc">PMC7126635</ArticleId><ArticleId IdType="pubmed">17336442</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Sastre, A. (2017) Ten strategies of interferon evasion by viruses. Cell Host Microbe 22, 176&#x2013;184 10.1016/j.chom.2017.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.07.012</ArticleId><ArticleId IdType="pmc">PMC5576560</ArticleId><ArticleId IdType="pubmed">28799903</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas, J.M., Alejo, A., Martin, V. and Sevilla, N. (2021) Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway. Cell. Mol. Life Sci. 78, 1423&#x2013;1444 10.1007/s00018-020-03671-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03671-z</ArticleId><ArticleId IdType="pmc">PMC7576986</ArticleId><ArticleId IdType="pubmed">33084946</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, X., Dong, X., Ma, R., Wang, W., Xiao, X., Tian, Z.et al. (2020) Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 11, 3810 10.1038/s41467-020-17665-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17665-9</ArticleId><ArticleId IdType="pmc">PMC7392898</ArticleId><ArticleId IdType="pubmed">32733001</ArticleId></ArticleIdList></Reference><Reference><Citation>Triantafyllidis, K., Giannos, K., Mian, P., Kyrtsonis, I.T., and Kechagias, G. and S, K. (2021) Varicella zoster virus reactivation following COVID-19 vaccination: a systematic review of case reports. Vaccines (Basel) 9, 1013 10.3390/vaccines9091013</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9091013</ArticleId><ArticleId IdType="pmc">PMC8471236</ArticleId><ArticleId IdType="pubmed">34579250</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado, M.D. and Romero-Aibar, J. (2021) The Pfizer-BNT162b2 mRNA-based vaccine against SARS-CoV-2 may be responsible for awakening the latency of herpes varicella-zoster virus. Brain Behav. Immun. Health 18, 100381 10.1016/j.bbih.2021.100381</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100381</ArticleId><ArticleId IdType="pmc">PMC8556178</ArticleId><ArticleId IdType="pubmed">34746880</ArticleId></ArticleIdList></Reference><Reference><Citation>Psichogiou, M., Samarkos, M., Mikos, N. and Hatzakis, A. (2021) Reactivation of varicella zoster virus after vaccination for SARS-CoV-2. Vaccines (Basel) 9, 572 10.3390/vaccines9060572</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9060572</ArticleId><ArticleId IdType="pmc">PMC8228758</ArticleId><ArticleId IdType="pubmed">34205861</ArticleId></ArticleIdList></Reference><Reference><Citation>Posey, J.E. and Gherardini, F.C. (2000) Lack of a role for iron in the Lyme disease pathogen. Science 288, 1651&#x2013;1653 10.1126/science.288.5471.1651</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.288.5471.1651</ArticleId><ArticleId IdType="pubmed">10834845</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage, A.E. and Drakesmith, H. (2014) The battle for iron. Science 346, 1299&#x2013;1300 10.1126/science.aaa2468</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa2468</ArticleId><ArticleId IdType="pubmed">25504706</ArticleId></ArticleIdList></Reference><Reference><Citation>Carver, P.L. (2018) The battle for iron between humans and microbes. Curr. Med. Chem. 18, 25&#x2013;36 10.2174/0929867324666170720110049</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/0929867324666170720110049</ArticleId><ArticleId IdType="pubmed">28730969</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley, K.P. and Skaar, E.P. (2012) A battle for iron: host sequestration and Staphylococcus aureus acquisition. Microbes Infect. 14, 217&#x2013;227 10.1016/j.micinf.2011.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.11.001</ArticleId><ArticleId IdType="pmc">PMC3785375</ArticleId><ArticleId IdType="pubmed">22123296</ArticleId></ArticleIdList></Reference><Reference><Citation>McDermid, J.M. and Prentice, A.M. (2006) Iron and infection: effects of host iron status and the iron-regulatory genes haptoglobin and NRAMP1 (SLC11A1) on host-pathogen interactions in tuberculosis and HIV. Clin. Sci. (Lond.) 110, 503&#x2013;524 10.1042/CS20050273</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20050273</ArticleId><ArticleId IdType="pubmed">16597321</ArticleId></ArticleIdList></Reference><Reference><Citation>Miethke, M. (2013) Molecular strategies of microbial iron assimilation: from high-affinity complexes to cofactor assembly systems. Metallomics 5, 15&#x2013;28 10.1039/C2MT20193C</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C2MT20193C</ArticleId><ArticleId IdType="pubmed">23192658</ArticleId></ArticleIdList></Reference><Reference><Citation>Segond, D., Abi Khalil, E., Buisson, C., Daou, N., Kallassy, M., Lereclus, D.et al. (2014) Iron acquisition in Bacillus cereus: the roles of IlsA and bacillibactin in exogenous ferritin iron mobilization. PLoS Pathog. 10, e1003935 10.1371/journal.ppat.1003935</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003935</ArticleId><ArticleId IdType="pmc">PMC3923779</ArticleId><ArticleId IdType="pubmed">24550730</ArticleId></ArticleIdList></Reference><Reference><Citation>Nairz, M., Schroll, A., Sonnweber, T. and Weiss, G. (2010) The struggle for iron - a metal at the host-pathogen interface. Cell Microbiol. 12, 1691&#x2013;1702 10.1111/j.1462-5822.2010.01529.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1462-5822.2010.01529.x</ArticleId><ArticleId IdType="pubmed">20964797</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaar, E.P. (2010) The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog. 6, e1000949 10.1371/journal.ppat.1000949</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000949</ArticleId><ArticleId IdType="pmc">PMC2920840</ArticleId><ArticleId IdType="pubmed">20711357</ArticleId></ArticleIdList></Reference><Reference><Citation>Subashchandrabose, S. and Mobley, H.L.T. (2015) Back to the metal age: battle for metals at the host-pathogen interface during urinary tract infection. Metallomics 7, 935&#x2013;942 10.1039/C4MT00329B</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4MT00329B</ArticleId><ArticleId IdType="pmc">PMC4634365</ArticleId><ArticleId IdType="pubmed">25677827</ArticleId></ArticleIdList></Reference><Reference><Citation>Do, J., Zafar, H. and Saier, Jr., M.H. (2017) Comparative genomics of transport proteins in probiotic and pathogenic Escherichia coli and Salmonella enterica strains. Microb. Pathog. 107, 106&#x2013;115 10.1016/j.micpath.2017.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2017.03.022</ArticleId><ArticleId IdType="pmc">PMC5591646</ArticleId><ArticleId IdType="pubmed">28344124</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, F. and Saier, Jr., M.H. (2014) Transport proteins promoting Escherichia coli pathogenesis. Microb. Pathog. 71&#x2013;72, 41&#x2013;55 10.1016/j.micpath.2014.03.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2014.03.008</ArticleId><ArticleId IdType="pmc">PMC4106412</ArticleId><ArticleId IdType="pubmed">24747185</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 577, 825&#x2013;889 10.1007/s00204-010-0577-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-010-0577-x</ArticleId><ArticleId IdType="pmc">PMC2988997</ArticleId><ArticleId IdType="pubmed">20967426</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2015) On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr. Biol. 7, 1339&#x2013;1377 10.1039/C5IB00158G</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5IB00158G</ArticleId><ArticleId IdType="pubmed">26345428</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Page, M.J., Hendricks, L., Nkosi, N.B., Benson, S.R. and Kell, D.B. (2018) Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker&#x2122; stains. J. R. Soc. Interface 15, 20170941 10.1098/rsif.2017.0941</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2017.0941</ArticleId><ArticleId IdType="pmc">PMC5832738</ArticleId><ArticleId IdType="pubmed">29445039</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghiadoni, L., Salvetti, M., Muiesan, M.L. and Taddei, S. (2015) Evaluation of endothelial function by flow mediated dilation: methodological issues and clinical importance. High Blood Press. Cardiovasc. Prev. 22, 17&#x2013;22 10.1007/s40292-014-0047-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40292-014-0047-2</ArticleId><ArticleId IdType="pubmed">24619864</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia, P.Y., Teo, A. and Yeo, T.W. (2020) Overview of the assessment of endothelial function in humans. Front. Med. (Lausanne) 7, 542567 10.3389/fmed.2020.542567</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.542567</ArticleId><ArticleId IdType="pmc">PMC7575777</ArticleId><ArticleId IdType="pubmed">33117828</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirican, A., Ildir, S., Uzar, T., Karaman, I. and Ozkaya, S. (2021) The role of endotheliitis in COVID-19: real-world experience of 11 190 patients and literature review for a pathophysiological map to clinical categorisation. Int. J. Clin. Pract. 75, e14843 10.1111/ijcp.14843</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14843</ArticleId><ArticleId IdType="pmc">PMC8646438</ArticleId><ArticleId IdType="pubmed">34519155</ArticleId></ArticleIdList></Reference><Reference><Citation>Huertas, A., Montani, D., Savale, L., Pichon, J., Tu, L., Parent, F.et al. (2020) Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)? Eur. Respir. J. 56, 2001634 10.1183/13993003.01634-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01634-2020</ArticleId><ArticleId IdType="pmc">PMC7301835</ArticleId><ArticleId IdType="pubmed">32554538</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirschenbaum, D., Imbach, L.L., Rushing, E.J., Frauenknecht, K.B.M., Gascho, D., Ineichen, B.V.et al. (2021) Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19. Neuropathol. Appl. Neurobiol. 47, 454&#x2013;459 10.1111/nan.12677</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12677</ArticleId><ArticleId IdType="pmc">PMC7753688</ArticleId><ArticleId IdType="pubmed">33249605</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei, Y.Y., Zhang, J., Schiavon, C.R., He, M., Chen, L.L., Shen, H.et al. (2021) SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ. Res. 128, 1323&#x2013;1326 10.1161/CIRCRESAHA.121.318902</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio, U., Zinkernagel, A.S., Shambat, S.M., Zeng, X., Cathomas, G., Ruschitzka, F.et al. (2021) SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine 63, 103182 10.1016/j.ebiom.2020.103182</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103182</ArticleId><ArticleId IdType="pmc">PMC7808909</ArticleId><ArticleId IdType="pubmed">33422990</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen, L.A., Geldhof, V., Pasut, A. and Carmeliet, P. (2020) COVID-19: the vasculature unleashed. Nat. Rev. Immunol. 20, 389&#x2013;391 10.1038/s41577-020-0343-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId><ArticleId IdType="pmc">PMC7240244</ArticleId><ArticleId IdType="pubmed">32439870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur, S., Tripathi, D.M. and Yadav, A. (2020) The enigma of endothelium in COVID-19. Front. Physiol. 11, 989 10.3389/fphys.2020.00989</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00989</ArticleId><ArticleId IdType="pmc">PMC7417426</ArticleId><ArticleId IdType="pubmed">32848893</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga, Z., Flammer, A.J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A.S.et al. (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet 395, 1417&#x2013;1418 10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Amersfoort, J., Eelen, G. and Carmeliet, P. (2022) Immunomodulation by endothelial cells &#x2014; partnering up with the immune system? Nat. Rev. Immunol. in press. 10.1038/s41577-022-00694-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00694-4</ArticleId><ArticleId IdType="pmc">PMC8920067</ArticleId><ArticleId IdType="pubmed">35288707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann, M., Verleden, S.E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F.et al. (2020) Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19. N. Engl. J. Med. 383, 120&#x2013;128 10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabretta, E., Moraleda, J.M., Iacobelli, M., Jara, R., Vlodavsky, I., O'Gorman, P.et al. (2021) COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies. Br. J. Haematol. 193, 43&#x2013;51 10.1111/bjh.17240</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17240</ArticleId><ArticleId IdType="pmc">PMC8014053</ArticleId><ArticleId IdType="pubmed">33538335</ArticleId></ArticleIdList></Reference><Reference><Citation>Charfeddine, S., Ibn Hadj Amor, H., Jdidi, J., Torjmen, S., Kraiem, S., Hammami, R.et al. (2021) Long COVID 19 syndrome: is it related to microcirculation and endothelial dysfunction? Insights from TUN-EndCOV study. Front. Cardiovasc. Med. 8, 745758 10.3389/fcvm.2021.745758</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.745758</ArticleId><ArticleId IdType="pmc">PMC8670225</ArticleId><ArticleId IdType="pubmed">34917659</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty, H., Townsend, L., Morrin, H., Ahmad, A., Comerford, C., Karampini, E.et al. (2021) Persistent endotheliopathy in the pathogenesis of long COVID syndrome. J. Thromb. Haemost. 19, 2546&#x2013;2553 10.1111/jth.15490</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15490</ArticleId><ArticleId IdType="pmc">PMC8420256</ArticleId><ArticleId IdType="pubmed">34375505</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua, G., Pine, A.B., Meizlish, M.L., Chang, C.H., Zhang, H., Bahel, P.et al. (2020) Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 7, e575&#x2013;e582 10.1016/S2352-3026(20)30216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Altschul, D.J., Unda, S.R., de La Garza Ramos, R., Zampolin, R., Benton, J., Holland, R.et al. (2020) Hemorrhagic presentations of COVID-19: risk factors for mortality. Clin. Neurol. Neurosurg. 198, 106112 10.1016/j.clineuro.2020.106112</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.106112</ArticleId><ArticleId IdType="pmc">PMC7382923</ArticleId><ArticleId IdType="pubmed">32738585</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba, T., Levy, J.H., Levi, M. and Thachil, J. (2020) Coagulopathy in COVID-19. J. Thromb. Haemost. 18, 2103&#x2013;2109 10.1111/jth.14975</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14975</ArticleId><ArticleId IdType="pmc">PMC7323352</ArticleId><ArticleId IdType="pubmed">32558075</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok, F.A., Kruip, M., van der Meer, N.J.M., Arbous, M.S., Gommers, D., Kant, K.M.et al. (2020) Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb. Res. 191, 148&#x2013;150 10.1016/j.thromres.2020.04.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7192101</ArticleId><ArticleId IdType="pubmed">32381264</ArticleId></ArticleIdList></Reference><Reference><Citation>Malas, M.B., Naazie, I.N., Elsayed, N., Mathlouthi, A., Marmor, R. and Clary, B. (2020) Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: a systematic review and meta-analysis. EClinicalMedicine 29, 100639 10.1016/j.eclinm.2020.100639</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100639</ArticleId><ArticleId IdType="pmc">PMC7679115</ArticleId><ArticleId IdType="pubmed">33251499</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M.et al. (2020) ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J. Thromb. Haemost. 18, 1023&#x2013;1026 10.1111/jth.14810</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14810</ArticleId><ArticleId IdType="pmc">PMC9906133</ArticleId><ArticleId IdType="pubmed">32338827</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Mesa, J.E., Galindo-Coral, S., Montes, M.C. and Mu&#xf1;oz Martin, A.J. (2021) Thrombosis and coagulopathy in COVID-19. Curr. Probl. Cardiol. 46, 100742 10.1016/j.cpcardiol.2020.100742</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100742</ArticleId><ArticleId IdType="pmc">PMC7605852</ArticleId><ArticleId IdType="pubmed">33243440</ArticleId></ArticleIdList></Reference><Reference><Citation>Leentjens, J., van Haaps, T.F., Wessels, P.F., Schutgens, R.E.G. and Middeldorp, S. (2021) COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol. 8, e524&#x2013;e533 10.1016/S2352-3026(21)00105-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(21)00105-8</ArticleId><ArticleId IdType="pmc">PMC8078884</ArticleId><ArticleId IdType="pubmed">33930350</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorini, F.L., Di Matteo, M., Gritti, P., Grazioli, L., Benigni, A., Zacchetti, L.et al. (2021) Coagulopathy and COVID-19. Eur. Heart J. Suppl. 23, E95&#x2013;E98 10.1093/eurheartj/suab100</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab100</ArticleId><ArticleId IdType="pmc">PMC8503535</ArticleId><ArticleId IdType="pubmed">34650364</ArticleId></ArticleIdList></Reference><Reference><Citation>Polimeni, A., Leo, I., Spaccarotella, C., Mongiardo, A., Sorrentino, S., Sabatino, J.et al. (2021) Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients. Sci. Rep. 11, 10464 10.1038/s41598-021-89967-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89967-x</ArticleId><ArticleId IdType="pmc">PMC8128869</ArticleId><ArticleId IdType="pubmed">34001992</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar, M., Madabhavi, I.V., Quy, P.N. and Govindagoudar, M.B. (2021) COVID-19 and coagulopathy. Clin. Respir. J. 15, 1259&#x2013;1274 10.1111/crj.13438</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/crj.13438</ArticleId><ArticleId IdType="pmc">PMC8444678</ArticleId><ArticleId IdType="pubmed">34399021</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, J.L., Levi, M. and Hunt, B.J. (2021) Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia. Lancet Respir. Med. 10, 214&#x2013;220 10.1016/S2213-2600(21)00455-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00455-0</ArticleId><ArticleId IdType="pmc">PMC8616572</ArticleId><ArticleId IdType="pubmed">34838161</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Paz, L., Capodanno, D., Montalescot, G. and Angiolillo, D.J. (2021) Coronavirus disease 2019-associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management. J. Am. Heart Assoc. 10, e019650 10.1161/JAHA.120.019650</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.019650</ArticleId><ArticleId IdType="pmc">PMC7955431</ArticleId><ArticleId IdType="pubmed">33228447</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Z., Gao, X., Miao, H., Ma, X. and Ding, R. (2021) Understanding COVID-19-associated coagulopathy: from PIC to SIC or DIC. J. Intensive Med. 1, 35&#x2013;41 10.1016/j.jointm.2021.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jointm.2021.03.002</ArticleId><ArticleId IdType="pmc">PMC7997848</ArticleId><ArticleId IdType="pubmed">36943814</ArticleId></ArticleIdList></Reference><Reference><Citation>Douillet, D., Riou, J., Penaloza, A., Moumneh, T., Soulie, C., Savary, D.et al. (2021) Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: a comparison of two prospective European cohorts. Thromb. Res. 208, 4&#x2013;10 10.1016/j.thromres.2021.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.10.001</ArticleId><ArticleId IdType="pmc">PMC8498792</ArticleId><ArticleId IdType="pubmed">34653718</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi, M. and Thachil, J. (2020) Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy-either, neither, or both. Semin. Thromb. Hemost. 46, 781&#x2013;784 10.1055/s-0040-1712156</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1712156</ArticleId><ArticleId IdType="pmc">PMC7645819</ArticleId><ArticleId IdType="pubmed">32512589</ArticleId></ArticleIdList></Reference><Reference><Citation>Thachil, J. (2021) Lessons learnt from COVID-19 coagulopathy. EJHaem 2, 577&#x2013;584 10.1002/jha2.228</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jha2.228</ArticleId><ArticleId IdType="pmc">PMC8242569</ArticleId><ArticleId IdType="pubmed">34226900</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter, C., Bezuidenhout, J.A., Laubscher, G.J., Lourens, P.J., Steenkamp, J., Kell, D.B.et al. (2020) Erythrocyte, platelet, serum ferritin and P-selectin pathophysiology implicated in severe hypercoagulation and vascular complications in COVID-19. Int. J. Mol. Sci. 21, 8234 10.3390/ijms21218234</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218234</ArticleId><ArticleId IdType="pmc">PMC7662625</ArticleId><ArticleId IdType="pubmed">33153161</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogarty, H., Townsend, L., Ni Cheallaigh, C., Bergin, C., Martin-Loeches, I., Browne, P.et al. (2020) COVID19 coagulopathy in Caucasian patients. Br. J. Haematol. 189, 1044&#x2013;1049 10.1111/bjh.16749</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16749</ArticleId><ArticleId IdType="pmc">PMC7264579</ArticleId><ArticleId IdType="pubmed">32330308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bray, M.A., Sartain, S.E., Gollamudi, J. and Rumbaut, R.E. (2020) Microvascular thrombosis: experimental and clinical implications. Transl. Res. 225, 105&#x2013;130 10.1016/j.trsl.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7245314</ArticleId><ArticleId IdType="pubmed">32454092</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi, M., Thachil, J., Iba, T. and Levy, J.H. (2020) Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7, e438&#x2013;e440 10.1016/S2352-3026(20)30145-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Willyard, C. (2020) Coronavirus blood-clot mystery intensifies. Nature 581, 250 10.1038/d41586-020-01403-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-01403-8</ArticleId><ArticleId IdType="pubmed">32393875</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Venter, C., Laubscher, G.J., Lourens, P.J., Steenkamp, J. and Kell, D.B. (2020) Prevalence of amyloid blood clots in COVID-19 plasma. medRxiv 2020.2007.2028.20163543v20163541</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Asakura, H. and Ogawa, H. (2021) COVID-19-associated coagulopathy and disseminated intravascular coagulation. Int. J. Hematol. 113, 45&#x2013;57 10.1007/s12185-020-03029-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12185-020-03029-y</ArticleId><ArticleId IdType="pmc">PMC7648664</ArticleId><ArticleId IdType="pubmed">33161508</ArticleId></ArticleIdList></Reference><Reference><Citation>Wygrecka, M., Birnhuber, A., Seeliger, B., Michalick, L., Pak, O., Schultz, A.S.et al. (2021) Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19. Blood Adv. 6, 1074&#x2013;1087 10.1182/bloodadvances.2021004816</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/bloodadvances.2021004816</ArticleId><ArticleId IdType="pmc">PMC8648369</ArticleId><ArticleId IdType="pubmed">34861681</ArticleId></ArticleIdList></Reference><Reference><Citation>Wool, G.D. and Miller, J.L. (2021) The impact of COVID-19 disease on platelets and coagulation. Pathobiology 88, 15&#x2013;27 10.1159/000512007</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000512007</ArticleId><ArticleId IdType="pmc">PMC7649697</ArticleId><ArticleId IdType="pubmed">33049751</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba, T., Levy, J.H., Connors, J.M., Warkentin, T.E., Thachil, J. and Levi, M. (2020) The unique characteristics of COVID-19 coagulopathy. Crit. Care 24, 360 10.1186/s13054-020-03077-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03077-0</ArticleId><ArticleId IdType="pmc">PMC7301352</ArticleId><ArticleId IdType="pubmed">32552865</ArticleId></ArticleIdList></Reference><Reference><Citation>Loo, J., Spittle, D.A. and Newnham, M. (2021) COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 76, 412&#x2013;420 10.1136/thoraxjnl-2020-216243</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216243</ArticleId><ArticleId IdType="pubmed">33408195</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolis, A.S., Manolis, T.A., Manolis, A.A., Papatheou, D. and Melita, H. (2021) COVID-19 Infection: viral macro- and micro-vascular coagulopathy and thromboembolism/prophylactic and therapeutic management. J. Cardiovasc. Pharmacol. Ther. 26, 12&#x2013;24 10.1177/1074248420958973</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1074248420958973</ArticleId><ArticleId IdType="pmc">PMC7492826</ArticleId><ArticleId IdType="pubmed">32924567</ArticleId></ArticleIdList></Reference><Reference><Citation>Poor, H.D. (2021) Pulmonary thrombosis and thromboembolism in COVID-19. Chest 160, 1471&#x2013;1480 10.1016/j.chest.2021.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.06.016</ArticleId><ArticleId IdType="pmc">PMC8213519</ArticleId><ArticleId IdType="pubmed">34153340</ArticleId></ArticleIdList></Reference><Reference><Citation>McGonagle, D., O'Donnell, J.S., Sharif, K., Emery, P. and Bridgewood, C. (2020) Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia. Lancet Rheumatol. 2, e437&#x2013;e445 10.1016/S2665-9913(20)30121-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30121-1</ArticleId><ArticleId IdType="pmc">PMC7252093</ArticleId><ArticleId IdType="pubmed">32835247</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z.et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395, 1054&#x2013;1062 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorog, D.A., Storey, R.F., Gurbel, P.A., Tantry, U.S., Berger, J.S., Chan, M.Y.et al. (2022) Current and novel biomarkers of thrombotic risk in COVID-19: a consensus statement from the international COVID-19 thrombosis biomarkers colloquium. Nat. Rev. Cardiol. 19, 475&#x2013;495 10.1038/s41569-021-00665-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-021-00665-7</ArticleId><ArticleId IdType="pmc">PMC8757397</ArticleId><ArticleId IdType="pubmed">35027697</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann, D., Sperhake, J.P., L&#xfc;tgehetmann, M., Steurer, S., Edler, C., Heinemann, A.et al. (2020) Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study. Ann. Intern. Med. 173, 268&#x2013;277 10.7326/M20-2003</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2003</ArticleId><ArticleId IdType="pmc">PMC7240772</ArticleId><ArticleId IdType="pubmed">32374815</ArticleId></ArticleIdList></Reference><Reference><Citation>Panigada, M., Bottino, N., Tagliabue, P., Grasselli, G., Novembrino, C., Chantarangkul, V.et al. (2020) Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost. 18, 1738&#x2013;1742 10.1111/jth.14850</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14850</ArticleId><ArticleId IdType="pmc">PMC9906150</ArticleId><ArticleId IdType="pubmed">32302438</ArticleId></ArticleIdList></Reference><Reference><Citation>Aktaa, S., Wu, J., Nadarajah, R., Rashid, M., de Belder, M., Deanfield, J.et al. (2021) Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: multi-sourced population-based health records cohort study. Thromb. Res. 202, 17&#x2013;23 10.1016/j.thromres.2021.03.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.03.006</ArticleId><ArticleId IdType="pmc">PMC7938753</ArticleId><ArticleId IdType="pubmed">33711754</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuin, M., Engelen, M.M., Barco, S., Spyropoulos, A.C., Vanassche, T., Hunt, B.J.et al. (2021) Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: a systematic review and meta-analysis. Thromb. Res. 209, 94&#x2013;98 10.1016/j.thromres.2021.11.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2021.11.029</ArticleId><ArticleId IdType="pmc">PMC8648604</ArticleId><ArticleId IdType="pubmed">34896917</ArticleId></ArticleIdList></Reference><Reference><Citation>Kastenhuber, E. R., Mercadante, M., Nilsson-Payant, B., Johnson, J. L., Jaimes, J. A., Muecksch, F.et al. (2022) Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry. eLife 11, e77444 10.7554/eLife.77444</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.77444</ArticleId><ArticleId IdType="pmc">PMC8942469</ArticleId><ArticleId IdType="pubmed">35294338</ArticleId></ArticleIdList></Reference><Reference><Citation>Hess, J.R., Brohi, K., Dutton, R.P., Hauser, C.J., Holcomb, J.B., Kluger, Y.et al. (2008) The coagulopathy of trauma: a review of mechanisms. J. Trauma 65, 748&#x2013;754 10.1097/TA.0b013e3181877a9c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TA.0b013e3181877a9c</ArticleId><ArticleId IdType="pubmed">18849786</ArticleId></ArticleIdList></Reference><Reference><Citation>Curry, N., Stanworth, S., Hopewell, S., Doree, C., Brohi, K. and Hyde, C. (2011) Trauma-induced coagulopathy--a review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice? Transfus. Med. Rev. 25, 217&#x2013;231.e212 10.1016/j.tmrv.2011.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tmrv.2011.01.001</ArticleId><ArticleId IdType="pubmed">21377318</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons, J.W., Pittet, J.F. and Pierce, B. (2014) Trauma-induced coagulopathy. Curr. Anesthesiol. Rep. 4, 189&#x2013;199 10.1007/s40140-014-0063-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40140-014-0063-8</ArticleId><ArticleId IdType="pmc">PMC4288848</ArticleId><ArticleId IdType="pubmed">25587242</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankun, J., Landeta, P., Pretorius, E., Skrzypczak-Jankun, E. and Lipinski, B. (2014) Unusual clotting dynamics of plasma supplemented with iron(III). Int. J. Mol. Med. 33, 367&#x2013;372 10.3892/ijmm.2013.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2013.1585</ArticleId><ArticleId IdType="pubmed">24337469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2015) The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen). Integr. Biol. 7, 24&#x2013;52 10.1039/c4ib00173g</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4ib00173g</ArticleId><ArticleId IdType="pubmed">25335120</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski, B. and Pretorius, E. (2012) Novel pathway of iron-induced blood coagulation: implications for diabetes mellitus and its complications. Pol. Arch. Med. Wewn 122, 115&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pubmed">22460041</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Vermeulen, N., Bester, J., Lipinski, B. and Kell, D.B. (2013) A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy. Toxicol. Mech. Methods 23, 352&#x2013;359 10.3109/15376516.2012.762082</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15376516.2012.762082</ArticleId><ArticleId IdType="pubmed">23278212</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. and Lipinski, B. (2013) Differences in morphology of fibrin clots induced with thrombin and ferric ions and its pathophysiological consequences. Heart Lung Circ. 22, 447&#x2013;449 10.1016/j.hlc.2012.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hlc.2012.10.010</ArticleId><ArticleId IdType="pubmed">23219312</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Bester, J., Vermeulen, N., Lipinski, B., Gericke, G.S. and Kell, D.B. (2014) Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents. PLoS One 9, e85271 10.1371/journal.pone.0085271</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085271</ArticleId><ArticleId IdType="pmc">PMC3887013</ArticleId><ArticleId IdType="pubmed">24416376</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Mbotwe, S., Bester, J., Robinson, C. and Kell, D.B. (2016) Acute induction of anomalous blood clotting by highly substoichiometric levels of bacterial lipopolysaccharide (LPS). bioRxiv version. bioRxiv 2016-053538v053531</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Page, M.J., Mbotwe, S. and Kell, D.B. (2018) Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease. PLoS One 13, e0192121 10.1371/journal.pone.0192121</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192121</ArticleId><ArticleId IdType="pmc">PMC5832207</ArticleId><ArticleId IdType="pubmed">29494603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Bester, J., Page, M.J. and Kell, D.B. (2018) The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia. Front. Aging Neurosci. 10, 257 10.3389/fnagi.2018.00257</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00257</ArticleId><ArticleId IdType="pmc">PMC6113936</ArticleId><ArticleId IdType="pubmed">30186156</ArticleId></ArticleIdList></Reference><Reference><Citation>Conn, D.L., Mcduffie, F.C., Kazmier, F.J., Schroeter, A.L. and Sun, N.C.J. (1976) Coagulation abnormalities in rheumatoid disease. Arthritis Rheum. 19, 1237&#x2013;1243 10.1002/art.1780190602</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780190602</ArticleId><ArticleId IdType="pubmed">999734</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezuidenhout, J., Venter, C., Roberts, T., Tarr, G., Kell, D. and Pretorius, E. (2020) Detection of citrullinated fibrin in plasma clots of RA patients and its relation to altered structural clot properties, disease-related inflammation and prothrombotic tendency. Front. Immunol. 11, 577523 10.3389/fimmu.2020.577523</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.577523</ArticleId><ArticleId IdType="pmc">PMC7793985</ArticleId><ArticleId IdType="pubmed">33424834</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Oberholzer, H.M., van der Spuy, W.J., Swanepoel, A.C. and Soma, P. (2012) Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis. Rheumatol. Int. 32, 1611&#x2013;1615 10.1007/s00296-011-1805-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1805-2</ArticleId><ArticleId IdType="pubmed">21331577</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, P., Liu, J. and Tan, B. (2015) Hypercoagulation in patients with rheumatoid arthritis correlates with activation of Act1/NF-&#x39a;b signaling pathway. J. Rheum. Dis. Treat. 1, 4 10.23937/2469-5726/1510024</Citation><ArticleIdList><ArticleId IdType="doi">10.23937/2469-5726/1510024</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusse, L.M., Rios, D.R.A., Pinheiro, M.B., Cooper, A.J. and Lwaleed, B.A. (2011) Pre-eclampsia: relationship between coagulation, fibrinolysis and inflammation. Clin. Chim. Acta 412, 17&#x2013;21 10.1016/j.cca.2010.09.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2010.09.030</ArticleId><ArticleId IdType="pubmed">20888809</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmon, C.T. (2005) The interactions between inflammation and coagulation. Br. J. Haematol. 131, 417&#x2013;430 10.1111/j.1365-2141.2005.05753.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.2005.05753.x</ArticleId><ArticleId IdType="pubmed">16281932</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennewein, C., Paulus, P. and Zacharowski, K. (2011) Linking inflammation and coagulation: novel drug targets to treat organ ischemia. Curr. Opin. Anaesthesiol. 24, 375&#x2013;380 10.1097/ACO.0b013e3283489ac0</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ACO.0b013e3283489ac0</ArticleId><ArticleId IdType="pubmed">21659867</ArticleId></ArticleIdList></Reference><Reference><Citation>Schouten, M., Wiersinga, W.J., Levi, M. and van der Poll, T. (2008) Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 83, 536&#x2013;545 10.1189/jlb.0607373</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0607373</ArticleId><ArticleId IdType="pubmed">18032692</ArticleId></ArticleIdList></Reference><Reference><Citation>Tantry, U.S., Bliden, K.P., Suarez, T.A., Kreutz, R.P., Dichiara, J. and Gurbel, P.A. (2010) Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: results of the thrombotic risk progression (TRIP) study. Platelets 21, 360&#x2013;367 10.3109/09537100903548903</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537100903548903</ArticleId><ArticleId IdType="pubmed">20377327</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Poll, T., de Boer, J.D. and Levi, M. (2011) The effect of inflammation on coagulation and vice versa. Curr. Opin. Infect. Dis. 24, 273&#x2013;278 10.1097/QCO.0b013e328344c078</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0b013e328344c078</ArticleId><ArticleId IdType="pubmed">21330919</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Poll, T. and Levi, M. (2012) Crosstalk between inflammation and coagulation: the lessons of sepsis. Curr. Vasc. Pharmacol. 10, 632&#x2013;638 10.2174/157016112801784549</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157016112801784549</ArticleId><ArticleId IdType="pubmed">22272914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zia, A., Russell, J., Sarode, R., Veeram, S.R., Josephs, S., Malone, K.et al. (2017) Markers of coagulation activation, inflammation and fibrinolysis as predictors of poor outcomes after pediatric venous thromboembolism: a systematic review and meta-analysis. Thromb. Res. 160, 1&#x2013;8 10.1016/j.thromres.2017.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2017.10.003</ArticleId><ArticleId IdType="pmc">PMC5831248</ArticleId><ArticleId IdType="pubmed">29078111</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro, G. (2020) COVID-19: review on latest available drugs and therapies against SARS-CoV-2. coagulation and inflammation cross-talking. Virus Res. 286, 198070 10.1016/j.virusres.2020.198070</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198070</ArticleId><ArticleId IdType="pmc">PMC7305708</ArticleId><ArticleId IdType="pubmed">32569708</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya, R., Iyer, P., Phua, G.C. and Lee, J.H. (2020) The interplay between coagulation and inflammation pathways in COVID-19-associated respiratory failure: a narrative review. Pulm. Ther. 6, 215&#x2013;231 10.1007/s41030-020-00126-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41030-020-00126-5</ArticleId><ArticleId IdType="pmc">PMC7446744</ArticleId><ArticleId IdType="pubmed">32844302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalewski, M., Fina, D., Slomka, A., Raffa, G.M., Martucci, G., Lo Coco, V.et al. (2020) COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review. Crit. Care 24, 205 10.1186/s13054-020-02925-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02925-3</ArticleId><ArticleId IdType="pmc">PMC7209766</ArticleId><ArticleId IdType="pubmed">32384917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulshof, A.M., Br&#xfc;ggemann, R.A.G., Mulder, M.M.G., van de Berg, T.W., Sels, J.E.M., Olie, R.H.et al. and Dutch COVID-19 thrombosis consortium (DCTC) (2021) Serial EXTEM, FIBTEM, and tPA rotational thromboelastometry observations in the maastricht intensive care COVID cohort-persistence of hypercoagulability and hypofibrinolysis despite anticoagulation. Front. Cardiovasc. Med. 8, 654174 10.3389/fcvm.2021.654174</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.654174</ArticleId><ArticleId IdType="pmc">PMC8107372</ArticleId><ArticleId IdType="pubmed">33981736</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg, D., Berg, L.H., Couvaras, J. and Harrison, H. (1999) Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis. Blood Coagul. Fibrinolysis 10, 435&#x2013;438 10.1097/00001721-199910000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-199910000-00006</ArticleId><ArticleId IdType="pubmed">10695770</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer, J.H. and Berg, D. (2011) Hypercoagulable state associated with active human herpesvirus-6 (HHV-6) viremia in patients with chronic fatigue syndrome. J. Chron. Fatigue Syndr. 8, 111&#x2013;116 10.1300/J092v08n03_10</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v08n03_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes, J.M., Kruger, A., Proal, A., Kell, D.B. and Pretorius, E. (2022) The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Res. Sq. 10.21203/rs.3.rs-1727226/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1727226/v1</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2018) To what extent are the terminal stages of sepsis, septic shock, SIRS, and multiple organ dysfunction syndrome actually driven by a toxic prion/amyloid form of fibrin? Semin. Thromb. Hemost. 44, 224&#x2013;238 10.1055/s-0037-1604108</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0037-1604108</ArticleId><ArticleId IdType="pmc">PMC6193370</ArticleId><ArticleId IdType="pubmed">28778104</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Mbotwe, S., Bester, J., Robinson, C.J. and Kell, D.B. (2016) Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J. R. Soc. Interface 123, 20160539 10.1098/rsif.2016.0539</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2016.0539</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. and Pretorius, E. (2017) Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting. Progr. Biophys. Mol. Biol. 123, 16&#x2013;41 10.1016/j.pbiomolbio.2016.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2016.08.006</ArticleId><ArticleId IdType="pubmed">27554450</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Mbotwe, S. and Kell, D.B. (2017) Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular comorbidities. Sci. Rep. 7, 9680 10.1038/s41598-017-09860-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09860-4</ArticleId><ArticleId IdType="pmc">PMC5574907</ArticleId><ArticleId IdType="pubmed">28851981</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Vlok, M., Venter, C., Bezuidenhout, J.A., Laubscher, G.J., Steenkamp, J.et al. (2021) Persistent clotting protein pathology in Long COVID/ post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. medRxiv 2021.2005.2021.21257578</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause scrapie. Science 216, 136&#x2013;144 10.1126/science.6801762</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6801762</ArticleId><ArticleId IdType="pubmed">6801762</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi, A., Heikenwalder, M. and Polymenidou, M. (2007) Insights into prion strains and neurotoxicity. Nat. Rev. Mol. Cell Biol. 8, 552&#x2013;561 10.1038/nrm2204</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm2204</ArticleId><ArticleId IdType="pubmed">17585315</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi, A. and Calella, A.M. (2009) Prions: protein aggregation and infectious diseases. Physiol. Rev. 89, 1105&#x2013;1152 10.1152/physrev.00006.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00006.2009</ArticleId><ArticleId IdType="pubmed">19789378</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguzzi, A. and Lakkaraju, A.K.K. (2016) Cell biology of prions and prionoids: a status report. Trends Cell Biol. 26, 40&#x2013;51 10.1016/j.tcb.2015.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2015.08.007</ArticleId><ArticleId IdType="pubmed">26455408</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng, X., Munishkina, L.A., Fink, A.L. and Uversky, V.N. (2009) Molecular mechanisms underlying the flavonoid-induced inhibition of alpha-synuclein fibrillation. Biochemistry 48, 8206&#x2013;8224 10.1021/bi900506b</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi900506b</ArticleId><ArticleId IdType="pubmed">19634918</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes-Canteli, M., Paul, J., Norris, E.H., Bronstein, R., Ahn, H.J., Zamolodchikov, D.et al. (2010) Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease. Neuron 66, 695&#x2013;709 10.1016/j.neuron.2010.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.05.014</ArticleId><ArticleId IdType="pmc">PMC2895773</ArticleId><ArticleId IdType="pubmed">20547128</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill, J.M. and Lukiw, W.J. (2015) Microbial-generated amyloids and Alzheimer's disease (AD). Front. Aging Neurosci. 7, 9 10.3389/fnagi.2015.00009</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00009</ArticleId><ArticleId IdType="pmc">PMC4322713</ArticleId><ArticleId IdType="pubmed">25713531</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn, H.J., Chen, Z.L., Zamolodchikov, D., Norris, E.H. and Strickland, S. (2017) Interactions of beta-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease. Curr. Opin. Hematol. 24, 427&#x2013;431 10.1097/MOH.0000000000000368</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000368</ArticleId><ArticleId IdType="pmc">PMC5540762</ArticleId><ArticleId IdType="pubmed">28661939</ArticleId></ArticleIdList></Reference><Reference><Citation>Jana, A.K., Greenwood, A.B. and Hansmann, U.H.E. (2021) Presence of a SARS-CoV-2 protein enhances amyloid formation of serum amyloid A. J. Phys. Chem. B 125, 9155&#x2013;9167 10.1021/acs.jpcb.1c04871</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpcb.1c04871</ArticleId><ArticleId IdType="pmc">PMC8369982</ArticleId><ArticleId IdType="pubmed">34370466</ArticleId></ArticleIdList></Reference><Reference><Citation>Michiels, E., Rousseau, F. and Schymkowitz, J. (2021) Mechanisms and therapeutic potential of interactions between human amyloids and viruses. Cell. Mol. Life Sci. 78, 2485&#x2013;2501 10.1007/s00018-020-03711-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-020-03711-8</ArticleId><ArticleId IdType="pmc">PMC7690653</ArticleId><ArticleId IdType="pubmed">33244624</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m, S. and Hammarstr&#xf6;m, P. (2021) Amyloidogenesis of SARS-CoV-2 spike protein. bioRxiv 2021.2012.2016.472920</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzat, K., Pernemalm, M., Palsson, S., Roberts, T.C., J&#xe4;rver, P., Dondalska, A.et al. (2019) The viral protein corona directs viral pathogenesis and amyloid aggregation. Nat. Commun. 10, 2331 10.1038/s41467-019-10192-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10192-2</ArticleId><ArticleId IdType="pmc">PMC6536551</ArticleId><ArticleId IdType="pubmed">31133680</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard, L. (2021) SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol. Rep. 9, e14726 10.14814/phy2.14726</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14726</ArticleId><ArticleId IdType="pmc">PMC7849453</ArticleId><ArticleId IdType="pubmed">33523608</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanepoel, A.C., Lindeque, B.G., Swart, P.J., Abdool, Z. and Pretorius, E. (2014) Estrogen causes ultrastructural changes of fibrin networks during the menstrual cycle: a qualitative investigation. Microsc. Res. Tech. 77, 594&#x2013;601 10.1002/jemt.22378</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jemt.22378</ArticleId><ArticleId IdType="pubmed">24841871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B., Heyden, E.L. and Pretorius, E. (2020) The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria. Front. Immunol. 11, 1221 10.3389/fimmu.2020.01221</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01221</ArticleId><ArticleId IdType="pmc">PMC7271924</ArticleId><ArticleId IdType="pubmed">32574271</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. and Kell, D.B. (2014) Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases. Integr. Biol. 6, 486&#x2013;510 10.1039/C4IB00025K</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C4IB00025K</ArticleId><ArticleId IdType="pubmed">24714688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski, B. and Pretorius, E. (2013) The role of iron-induced fibrin in the pathogenesis of Alzheimer's disease and the protective role of magnesium. Front. Hum. Neurosci. 7, 735 10.3389/fnhum.2013.00735</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnhum.2013.00735</ArticleId><ArticleId IdType="pmc">PMC3810650</ArticleId><ArticleId IdType="pubmed">24194714</ArticleId></ArticleIdList></Reference><Reference><Citation>Groen, A.K., Wanders, R.J., Westerhoff, H.V., van der Meer, R. and Tager, J.M. (1982) Quantification of the contribution of various steps to the control of mitochondrial respiration. J. Biol. Chem. 257, 2754&#x2013;2757 10.1016/S0021-9258(19)81026-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)81026-8</ArticleId><ArticleId IdType="pubmed">7061448</ArticleId></ArticleIdList></Reference><Reference><Citation>van Beest, P., Wietasch, G., Scheeren, T., Spronk, P. and Kuiper, M. (2011) Clinical review: use of venous oxygen saturations as a goal - a yet unfinished puzzle. Crit. Care 15, 232 10.1186/cc10351</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/cc10351</ArticleId><ArticleId IdType="pmc">PMC3334733</ArticleId><ArticleId IdType="pubmed">22047813</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson, L.D. (1986) Continuous venous oximetry in surgical patients. Ann. Surg. 203, 329&#x2013;333 10.1097/00000658-198603000-00020</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000658-198603000-00020</ArticleId><ArticleId IdType="pmc">PMC1251100</ArticleId><ArticleId IdType="pubmed">3954486</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliynyk, O.V., Rorat, M. and Barg, W. (2021) Oxygen metabolism markers as predictors of mortality in severe COVID-19. Int. J. Infect. Dis. 103, 452&#x2013;456 10.1016/j.ijid.2020.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.12.012</ArticleId><ArticleId IdType="pmc">PMC7833681</ArticleId><ArticleId IdType="pubmed">33310024</ArticleId></ArticleIdList></Reference><Reference><Citation>Elezagic, D., Johannis, W., Burst, V., Klein, F. and Streichert, T. (2021) Venous blood gas analysis in patients with COVID-19 symptoms in the early assessment of virus positivity. J. Lab. Med. 45, 27&#x2013;30 10.1515/labmed-2020-0126</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/labmed-2020-0126</ArticleId></ArticleIdList></Reference><Reference><Citation>Philip, K.E.J., Bennett, B., Fuller, S., Lonergan, B., McFadyen, C., Burns, J.et al. (2020) Working accuracy of pulse oximetry in COVID-19 patients stepping down from intensive care: a clinical evaluation. BMJ Open Respir. Res. 7, e000778 10.1136/bmjresp-2020-000778</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000778</ArticleId><ArticleId IdType="pmc">PMC7759755</ArticleId><ArticleId IdType="pubmed">33361436</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubano, J.A., Maloney, L.M., Simon, J., Rutigliano, D.N., Botwinick, I., Jawa, R.S.et al. (2021) An evolving clinical need: discordant oxygenation measurements of intubated COVID-19 patients. Ann. Biomed. Eng. 49, 959&#x2013;963 10.1007/s10439-020-02722-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10439-020-02722-7</ArticleId><ArticleId IdType="pmc">PMC7815279</ArticleId><ArticleId IdType="pubmed">33469819</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson-Baig, N., McDonnell, T. and Bentley, A. (2021) Discrepancy between Sp O2 and Sa O2 in patients with COVID-19. Anaesthesia 76, 6&#x2013;7 10.1111/anae.15228</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anae.15228</ArticleId><ArticleId IdType="pmc">PMC7436453</ArticleId><ArticleId IdType="pubmed">32738055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari, M. and Quaresima, V. (2020) Hypoxemia in COVID-19: cerebral oximetry should be explored as a warning indicator for mechanically ventilated adults with COVID-19. Respir. Res. 21, 261 10.1186/s12931-020-01530-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01530-w</ArticleId><ArticleId IdType="pmc">PMC7545796</ArticleId><ArticleId IdType="pubmed">33036611</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi, A., Torre, A., Parrulli, S., Zicarelli, F., Schiuma, M., Colombo, V.et al. (2020) Retinal findings in patients with COVID-19: results from the SERPICO-19 study. EClinicalMedicine 27, 100550 10.1016/j.eclinm.2020.100550</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100550</ArticleId><ArticleId IdType="pmc">PMC7502280</ArticleId><ArticleId IdType="pubmed">32984785</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi, A., Schiuma, M., Parrulli, S., Torre, A., Zicarelli, F., Colombo, V.et al. (2021) Retinal vessels modifications in acute and post-COVID-19. Sci. Rep. 11, 19373 10.1038/s41598-021-98873-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-98873-1</ArticleId><ArticleId IdType="pmc">PMC8481283</ArticleId><ArticleId IdType="pubmed">34588541</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi, A. (2022) The impact of COVID-19 on the retina: clinical features and management considerations. Expert. Rev. Ophthalmol. 17, 53&#x2013;60 10.1080/17469899.2022.2021877</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17469899.2022.2021877</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo, K.Y., Invernizzi, A., Staurenghi, G. and Cheung, C.M.G. (2022) COVID-19-related retinal micro-vasculopathy - a review of current evidence. Am. J. Ophthalmol. 235, 98&#x2013;110 10.1016/j.ajo.2021.09.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2021.09.019</ArticleId><ArticleId IdType="pmc">PMC8465265</ArticleId><ArticleId IdType="pubmed">34587494</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ng, X., Betzler, B.K., Testi, I., Ho, S.L., Tien, M., Ngo, W.K.et al. (2021) Ocular adverse events after COVID-19 vaccination. Ocul. Immunol. Inflamm. 29, 1216&#x2013;1224 10.1080/09273948.2021.1976221</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2021.1976221</ArticleId><ArticleId IdType="pmc">PMC8477588</ArticleId><ArticleId IdType="pubmed">34559576</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien, N., Le Guen, M., Russel, S., Touche, P., Huang, F. and Vallee, A. (2021) Clinical characterization of dysautonomia in long COVID-19 patients. Sci. Rep. 11, 14042 10.1038/s41598-021-93546-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Asarcikli, L.D., Hayiroglu, M.I., Osken, A., Keskin, K., Kolak, Z. and Aksu, T. (2022) Heart rate variability and cardiac autonomic functions in post-COVID period. J. Interv. Card. Electrophysiol. 63, 715&#x2013;721 10.1007/s10840-022-01138-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10840-022-01138-8</ArticleId><ArticleId IdType="pmc">PMC8806134</ArticleId><ArticleId IdType="pubmed">35106678</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, B., Kunal, S., Bansal, A., Jain, J., Poundrik, S., Shetty, M.K.et al. (2022) Heart rate variability as a marker of cardiovascular dysautonomia in post-COVID-19 syndrome using artificial intelligence. Indian Pacing Electrophysiol. J. 22, 70&#x2013;76 10.1016/j.ipej.2022.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ipej.2022.01.004</ArticleId><ArticleId IdType="pmc">PMC8800539</ArticleId><ArticleId IdType="pubmed">35101582</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda, K.R., Blakey, E.E., Huang, C.L. and Jeevaratnam, K. (2022) Long COVID-19 and postural orthostatic tachycardia syndrome- is dysautonomia to be blamed? Front. Cardiovasc. Med. 9, 860198 10.3389/fcvm.2022.860198</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.860198</ArticleId><ArticleId IdType="pmc">PMC8959615</ArticleId><ArticleId IdType="pubmed">35355961</ArticleId></ArticleIdList></Reference><Reference><Citation>Varanasi, S., Sathyamoorthy, M., Chamakura, S. and Shah, S.A. (2021) Management of long-COVID postural orthostatic tachycardia syndrome with enhanced external counterpulsation. Cureus 13, e18398 10.7759/cureus.18398</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.18398</ArticleId><ArticleId IdType="pmc">PMC8555928</ArticleId><ArticleId IdType="pubmed">34729276</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaghan, A., Jennings, G., Xue, F., Byrne, L., Duggan, E. and Romero-Ortuno, R. (2022) Orthostatic intolerance in adults reporting long COVID symptoms was not associated with postural orthostatic tachycardia syndrome. Front. Physiol. 13, 833650 10.3389/fphys.2022.833650</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.833650</ArticleId><ArticleId IdType="pmc">PMC8931464</ArticleId><ArticleId IdType="pubmed">35309052</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen, N.W., Stiles, L.E. and Miglis, M.G. (2021) Preparing for the long-haul: autonomic complications of COVID-19. Auton. Neurosci. 235, 102841 10.1016/j.autneu.2021.102841</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102841</ArticleId><ArticleId IdType="pmc">PMC8254396</ArticleId><ArticleId IdType="pubmed">34265539</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay, G.N., Ashar, M.S., Bubien, R.S. and Dailey, S.M. (1995) Relationship between heart rate and oxygen kinetics during constant workload exercise. Pacing Clin. Electrophysiol. 18, 1853&#x2013;1860 10.1111/j.1540-8159.1995.tb03832.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8159.1995.tb03832.x</ArticleId><ArticleId IdType="pubmed">8539152</ArticleId></ArticleIdList></Reference><Reference><Citation>Emblem, K.E., Scheie, D., Due-Tonnessen, P., Nedregaard, B., Nome, T., Hald, J.K.et al. (2008) Histogram analysis of MR imaging-derived cerebral blood volume maps: combined glioma grading and identification of low-grade oligodendroglial subtypes. AJNR Am. J. Neuroradiol. 29, 1664&#x2013;1670 10.3174/ajnr.A1182</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A1182</ArticleId><ArticleId IdType="pmc">PMC8118772</ArticleId><ArticleId IdType="pubmed">18583405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhargava, A., Monteagudo, B., Kushwaha, P., Senarathna, J., Ren, Y., Riddle, R.C.et al. (2022) Vascuviz: a multimodality and multiscale imaging and visualization pipeline for vascular systems biology. Nat. Methods 19, 242&#x2013;254 10.1038/s41592-021-01363-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-021-01363-5</ArticleId><ArticleId IdType="pmc">PMC8842955</ArticleId><ArticleId IdType="pubmed">35145319</ArticleId></ArticleIdList></Reference><Reference><Citation>Epah, J., Palfi, K., Dienst, F.L., Malacarne, P.F., Bremer, R., Salamon, M.et al. (2018) 3D imaging and quantitative analysis of vascular networks: a comparison of ultramicroscopy and micro-computed tomography. Theranostics 8, 2117&#x2013;2133 10.7150/thno.22610</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.22610</ArticleId><ArticleId IdType="pmc">PMC5928875</ArticleId><ArticleId IdType="pubmed">29721067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirst, C., Skriabine, S., Vieites-Prado, A., Topilko, T., Bertin, P., Gerschenfeld, G.et al. (2020) Mapping the fine-scale organization and plasticity of the brain vasculature. Cell 180, 780&#x2013;795.e725 10.1016/j.cell.2020.01.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.01.028</ArticleId><ArticleId IdType="pubmed">32059781</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaigneau, E., Oheim, M., Audinat, E. and Charpak, S. (2003) Two-photon imaging of capillary blood flow in olfactory bulb glomeruli. Proc. Natl Acad. Sci. U.S.A. 100, 13081&#x2013;13086 10.1073/pnas.2133652100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2133652100</ArticleId><ArticleId IdType="pmc">PMC240748</ArticleId><ArticleId IdType="pubmed">14569029</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, A.F., Doyeux, V., Berg, M., Peyrounette, M., Haft-Javaherian, M., Larue, A.E.et al. (2019) Brain capillary networks across species: a few simple organizational requirements are sufficient to reproduce both structure and function. Front. Physiol. 10, 233 10.3389/fphys.2019.00233</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00233</ArticleId><ArticleId IdType="pmc">PMC6444172</ArticleId><ArticleId IdType="pubmed">30971935</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould, I.G., Tsai, P., Kleinfeld, D. and Linninger, A. (2017) The capillary bed offers the largest hemodynamic resistance to the cortical blood supply. J. Cereb. Blood Flow Metab. 37, 52&#x2013;68 10.1177/0271678X16671146</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X16671146</ArticleId><ArticleId IdType="pmc">PMC5363755</ArticleId><ArticleId IdType="pubmed">27780904</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan, C.A., Maxwell, L.C. and Shepherd, A.P. (1986) Estimation of the distribution of blood vessel diameters from the arteriovenous passage of microspheres. Biometrics 42, 371&#x2013;380 10.2307/2531057</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2531057</ArticleId><ArticleId IdType="pubmed">3741975</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller, B., Lang, S., Dominietto, M., Rudin, M., Schulz, G., Deyhle, H.et al. (2008) High-resolution tomographic imaging of microvessels. Proc. SPIE 7078, 70780B 10.1117/12.794157</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/12.794157</ArticleId></ArticleIdList></Reference><Reference><Citation>Razavi, M.S., Shirani, E. and Kassab, G.S. (2018) Scaling laws of flow rate, vessel blood volume, lengths, and transit times with number of capillaries. Front. Physiol. 9, 581 10.3389/fphys.2018.00581</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00581</ArticleId><ArticleId IdType="pmc">PMC5974547</ArticleId><ArticleId IdType="pubmed">29875687</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Silva, M., Dao, M., Han, J., Lim, C.T. and Suresh, S. (2010) Shape and biomechanical characteristics of human red blood cells in health and disease. MRS Bull./Mater. Res. Soc. 35, 382&#x2013;388 10.1557/mrs2010.571</Citation><ArticleIdList><ArticleId IdType="doi">10.1557/mrs2010.571</ArticleId><ArticleId IdType="pmc">PMC2998922</ArticleId><ArticleId IdType="pubmed">21151848</ArticleId></ArticleIdList></Reference><Reference><Citation>Pries, A.R., Neuhaus, D. and Gaehtgens, P. (1992) Blood viscosity in tube flow: dependence on diameter and hematocrit. Am. J. Physiol. 263, H1770&#x2013;H1778 10.1152/ajpheart.1992.263.6.H1770</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.1992.263.6.H1770</ArticleId><ArticleId IdType="pubmed">1481902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelch, I.D., Bogle, G., Sands, G.B., Phillips, A.R.J., LeGrice, I.J. and Dunbar, P.R. (2015) Organ-wide 3D-imaging and topological analysis of the continuous microvascular network in a murine lymph node. Sci. Rep. 5, 16534 10.1038/srep16534</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep16534</ArticleId><ArticleId IdType="pmc">PMC4645097</ArticleId><ArticleId IdType="pubmed">26567707</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L., Yuan, J., Jiang, H., Yan, W., Cintr&#xf3;n-Col&#xf3;n, H.R., Perez, V.L.et al. (2016) Vessel sampling and blood flow velocity distribution with vessel diameter for characterizing the human bulbar conjunctival microvasculature. Eye Contact Lens 42, 135&#x2013;140 10.1097/ICL.0000000000000146</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ICL.0000000000000146</ArticleId><ArticleId IdType="pmc">PMC4591084</ArticleId><ArticleId IdType="pubmed">25839347</ArticleId></ArticleIdList></Reference><Reference><Citation>Downey, G.P., Doherty, D.E., Schwab, III, B., Elson, E.L., Henson, P.M. and Worthen, G.S. (1990) Retention of leukocytes in capillaries: role of cell size and deformability. J. Appl. Physiol. (1985) 69, 1767&#x2013;1778 10.1152/jappl.1990.69.5.1767</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1990.69.5.1767</ArticleId><ArticleId IdType="pubmed">2272970</ArticleId></ArticleIdList></Reference><Reference><Citation>Schimmel, L., Heemskerk, N. and van Buul, J.D. (2017) Leukocyte transendothelial migration: a local affair. Small GTPases 8, 1&#x2013;15 10.1080/21541248.2016.1197872</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21541248.2016.1197872</ArticleId><ArticleId IdType="pmc">PMC5331897</ArticleId><ArticleId IdType="pubmed">27715453</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha, A.K., Schmidt, B.R., Wilhelmy, J., Nguyen, V., Abugherir, A., Do, J.K.et al. (2019) Red blood cell deformability is diminished in patients with chronic fatigue syndrome. Clin. Hemorheol. Microcirc. 71, 113&#x2013;116 10.3233/CH-180469</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-180469</ArticleId><ArticleId IdType="pmc">PMC6398549</ArticleId><ArticleId IdType="pubmed">30594919</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkelmann, J.A., Eid, A., Spicer, G., Almassalha, L.M., Nguyen, T.Q. and Backman, V. (2019) Spectral contrast optical coherence tomography angiography enables single-scan vessel imaging. Light-Sci. Appl. 8, article no. 7 10.1038/s41377-018-0117-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41377-018-0117-7</ArticleId><ArticleId IdType="pmc">PMC6333625</ArticleId><ArticleId IdType="pubmed">30651982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilty, M.P., Guerci, P., Ince, Y., Toraman, F. and Ince, C. (2019) Microtools enables automated quantification of capillary density and red blood cell velocity in handheld vital microscopy. Commun. Biol. 2, 217 10.1038/s42003-019-0473-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0473-8</ArticleId><ArticleId IdType="pmc">PMC6584696</ArticleId><ArticleId IdType="pubmed">31240255</ArticleId></ArticleIdList></Reference><Reference><Citation>Behrens, F., Holle, J., Kuebler, W.M. and Simmons, S. (2020) Extracellular vesicles as regulators of kidney function and disease. Intensive Care Med. Exp. 8, 22 10.1186/s40635-020-00306-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40635-020-00306-2</ArticleId><ArticleId IdType="pmc">PMC7746786</ArticleId><ArticleId IdType="pubmed">33336297</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, J., Sivan, U., Tan, S.L., Lippo, L., De Angelis, J., Labella, R.et al. (2021) High-resolution 3D imaging uncovers organ-specific vascular control of tissue aging. Sci. Adv. 7, eabd7819 10.1126/sciadv.abd7819</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abd7819</ArticleId><ArticleId IdType="pmc">PMC7857692</ArticleId><ArticleId IdType="pubmed">33536212</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdou, M.A.H., Truong, T.T., Dykky, A., Ferreira, P. and Jul, E. (2022) Capillarynet: an automated system to quantify skin capillary density and red blood cell velocity from handheld vital microscopy. Artif. Intell. Med. 127, 102287 10.1016/j.artmed.2022.102287</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.artmed.2022.102287</ArticleId><ArticleId IdType="pubmed">35430045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugo-Hernandez, E., Squire, A., Hagemann, N., Brenzel, A., Sardari, M., Schlechter, J.et al. (2017) 3D visualization and quantification of microvessels in the whole ischemic mouse brain using solvent-based clearing and light sheet microscopy. J. Cereb. Blood Flow Metab. 37, 3355&#x2013;3367 10.1177/0271678X17698970</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X17698970</ArticleId><ArticleId IdType="pmc">PMC5624395</ArticleId><ArticleId IdType="pubmed">28350253</ArticleId></ArticleIdList></Reference><Reference><Citation>Basser, P. (2022) Detection of stroke by portable, low-field MRI: a milestone in medical imaging. Sci. Adv. 8, eabp9307 10.1126/sciadv.abp9307</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abp9307</ArticleId><ArticleId IdType="pmc">PMC11323981</ArticleId><ArticleId IdType="pubmed">35442726</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen, M.M., Prabhat, A.M., Mazurek, M.H., Chavva, I.R., Crawford, A., Cahn, B.A.et al. (2022) Portable, low-field magnetic resonance imaging enables highly accessible and dynamic bedside evaluation of ischemic stroke. Sci. Adv. 8, eabm3952 10.1126/sciadv.abm3952</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abm3952</ArticleId><ArticleId IdType="pmc">PMC9020661</ArticleId><ArticleId IdType="pubmed">35442729</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Venter, C., Laubscher, G.J., Kotze, M.J., Oladejo, S., Watson, L.R.et al. (2022) Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/ post-acute sequelae of COVID-19 (PASC) cardiovasc diabetol 21, 148 10.1186/s12933-022-01579-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins, P.D., Dorronsoro, A. and Booker, C.N. (2016) Regulation of chronic inflammatory and immune processes by extracellular vesicles. J. Clin. Invest. 126, 1173&#x2013;1180 10.1172/JCI81131</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI81131</ArticleId><ArticleId IdType="pmc">PMC4811148</ArticleId><ArticleId IdType="pubmed">27035808</ArticleId></ArticleIdList></Reference><Reference><Citation>Benedikter, B.J., Wouters, E.F.M., Savelkoul, P.H.M., Rohde, G.G.U. and Stassen, F.R.M. (2018) Extracellular vesicles released in response to respiratory exposures: implications for chronic disease. J. Toxicol. Environ. Health B Crit. Rev. 21, 142&#x2013;160 10.1080/10937404.2018.1466380</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10937404.2018.1466380</ArticleId><ArticleId IdType="pubmed">29714636</ArticleId></ArticleIdList></Reference><Reference><Citation>Shetty, A.K. and Upadhya, R. (2021) Extracellular vesicles in health and disease. Aging Dis. 12, 1358&#x2013;1362 10.14336/AD.2021.0827</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.0827</ArticleId><ArticleId IdType="pmc">PMC8407881</ArticleId><ArticleId IdType="pubmed">34527414</ArticleId></ArticleIdList></Reference><Reference><Citation>Trappe, A., Donnelly, S.C., McNally, P. and Coppinger, J.A. (2021) Role of extracellular vesicles in chronic lung disease. Thorax 76, 1047&#x2013;1056 10.1136/thoraxjnl-2020-216370</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216370</ArticleId><ArticleId IdType="pmc">PMC8461402</ArticleId><ArticleId IdType="pubmed">33712504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez, N., James, V., Onion, D. and Fairclough, L.C. (2022) Extracellular vesicles and chronic obstructive pulmonary disease (COPD): a systematic review. Respir. Res. 23, 82 10.1186/s12931-022-01984-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-01984-0</ArticleId><ArticleId IdType="pmc">PMC8985325</ArticleId><ArticleId IdType="pubmed">35382831</ArticleId></ArticleIdList></Reference><Reference><Citation>Withrow, J., Murphy, C., Liu, Y., Hunter, M., Fulzele, S. and Hamrick, M.W. (2016) Extracellular vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis. Arthritis. Res. Ther. 18, 286 10.1186/s13075-016-1178-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-016-1178-8</ArticleId><ArticleId IdType="pmc">PMC5134070</ArticleId><ArticleId IdType="pubmed">27906035</ArticleId></ArticleIdList></Reference><Reference><Citation>Burbano, C., Rojas, M., Mu&#xf1;oz-Vahos, C., Vanegas-Garc&#xed;a, A., Correa, L.A., V&#xe1;squez, G.et al. (2018) Extracellular vesicles are associated with the systemic inflammation of patients with seropositive rheumatoid arthritis. Sci. Rep. 8, 17917 10.1038/s41598-018-36335-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36335-x</ArticleId><ArticleId IdType="pmc">PMC6297132</ArticleId><ArticleId IdType="pubmed">30559453</ArticleId></ArticleIdList></Reference><Reference><Citation>Schioppo, T., Ubiali, T., Ingegnoli, F., Bollati, V. and Caporali, R. (2021) The role of extracellular vesicles in rheumatoid arthritis: a systematic review. Clin. Rheumatol. 40, 3481&#x2013;3497 10.1007/s10067-021-05614-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-021-05614-w</ArticleId><ArticleId IdType="pmc">PMC8357675</ArticleId><ArticleId IdType="pubmed">33544235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, W., Deng, Z., Liu, G., Yang, J., Zhou, W., Zhang, C.et al. (2021) Platelet-derived extracellular vesicles promote the migration and invasion of rheumatoid arthritis fibroblast-like synoviocytes via CXCR2 signaling. Exp. Ther. Med. 22, 1120 10.3892/etm.2021.10554</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2021.10554</ArticleId><ArticleId IdType="pmc">PMC8383774</ArticleId><ArticleId IdType="pubmed">34504574</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi, M., Alamry, S.A., Bahlas, S.M., Uversky, V.N. and Redwan, E.M. (2022) Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis. Cell. Mol. Life Sci. 79, 25 10.1007/s00018-021-04020-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-04020-4</ArticleId><ArticleId IdType="pmc">PMC11072894</ArticleId><ArticleId IdType="pubmed">34971426</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao, H.B., Wang, F., Lin, S. and Chen, Z. (2022) Update on the role of extracellular vesicles in rheumatoid arthritis. Expert. Rev. Mol. Med. 24, e12 10.1017/erm.2021.33</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/erm.2021.33</ArticleId><ArticleId IdType="pmc">PMC9884793</ArticleId><ArticleId IdType="pubmed">35297366</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Cebri&#xe1;n, A., Almenar-P&#xe9;rez, E., Xu, J., Yu, T., Huang, W.E., Gim&#xe9;nez-Orenga, K.et al. (2022) Diagnosis of myalgic encephalomyelitis/chronic fatigue syndrome with partial least squares discriminant analysis: relevance of Blood extracellular vesicles. Front. Med . 9, 842991 10.3389/fmed.2022.842991</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.842991</ArticleId><ArticleId IdType="pmc">PMC9011062</ArticleId><ArticleId IdType="pubmed">35433768</ArticleId></ArticleIdList></Reference><Reference><Citation>Wai Yim, K.H., Borgoni, S. and Chahwan, R. (2022) Serum extracellular vesicles trace COVID-19 progression and immune responses. medRxiv 2022.2001.2019.22269529</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9088353</ArticleId><ArticleId IdType="pubmed">35574251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, B., Tang, N., Peluso, M.J., Iyer, N.S., Torres, L., Donatelli, J.L.et al. (2021) Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations. Cells 10, 386 10.3390/cells10020386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards, R.S., Wang, L. and Jelinek, H. (2007) Erythrocyte oxidative damage in chronic fatigue syndrome. Arch. Med. Res. 38, 94&#x2013;98 10.1016/j.arcmed.2006.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2006.06.008</ArticleId><ArticleId IdType="pubmed">17174731</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, T., Stefanoni, D., Dzieciatkowska, M., Issaian, A., Nemkov, T., Hill, R.C.et al. (2020) Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. J. Proteome Res. 19, 4455&#x2013;4469 10.1021/acs.jproteome.0c00606</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00606</ArticleId><ArticleId IdType="pmc">PMC7640979</ArticleId><ArticleId IdType="pubmed">33103907</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson, L.O. (1989) Nondiscocytic erythrocytes in myalgic encephalomyelitis. N. .Z Med. J. 102, 126&#x2013;127</Citation><ArticleIdList><ArticleId IdType="pubmed">2927808</ArticleId></ArticleIdList></Reference><Reference><Citation>Baklund, I.H., Dammen, T., Moum, T&#xc5;, Kristiansen, W., Duarte, D.S., Castro-Marrero, J.et al. (2021) Evaluating routine blood tests according to clinical symptoms and diagnostic criteria in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. J. Clin. Med 10, 3105 10.3390/jcm10143105</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10143105</ArticleId><ArticleId IdType="pmc">PMC8307418</ArticleId><ArticleId IdType="pubmed">34300271</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon, C.J., Hopkins, S., Vail, A., King, A.T., Smith, D., Illingworth, K.J.et al. (2013) Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J. Neurointerv. Surg. 5, 512&#x2013;517 10.1136/neurintsurg-2012-010386</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/neurintsurg-2012-010386</ArticleId><ArticleId IdType="pmc">PMC3812893</ArticleId><ArticleId IdType="pubmed">22952245</ArticleId></ArticleIdList></Reference><Reference><Citation>Broadbent, S. and Coutts, R. (2015) Irregularities in red cell distribution width and lymphocyte concentration in individuals with chronic fatigue syndrome. Int. J. Health Sci. 3, 71&#x2013;78 10.15640/ijhs.v3n4a7</Citation><ArticleIdList><ArticleId IdType="doi">10.15640/ijhs.v3n4a7</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasini, E., Corsetti, G., Romano, C., Scarabelli, T.M., Chen-Scarabelli, C., Saravolatz, L.et al. (2021) Serum metabolic profile in patients with long-COVID (PASC) syndrome: clinical implications. Front. Med. 8, 714426 10.3389/fmed.2021.714426</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.714426</ArticleId><ArticleId IdType="pmc">PMC8339407</ArticleId><ArticleId IdType="pubmed">34368201</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinellu, A. and Mangoni, A.A. (2021) Red blood cell distribution width, disease severity, and mortality in hospitalized patients with SARS-CoV-2 infection: a systematic review and meta-analysis. J. Clin. Med. 10, 286 10.3390/jcm10020286</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10020286</ArticleId><ArticleId IdType="pmc">PMC7830717</ArticleId><ArticleId IdType="pubmed">33466770</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo, A., Tellone, E., Barreca, D., Ficarra, S. and Lagana, G. (2022) Implication of COVID-19 on erythrocytes functionality: red blood cell biochemical implications and morpho-Functional aspects. Int. J. Mol. Sci. 23, 2171 10.3390/ijms23042171</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042171</ArticleId><ArticleId IdType="pmc">PMC8878454</ArticleId><ArticleId IdType="pubmed">35216286</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Z.H., Fu, B.Q., Lin, Y.W., Wei, X.B., Geng, H., Guo, W.X.et al. (2022) Red blood cell distribution width: a severity indicator in patients with COVID-19. J. Med. Virol. 94, 2133&#x2013;2138 10.1002/jmv.27602</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27602</ArticleId><ArticleId IdType="pmc">PMC9015531</ArticleId><ArticleId IdType="pubmed">35048392</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampitsakos, T., Akinosoglou, K., Papaioannou, O., Panou, V., Koromilias, A., Bakakos, P.et al. (2020) Increased Red cell distribution width Is associated with disease severity in hospitalized adults with SARS-CoV-2 infection: an observational multicentric study. Front. Med. (Lausanne) 7, 616292 10.3389/fmed.2020.616292</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.616292</ArticleId><ArticleId IdType="pmc">PMC7759673</ArticleId><ArticleId IdType="pubmed">33363191</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan&#xed;-Guerra, E., Torres-Murillo, B., Mu&#xf1;oz-Corona, C., Rodr&#xed;guez-Jim&#xe9;nez, J.C., Macias, A.E., Scavo-Montes, D.A.et al. (2022) Diagnostic accuracy of the RDW for predicting death in COVID-19. Medicina (Kaunas) 58, 613 10.3390/medicina58050613</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58050613</ArticleId><ArticleId IdType="pmc">PMC9144906</ArticleId><ArticleId IdType="pubmed">35630030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam, L.K.M., Reilly, J.P., Rux, A.H., Murphy, S.J., Kuri-Cervantes, L., Weisman, A.R.et al. (2021) Erythrocytes identify complement activation in patients with COVID-19. Am. J. Physiol. Lung Cell. Mol. Physiol. 321, L485&#x2013;L489 10.1152/ajplung.00231.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00231.2021</ArticleId><ArticleId IdType="pmc">PMC8384475</ArticleId><ArticleId IdType="pubmed">34231390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisserli, A., Schneider, N., Audonnet, S., Tabary, T., Goury, A., Cousson, J.et al. (2021) Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients. Immunobiology 226, 152093 10.1016/j.imbio.2021.152093</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2021.152093</ArticleId><ArticleId IdType="pmc">PMC8106962</ArticleId><ArticleId IdType="pubmed">34022670</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, F., Abed, M., Lang, E. and F&#xf6;ller, M. (2014) Oxidative stress and suicidal erythrocyte death. Antioxid. Redox Signal. 21, 138&#x2013;153 10.1089/ars.2013.5747</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5747</ArticleId><ArticleId IdType="pubmed">24359125</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., du Plooy, J.N. and Bester, J. (2016) A comprehensive review on eryptosis. Cell. Physiol. Biochem. 39, 1977&#x2013;2000 10.1159/000447895</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000447895</ArticleId><ArticleId IdType="pubmed">27771701</ArticleId></ArticleIdList></Reference><Reference><Citation>Qadri, S.M., Bissinger, R., Solh, Z. and Oldenborg, P.A. (2017) Eryptosis in health and disease: a paradigm shift towards understanding the (patho)physiological implications of programmed cell death of erythrocytes. Blood Rev. 31, 349&#x2013;361 10.1016/j.blre.2017.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2017.06.001</ArticleId><ArticleId IdType="pubmed">28669393</ArticleId></ArticleIdList></Reference><Reference><Citation>Repsold, L. and Joubert, A.M. (2018) Eryptosis: an erythrocyte's suicidal type of cell death. Biomed. Res. Int. 2018, 9405617 10.1155/2018/9405617</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/9405617</ArticleId><ArticleId IdType="pmc">PMC5817309</ArticleId><ArticleId IdType="pubmed">29516014</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun, J.F., Varlet-Marie, E., Myzia, J., de Mauverger, E.R. and Pretorius, E. (2022) Metabolic influences modulating erythrocyte deformability and eryptosis. Metabolites 12, 4 10.3390/metabo12010004</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12010004</ArticleId><ArticleId IdType="pmc">PMC8778269</ArticleId><ArticleId IdType="pubmed">35050126</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzoubi, K., Egler, J., Abed, M. and Lang, F. (2015) Enhanced eryptosis following auranofin exposure. Cell. Physiol. Biochem. 37, 1018&#x2013;1028 10.1159/000430228</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000430228</ArticleId><ArticleId IdType="pubmed">26397807</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, F., Lang, E. and Foller, M. (2012) Physiology and pathophysiology of eryptosis. Transfus. Med. Hemother. 39, 308&#x2013;314 10.1159/000342534</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000342534</ArticleId><ArticleId IdType="pmc">PMC3678267</ArticleId><ArticleId IdType="pubmed">23801921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, E. and Lang, F. (2015) Mechanisms and pathophysiological significance of eryptosis, the suicidal erythrocyte death. Semin. Cell Dev. Biol. 39, 35&#x2013;42 10.1016/j.semcdb.2015.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2015.01.009</ArticleId><ArticleId IdType="pubmed">25636585</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang, E., Qadri, S.M. and Lang, F. (2012) Killing me softly - suicidal erythrocyte death. Int. J. Biochem. Cell Biol. 44, 1236&#x2013;1243 10.1016/j.biocel.2012.04.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2012.04.019</ArticleId><ArticleId IdType="pubmed">22561748</ArticleId></ArticleIdList></Reference><Reference><Citation>Mameli, A., Barcellona, D. and Marongiu, F. (2009) Rheumatoid arthritis and thrombosis. Clin. Exp. Rheumatol. 27, 846&#x2013;855</Citation><ArticleIdList><ArticleId IdType="pubmed">19917173</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmqvist, M.E., Neovius, M., Eriksson, J., Mantel, &#xc4;, W&#xe5;llberg-Jonsson, S., Jacobsson, L.T.H.et al. (2012) Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. J. Am. Med. Assoc. 308, 1350&#x2013;1356 10.1001/2012.jama.11741</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/2012.jama.11741</ArticleId><ArticleId IdType="pubmed">23032551</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi, H.K., Rho, Y.H., Zhu, Y., Cea-Soriano, L., Avina-Zubieta, J.A. and Zhang, Y. (2013) The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann. Rheum. Dis. 72, 1182&#x2013;1187 10.1136/annrheumdis-2012-201669</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-201669</ArticleId><ArticleId IdType="pubmed">22930596</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, S.C., Schneeweiss, S., Liu, J. and Solomon, D.H. (2013) Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res. (Hoboken) 65, 1600&#x2013;1607 10.1002/acr.22039</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22039</ArticleId><ArticleId IdType="pmc">PMC4090802</ArticleId><ArticleId IdType="pubmed">23666917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung, W.S., Peng, C.L., Lin, C.L., Chang, Y.J., Chen, Y.F., Chiang, J.Y.et al. (2014) Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann. Rheum. Dis. 73, 1774&#x2013;1780 10.1136/annrheumdis-2013-203380</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203380</ArticleId><ArticleId IdType="pubmed">23926057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ungprasert, P., Srivali, N., Spanuchart, I., Thongprayoon, C. and Knight, E.L. (2014) Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin. Rheumatol. 33, 297&#x2013;304 10.1007/s10067-014-2492-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-014-2492-7</ArticleId><ArticleId IdType="pubmed">24424839</ArticleId></ArticleIdList></Reference><Reference><Citation>Ketfi, C., Boutigny, A., Mohamedi, N., Bouajil, S., Magnan, B., Amah, G.et al. (2021) Risk of venous thromboembolism in rheumatoid arthritis. Joint Bone Spine 88, 105122 10.1016/j.jbspin.2020.105122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2020.105122</ArticleId><ArticleId IdType="pubmed">33346109</ArticleId></ArticleIdList></Reference><Reference><Citation>Molander, V., Bower, H., Frisell, T. and Askling, J. (2021) Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden. Ann. Rheum. Dis. 80, 169&#x2013;175 10.1136/annrheumdis-2020-218419</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218419</ArticleId><ArticleId IdType="pubmed">33032998</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui, S., Chen, S., Li, X., Liu, S. and Wang, F. (2020) Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J. Thromb. Haemost. 18, 1421&#x2013;1424 10.1111/jth.14830</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14830</ArticleId><ArticleId IdType="pmc">PMC7262324</ArticleId><ArticleId IdType="pubmed">32271988</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman, I.A., Ye, K. and Scheinfeld, M.H. (2020) Lower-extremity arterial thrombosis associated with COVID-19 is characterized by greater thrombus burden and increased rate of amputation and death. Radiology 297, E263&#x2013;E269 10.1148/radiol.2020202348</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202348</ArticleId><ArticleId IdType="pmc">PMC7370378</ArticleId><ArticleId IdType="pubmed">32673190</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakr, Y., Giovini, M., Leone, M., Pizzilli, G., Kortgen, A., Bauer, M.et al. (2020) Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: a narrative review. Ann. Intensive Care 10, 124 10.1186/s13613-020-00741-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00741-0</ArticleId><ArticleId IdType="pmc">PMC7492788</ArticleId><ArticleId IdType="pubmed">32953201</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez, C.A., Sun, C.K., Tsai, I.T., Chang, Y.P., Lin, M.C., Hung, I.Y.et al. (2021) Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis. Sci. Rep. 11, 16025 10.1038/s41598-021-95512-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95512-7</ArticleId><ArticleId IdType="pmc">PMC8346591</ArticleId><ArticleId IdType="pubmed">34362946</ArticleId></ArticleIdList></Reference><Reference><Citation>Hesam-Shariati, S., Fatehi, P., Abouzaripour, M., Fathi, F., Hesam-Shariati, N. and Hesam Shariati, M.B. (2021) Increased pulmonary embolism in patients with COVID-19: a case series and literature review. Trop. Dis. Travel. Med. Vaccines 7, 16 10.1186/s40794-021-00145-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40794-021-00145-3</ArticleId><ArticleId IdType="pmc">PMC8196288</ArticleId><ArticleId IdType="pubmed">34118995</ArticleId></ArticleIdList></Reference><Reference><Citation>Husser, D., Hohenstein, S., Pellissier, V., Ueberham, L., Konig, S., Hindricks, G.et al. (2021) Potential contributors to increased pulmonary embolism hospitalizations during the COVID-19 pandemic: insights from the German-wide Helios Hospital Network. Front. Cardiovasc. Med. 8, 715761 10.3389/fcvm.2021.715761</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.715761</ArticleId><ArticleId IdType="pmc">PMC8387932</ArticleId><ArticleId IdType="pubmed">34458341</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevnikar, M., Sanchez, O., Chocron, R., Andronikof, M., Raphael, M., Meyrignac, O.et al. (2021) Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission. Eur. Respir. J. 58, 2100116 10.1183/13993003.00116-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00116-2021</ArticleId><ArticleId IdType="pmc">PMC7947356</ArticleId><ArticleId IdType="pubmed">33692122</ArticleId></ArticleIdList></Reference><Reference><Citation>Mir&#xf3;, &#xd3;, Jim&#xe9;nez, S., Mebazaa, A., Freund, Y., Burillo-Putze, G., Martin, A.et al. (2021) Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur. Heart J. 42, 3127&#x2013;3142 10.1093/eurheartj/ehab314</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab314</ArticleId><ArticleId IdType="pmc">PMC8344714</ArticleId><ArticleId IdType="pubmed">34164664</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba, S., Hosoya, T., Amamiya, M., Mitsumura, T., Kawata, D., Sasaki, H.et al. (2021) Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan. Front. Cardiovasc. Med. 8, 767074 10.3389/fcvm.2021.767074</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.767074</ArticleId><ArticleId IdType="pmc">PMC8639692</ArticleId><ArticleId IdType="pubmed">34869681</ArticleId></ArticleIdList></Reference><Reference><Citation>Parekh, Y.H., Altomare, N.J., McDonnell, E.P., Blaser, M.J. and Parikh, P.D. (2021) Recurrence of upper extremity deep vein thrombosis secondary to COVID-19. Viruses 13, 878 10.3390/v13050878</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13050878</ArticleId><ArticleId IdType="pmc">PMC8151248</ArticleId><ArticleId IdType="pubmed">34064763</ArticleId></ArticleIdList></Reference><Reference><Citation>Porfidia, A., Mosoni, C., Talerico, R., Porceddu, E., Lupascu, A., Tondi, P.et al. (2021) Pulmonary embolism in COVID-19 patients: which diagnostic algorithm should we use? Front. Cardiovasc. Med. 8, 714003 10.3389/fcvm.2021.714003</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.714003</ArticleId><ArticleId IdType="pmc">PMC8414135</ArticleId><ArticleId IdType="pubmed">34485411</ArticleId></ArticleIdList></Reference><Reference><Citation>Riyahi, S., Dev, H., Behzadi, A., Kim, J., Attari, H., Raza, S.I.et al. (2021) Pulmonary embolism in hospitalized patients with COVID-19: a multicenter study. Radiology 301, E426&#x2013;E433 10.1148/radiol.2021210777</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210777</ArticleId><ArticleId IdType="pmc">PMC8294351</ArticleId><ArticleId IdType="pubmed">34254850</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund, L.C., Hallas, J., Nielsen, H., Koch, A., Mogensen, S.H., Brun, N.C.et al. (2021) Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect. Dis. 21, 1373&#x2013;1382 10.1016/S1473-3099(21)00211-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, Z., Yang, M. and Lai, C.L. (2021) Long COVID-19 syndrome: a comprehensive review of its effect on various organ systems and recommendation on rehabilitation plans. Biomedicines 9, 966 10.3390/biomedicines9080966</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9080966</ArticleId><ArticleId IdType="pmc">PMC8394513</ArticleId><ArticleId IdType="pubmed">34440170</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponomaryov, T., Payne, H., Fabritz, L., Wagner, D.D. and Brill, A. (2017) Mast cells granular contents are crucial for deep vein thrombosis in mice. Circ. Res. 121, 941&#x2013;950 10.1161/CIRCRESAHA.117.311185</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.117.311185</ArticleId><ArticleId IdType="pmc">PMC5623089</ArticleId><ArticleId IdType="pubmed">28739590</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi, M. and van der Poll, T. (2017) Coagulation and sepsis. Thromb. Res. 149, 38&#x2013;44 10.1016/j.thromres.2016.11.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2016.11.007</ArticleId><ArticleId IdType="pubmed">27886531</ArticleId></ArticleIdList></Reference><Reference><Citation>Connors, J.M. and Levy, J.H. (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135, 2033&#x2013;2040 10.1182/blood.2020006000</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006000</ArticleId><ArticleId IdType="pmc">PMC7273827</ArticleId><ArticleId IdType="pubmed">32339221</ArticleId></ArticleIdList></Reference><Reference><Citation>Whyte, C.S., Morrow, G.B., Mitchell, J.L., Chowdary, P. and Mutch, N.J. (2020) Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19. J. Thromb. Haemost. 18, 1548&#x2013;1555 10.1111/jth.14872</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14872</ArticleId><ArticleId IdType="pmc">PMC7264738</ArticleId><ArticleId IdType="pubmed">32329246</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Slikke, E.C., An, A.Y., Hancock, R.E.W. and Bouma, H.R. (2020) Exploring the pathophysiology of post-sepsis syndrome to identify therapeutic opportunities. EBioMedicine 61, 103044 10.1016/j.ebiom.2020.103044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103044</ArticleId><ArticleId IdType="pmc">PMC7544455</ArticleId><ArticleId IdType="pubmed">33039713</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostel, Z., Perl, A., Marck, M., Mehdi, S.F., Lowell, B., Bathija, S.et al. (2019) Post-sepsis syndrome - an evolving entity that afflicts survivors of sepsis. Mol. Med. 26, 6 10.1186/s10020-019-0132-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10020-019-0132-z</ArticleId><ArticleId IdType="pmc">PMC6938630</ArticleId><ArticleId IdType="pubmed">31892321</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, C.Y., Daniels, R., Lembo, A., Hartog, C., O'Brien, J., Heymann, T.et al. (2019) Life after sepsis: an international survey of survivors to understand the post-sepsis syndrome. Int. J. Qual. Health Care 31, 191&#x2013;198 10.1093/intqhc/mzy137</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intqhc/mzy137</ArticleId><ArticleId IdType="pubmed">29924325</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, X., Wu, Y., Lv, X., Liu, Y., Du, G., Li, J.et al. (2022) Combining CRISPR-Cpf1 and recombineering facilitates fast and efficient genome editing in Escherichia coli. ACS Synth. Biol. 11, 1897&#x2013;1907 10.1021/acssynbio.2c00041</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acssynbio.2c00041</ArticleId><ArticleId IdType="pubmed">35471009</ArticleId></ArticleIdList></Reference><Reference><Citation>Shovman, O., Tiosano, S., Comaneshter, D., Cohen, A.D., Amital, H. and Sherf, M. (2016) Aortic aneurysm associated with rheumatoid arthritis: a population-based cross-sectional study. Clin. Rheumatol. 35, 2657&#x2013;2661 10.1007/s10067-016-3372-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-016-3372-0</ArticleId><ArticleId IdType="pubmed">27502778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiani, B., Fowler, J.B., Figueras, R.A., Hessamian, K., Mercado, N., Vukcevich, O.et al. (2021) Ruptured cerebral aneurysms in COVID-19 patients: a review of literature with case examples. Surg. Neurol. Int. 12, 187 10.25259/SNI_214_2021</Citation><ArticleIdList><ArticleId IdType="doi">10.25259/SNI_214_2021</ArticleId><ArticleId IdType="pmc">PMC8168707</ArticleId><ArticleId IdType="pubmed">34084615</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson, K.L., Jain, A., Evans, J. and Uzun, O. (2021) Giant coronary artery aneurysm as a feature of coronavirus-related inflammatory syndrome. BMJ Case Rep. 14, e238740 10.1136/bcr-2020-238740</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-238740</ArticleId><ArticleId IdType="pmc">PMC8252672</ArticleId><ArticleId IdType="pubmed">34210694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L., Zhang, S., Ma, J., Ni, J., Wang, J., Li, X.et al. (2021) Kawasaki disease- management strategies given symptoms overlap to COVID-19: a review. JNMA J. Nepal. Med. Assoc. 59, 417&#x2013;424 10.31729/jnma.5698</Citation><ArticleIdList><ArticleId IdType="doi">10.31729/jnma.5698</ArticleId><ArticleId IdType="pmc">PMC8369595</ArticleId><ArticleId IdType="pubmed">34508537</ArticleId></ArticleIdList></Reference><Reference><Citation>Western, E., Sorteberg, A., Brunborg, C. and Nordenmark, T.H. (2020) Prevalence and predictors of fatigue after aneurysmal subarachnoid hemorrhage. Acta Neurochir. (Wien) 162, 3107&#x2013;3116 10.1007/s00701-020-04538-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-020-04538-9</ArticleId><ArticleId IdType="pmc">PMC7593293</ArticleId><ArticleId IdType="pubmed">32809068</ArticleId></ArticleIdList></Reference><Reference><Citation>Western, E., Nordenmark, T.H., Sorteberg, W., Karic, T. and Sorteberg, A. (2021) Fatigue after aneurysmal subarachnoid hemorrhage: clinical characteristics and associated factors in patients with good outcome. Front. Behav. Neurosci. 15, 633616 10.3389/fnbeh.2021.633616</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnbeh.2021.633616</ArticleId><ArticleId IdType="pmc">PMC8149596</ArticleId><ArticleId IdType="pubmed">34054441</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey, P.R. and Jones, K.M. (2020) Going viral: a brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic. Semin. Oncol. 47, 330&#x2013;334 10.1053/j.seminoncol.2020.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminoncol.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7245293</ArticleId><ArticleId IdType="pubmed">32736881</ArticleId></ArticleIdList></Reference><Reference><Citation>Micevic, G., Morris, J., Lee, A.I. and King, B.A. (2020) Perniolike lesions and coagulopathy in a patient with COVID-19 infection. JAAD Case Rep. 6, 1294&#x2013;1296 10.1016/j.jdcr.2020.08.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jdcr.2020.08.042</ArticleId><ArticleId IdType="pmc">PMC7491482</ArticleId><ArticleId IdType="pubmed">32953959</ArticleId></ArticleIdList></Reference><Reference><Citation>Discepolo, V., Catzola, A., Pierri, L., Mascolo, M., Della Casa, F., Vastarella, M.et al. (2021) Bilateral chilblain-like lesions of the toes characterized by microvascular remodeling in adolescents during the COVID-19 pandemic. JAMA Netw. Open. 4, e2111369 10.1001/jamanetworkopen.2021.11369</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11369</ArticleId><ArticleId IdType="pmc">PMC8193438</ArticleId><ArticleId IdType="pubmed">34110396</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha, K.O., Zanuncio, V.V., de Freitas, C., and Lima, B.A. and M, L. (2021) "COVID toes": a meta-analysis of case and observational studies on clinical, histopathological, and laboratory findings. Pediatr. Dermatol. 38, 1143&#x2013;1149 10.1111/pde.14805</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pde.14805</ArticleId><ArticleId IdType="pmc">PMC8646534</ArticleId><ArticleId IdType="pubmed">34515379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashetsky, N., Mukovozov, I.M. and Bergman, J. (2021) Chilblain-like lesions (CLL) associated with COVID-19 ("COVID toes"): a systematic review. J. Cutan Med. Surg. 25, 627&#x2013;633 10.1177/12034754211004575</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/12034754211004575</ArticleId><ArticleId IdType="pubmed">33849305</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilmaz, M.M., Szabolcs, M.J., Geskin, L.J. and Niedt, G.W. (2021) An autopsy review: "COVID toes". Am. J. Dermatopathol. 43, 554&#x2013;555 10.1097/DAD.0000000000001827</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/DAD.0000000000001827</ArticleId><ArticleId IdType="pubmed">33055537</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolivras, A., Thompson, C., Pastushenko, I., Mathieu, M., Bruderer, P., de Vicq, M.et al. (2022) A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. J. Cutan. Pathol. 49, 17&#x2013;28 10.1111/cup.14099</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cup.14099</ArticleId><ArticleId IdType="pmc">PMC8444728</ArticleId><ArticleId IdType="pubmed">34272741</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta, P., Bunker, C.B., Ciurtin, C., Porter, J.C., Chambers, R.C., Papdopoulou, C.et al. (2021) Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect. Dis. 21, 912 10.1016/S1473-3099(21)00133-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00133-X</ArticleId><ArticleId IdType="pmc">PMC8221732</ArticleId><ArticleId IdType="pubmed">33705725</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;, R., Hsieh, A. and Trellu, L.T. (2022) Chronic acral lesions ("COVID toes"): to add to long post- COVID-19 syndrome? Angiology 33197211068938 10.1177/00033197211068938</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/00033197211068938</ArticleId><ArticleId IdType="pmc">PMC9411688</ArticleId><ArticleId IdType="pubmed">34979814</ArticleId></ArticleIdList></Reference><Reference><Citation>Nirenberg, M.S., Requena, L., Santonja, C., Smith, G.T. and McClain, S.A. (2022) Histopathology of Persistent long COVID Toe: a case report. J. Cutan. Pathol. 9, 791&#x2013;794 10.1111/cup.14240</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cup.14240</ArticleId><ArticleId IdType="pmc">PMC9111773</ArticleId><ArticleId IdType="pubmed">35366017</ArticleId></ArticleIdList></Reference><Reference><Citation>Frumholtz, L., Bouaziz, J.D., Battistella, M., Hadjadj, J., Chocron, R., Bengoufa, D.et al. (2021) Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak. Br. J. Dermatol. 185, 1176&#x2013;1185 10.1111/bjd.20707</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjd.20707</ArticleId><ArticleId IdType="pmc">PMC8652826</ArticleId><ArticleId IdType="pubmed">34611893</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc7;akmak, F., Demirbuga, A., Demirkol, D., G&#xfc;m&#xfc;&#x15f;, S., Torun, S.H., Kayaalp, G.K.et al. (2021) Nailfold capillaroscopy: a sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc. Res. 138, 104196 10.1016/j.mvr.2021.104196</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2021.104196</ArticleId><ArticleId IdType="pmc">PMC8190529</ArticleId><ArticleId IdType="pubmed">34097919</ArticleId></ArticleIdList></Reference><Reference><Citation>Natalello, G., De Luca, G., Gigante, L., Campochiaro, C., De Lorenzis, E., Verardi, L.et al. (2021) Nailfold capillaroscopy findings in patients with coronavirus disease 2019: broadening the spectrum of COVID-19 microvascular involvement. Microvasc. Res. 133, 104071 10.1016/j.mvr.2020.104071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2020.104071</ArticleId><ArticleId IdType="pmc">PMC7494493</ArticleId><ArticleId IdType="pubmed">32949574</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulli, A., Gotelli, E., Bica, P.F., Schiavetti, I., Pizzorni, C., Aloe, T.et al. (2022) Detailed videocapillaroscopic microvascular changes detectable in adult COVID-19 survivors. Microvasc. Res. 142, 104361 10.1016/j.mvr.2022.104361</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2022.104361</ArticleId><ArticleId IdType="pmc">PMC8942583</ArticleId><ArticleId IdType="pubmed">35339493</ArticleId></ArticleIdList></Reference><Reference><Citation>Madamanchi, N.R., Vendrov, A. and Runge, M.S. (2005) Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 29&#x2013;38 10.1161/01.ATV.0000150649.39934.13</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000150649.39934.13</ArticleId><ArticleId IdType="pubmed">15539615</ArticleId></ArticleIdList></Reference><Reference><Citation>Kane, A.D., Kothmann, E. and Giussani, D.A. (2020) Detection and response to acute systemic hypoxia. BJA Educ. 20, 58&#x2013;64 10.1016/j.bjae.2019.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjae.2019.10.004</ArticleId><ArticleId IdType="pmc">PMC7807956</ArticleId><ArticleId IdType="pubmed">33456931</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavezzi, A., Troiani, E. and Corrao, S. (2020) COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin. Pract. 10, 1271 10.4081/cp.2020.1271</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/cp.2020.1271</ArticleId><ArticleId IdType="pmc">PMC7267810</ArticleId><ArticleId IdType="pubmed">32509258</ArticleId></ArticleIdList></Reference><Reference><Citation>Negri, E.M., Piloto, B.M., Morinaga, L.K., Jardim, C.V.P., Lamy, S.A.E., Ferreira, M.A.et al. (2020) Heparin therapy improving hypoxia in COVID-19 patients - a case series. Front. Physiol. 11, 573044 10.3389/fphys.2020.573044</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.573044</ArticleId><ArticleId IdType="pmc">PMC7604350</ArticleId><ArticleId IdType="pubmed">33192569</ArticleId></ArticleIdList></Reference><Reference><Citation>Somers, V.K., Kara, T. and Xie, J. (2020) Progressive hypoxia: a pivotal pathophysiologic mechanism of COVID-19 pneumonia. Mayo Clin. Proc. 95, 2339&#x2013;2342 10.1016/j.mayocp.2020.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.09.015</ArticleId><ArticleId IdType="pmc">PMC7524673</ArticleId><ArticleId IdType="pubmed">33153625</ArticleId></ArticleIdList></Reference><Reference><Citation>Alvis, B., Vaughn, L., Schmeckpeper, J., Huston, J., Case, M., Semler, M.et al. (2021) Respiratory non-invasive venous waveform analysis for assessment of respiratory distress in coronavirus disease 2019 patients: an observational study. Crit. Care Explor. 3, e0539 10.1097/CCE.0000000000000539</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000539</ArticleId><ArticleId IdType="pmc">PMC8489896</ArticleId><ArticleId IdType="pubmed">34617035</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xf6;ning, D., Kuebler, W.M. and Bloch, W. (2021) The oxygen dissociation curve of blood in COVID-19. Am. J. Physiol. Lung Cell Mol. Physiol. 321, L349&#x2013;L357 10.1152/ajplung.00079.2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00079.2021</ArticleId><ArticleId IdType="pmc">PMC8384474</ArticleId><ArticleId IdType="pubmed">33978488</ArticleId></ArticleIdList></Reference><Reference><Citation>Brouqui, P., Amrane, S., Million, M., Cortaredona, S., Parola, P., Lagier, J.C.et al. (2021) Asymptomatic hypoxia in COVID-19 is associated with poor outcome. Int. J. Infect. Dis. 102, 233&#x2013;238 10.1016/j.ijid.2020.10.067</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.10.067</ArticleId><ArticleId IdType="pmc">PMC7604151</ArticleId><ArticleId IdType="pubmed">33130200</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia, F., Medina, C., Cornejo, E., Morello, E., V&#xe1;squez, S., Alave, J.et al. (2020) Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One 15, e0244171 10.1371/journal.pone.0244171</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244171</ArticleId><ArticleId IdType="pmc">PMC7769479</ArticleId><ArticleId IdType="pubmed">33370364</ArticleId></ArticleIdList></Reference><Reference><Citation>Nechipurenko, Y.D., Semyonov, D.A., Lavrinenko, I.A., Lagutkin, D.A., Generalov, E.A., Zaitceva, A.Y.et al. (2021) The role of acidosis in the pathogenesis of severe forms of COVID-19. Biology (Basel) 10, 852 10.3390/biology10090852</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10090852</ArticleId><ArticleId IdType="pmc">PMC8469745</ArticleId><ArticleId IdType="pubmed">34571729</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;ez-Franco, J.C., Torres-Ruiz, J., Sosa-Hern&#xe1;ndez, V.A., Cervantes-D&#xed;az, R., Romero-Ram&#xed;rez, S., P&#xe9;rez-Fragoso, A.et al. (2021) Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients. Sci. Rep. 11, 6350 10.1038/s41598-021-85788-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85788-0</ArticleId><ArticleId IdType="pmc">PMC7973513</ArticleId><ArticleId IdType="pubmed">33737694</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman, A., Tabassum, T., Araf, Y., Al Nahid, A., Ullah, M.A. and Hosen, M.J. (2021) Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol. Biol. Rep. 48, 3863&#x2013;3869 10.1007/s11033-021-06358-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-021-06358-1</ArticleId><ArticleId IdType="pmc">PMC8062941</ArticleId><ArticleId IdType="pubmed">33891272</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd8;stergaard, L. (2020) Blood flow, capillary transit times, and tissue oxygenation: the centennial of capillary recruitment. J. Appl. Physiol. 129, 1413&#x2013;1421 10.1152/japplphysiol.00537.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00537.2020</ArticleId><ArticleId IdType="pubmed">33031017</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrmann, J., Mori, V., Bates, J.H.T. and Suki, B. (2020) Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia. Nat. Commun. 11, 4883 10.1038/s41467-020-18672-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18672-6</ArticleId><ArticleId IdType="pmc">PMC7522238</ArticleId><ArticleId IdType="pubmed">32985528</ArticleId></ArticleIdList></Reference><Reference><Citation>Olumuyiwa-Akeredolu, O.O. and Pretorius, E. (2016) Rheumatoid arthritis: notable biomarkers linking to chronic systemic conditions and cancer. Curr. Pharm. Des. 22, 918&#x2013;924 10.2174/1381612822666151209153535</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612822666151209153535</ArticleId><ArticleId IdType="pubmed">26648464</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantel, &#xc4;, Holmqvist, M., Andersson, D.C., Lund, L.H. and Askling, J. (2017) Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure. J. Am. Coll. Cardiol. 69, 1275&#x2013;1285 10.1016/j.jacc.2016.12.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2016.12.033</ArticleId><ArticleId IdType="pubmed">28279294</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezuidenhout, J., Venter, C., Roberts, T., Tarr, G., Kell, D. and Pretorius, E. (2020) The atypical fibrin fibre network in rheumatoid arthritis and its relation to autoimmunity, inflammation and thrombosis. bioRxiv 2020.2005.2028.121301v121301</Citation></Reference><Reference><Citation>Mirabello, V., Cortezon-Tamarit, F. and Pascu, S.I. (2018) Oxygen sensing, hypoxia tracing and in vivo imaging with functional metalloprobes for the early detection of non-communicable diseases. Front. Chem. 6, 27 10.3389/fchem.2018.00027</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fchem.2018.00027</ArticleId><ArticleId IdType="pmc">PMC5829448</ArticleId><ArticleId IdType="pubmed">29527524</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, X.C., Wang, X., Mao, H., Wu, W., Liu, B.R. and Jiang, X.Q. (2015) Hypoxia-specific ultrasensitive detection of tumours and cancer cells in vivo. Nat. Commun. 6, 5834 10.1038/ncomms6834</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6834</ArticleId><ArticleId IdType="pubmed">25556360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziello, J.E., Jovin, I.S. and Huang, Y. (2007) Hypoxia-inducible factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J. Biol. Med. 80, 51&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2140184</ArticleId><ArticleId IdType="pubmed">18160990</ArticleId></ArticleIdList></Reference><Reference><Citation>Batie, M. and Rocha, S. (2020) Gene transcription and chromatin regulation in hypoxia. Biochem. Soc. Trans. 48, 1121&#x2013;1128 10.1042/BST20191106</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20191106</ArticleId><ArticleId IdType="pmc">PMC7329336</ArticleId><ArticleId IdType="pubmed">32369557</ArticleId></ArticleIdList></Reference><Reference><Citation>Frost, J., Frost, M., Batie, M., Jiang, H. and Rocha, S. (2021) Roles of HIF and 2-oxoglutarate-dependent dioxygenases in controlling gene expression in hypoxia. Cancers (Basel) 13, 350 10.3390/cancers13020350</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13020350</ArticleId><ArticleId IdType="pmc">PMC7832865</ArticleId><ArticleId IdType="pubmed">33477877</ArticleId></ArticleIdList></Reference><Reference><Citation>Betteridge, D.J. (2000) What is oxidative stress? Metabolism 49, 3&#x2013;8 10.1016/S0026-0495(00)80077-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0026-0495(00)80077-3</ArticleId><ArticleId IdType="pubmed">10693912</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield, D.A. (2002) Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic. Res. 36, 1307&#x2013;1313 10.1080/1071576021000049890</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1071576021000049890</ArticleId><ArticleId IdType="pubmed">12607822</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler, R.G. and Rodriguez, H. (2002) Critical reviews of Oxidative Stress and Aging: Advances in Basic Science, Diagnostics And Intervention, World Scientific, Singapore</Citation></Reference><Reference><Citation>Maritim, A.C., Sanders, R.A. and Watkins, III, J.B. (2003) Diabetes, oxidative stress, and antioxidants: a review. J. Biochem. Mol. Toxicol. 17, 24&#x2013;38 10.1002/jbt.10058</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbt.10058</ArticleId><ArticleId IdType="pubmed">12616644</ArticleId></ArticleIdList></Reference><Reference><Citation>Uttara, B., Singh, A.V., Zamboni, P. and Mahajan, R.T. (2009) Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 7, 65&#x2013;74 10.2174/157015909787602823</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015909787602823</ArticleId><ArticleId IdType="pmc">PMC2724665</ArticleId><ArticleId IdType="pubmed">19721819</ArticleId></ArticleIdList></Reference><Reference><Citation>Valko, M., Leibfritz, D., Moncol, J., Cronin, M.T.D., Mazur, M. and Telser, J. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44&#x2013;84 10.1016/j.biocel.2006.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2006.07.001</ArticleId><ArticleId IdType="pubmed">16978905</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell, B. (2011) Free radicals and antioxidants - quo vadis? Trends Pharmacol. Sci. 32, 125&#x2013;130 10.1016/j.tips.2010.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2010.12.002</ArticleId><ArticleId IdType="pubmed">21216018</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell, B. and Gutteridge, J.M.C. (2015) Free Radicals in Biology and Medicine, 5th Ed., Oxford University Press, Oxford</Citation></Reference><Reference><Citation>Pisoschi, A.M. and Pop, A. (2015) The role of antioxidants in the chemistry of oxidative stress: a review. Eur. J. Med. Chem. 97, 55&#x2013;74 10.1016/j.ejmech.2015.04.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2015.04.040</ArticleId><ArticleId IdType="pubmed">25942353</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V.et al. (2017) Oxidative stress: harms and benefits for human health. Oxidative Med. Cell. Longev. 2017, 8416763 10.1155/2017/8416763</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8416763</ArticleId><ArticleId IdType="pmc">PMC5551541</ArticleId><ArticleId IdType="pubmed">28819546</ArticleId></ArticleIdList></Reference><Reference><Citation>Siti, H.N., Kamisah, Y. and Kamsiah, J. (2015) The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul. Pharmacol. 71, 40&#x2013;56 10.1016/j.vph.2015.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vph.2015.03.005</ArticleId><ArticleId IdType="pubmed">25869516</ArticleId></ArticleIdList></Reference><Reference><Citation>Poprac, P., Jomova, K., Simunkova, M., Kollar, V., Rhodes, C.J. and Valko, M. (2017) Targeting free radicals in oxidative stress-related human diseases. Trends Pharmacol. Sci. 38, 592&#x2013;607 10.1016/j.tips.2017.04.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2017.04.005</ArticleId><ArticleId IdType="pubmed">28551354</ArticleId></ArticleIdList></Reference><Reference><Citation>Simunkova, M., Alwasel, S.H., Alhazza, I.M., Jomova, K., Kollar, V., Rusko, M.et al. (2019) Management of oxidative stress and other pathologies in Alzheimer's disease. Arch. Toxicol. 93, 2491&#x2013;2513 10.1007/s00204-019-02538-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-019-02538-y</ArticleId><ArticleId IdType="pubmed">31440798</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisoschi, A.M., Pop, A., Iordache, F., Stanca, L., Predoi, G. and Serban, A.I. (2021) Oxidative stress mitigation by antioxidants - an overview on their chemistry and influences on health status. Eur. J. Med. Chem. 209, 112891 10.1016/j.ejmech.2020.112891</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2020.112891</ArticleId><ArticleId IdType="pubmed">33032084</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy, G., Spence, V.A., McLaren, M., Hill, A., Underwood, C. and Belch, J.J. (2005) Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic. Biol. Med. 39, 584&#x2013;589 10.1016/j.freeradbiomed.2005.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.04.020</ArticleId><ArticleId IdType="pubmed">16085177</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul, B.D., Lemle, M.D., Komaroff, A.L. and Snyder, S.H. (2021) Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl Acad. Sci. U.S.A. 118, e2024358118 10.1073/pnas.2024358118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood, P.L., Clauw, D.J., Phadke, S. and Hoffman, D. (2021) Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): where will the drugs come from? Pharmacol. Res. 165, 105465 10.1016/j.phrs.2021.105465</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105465</ArticleId><ArticleId IdType="pubmed">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucino, V., Certo, M., Bulusu, V., Cucchi, D., Goldmann, K., Pontarini, E.et al. (2019) Lactate buildup at the site of chronic inflammation promotes disease by inducing CD4(+) T cell metabolic rewiring. Cell Metab. 30, 1055&#x2013;1074.e1058 10.1016/j.cmet.2019.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2019.10.004</ArticleId><ArticleId IdType="pmc">PMC6899510</ArticleId><ArticleId IdType="pubmed">31708446</ArticleId></ArticleIdList></Reference><Reference><Citation>Pucino, V., Certo, M., Varricchi, G., Marone, G., Ursini, F., Rossi, F.W.et al. (2020) Metabolic checkpoints in rheumatoid arthritis. Front. Physiol. 11, 347 10.3389/fphys.2020.00347</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00347</ArticleId><ArticleId IdType="pmc">PMC7180190</ArticleId><ArticleId IdType="pubmed">32362840</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu, J., Wu, B., Goodman, S.B., Berry, G.J., Goronzy, J.J. and Weyand, C.M. (2021) Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front. Immunol. 12, 652771 10.3389/fimmu.2021.652771</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.652771</ArticleId><ArticleId IdType="pmc">PMC8050350</ArticleId><ArticleId IdType="pubmed">33868292</ArticleId></ArticleIdList></Reference><Reference><Citation>Shungu, D.C., Weiduschat, N., Murrough, J.W., Mao, X., Pillemer, S., Dyke, J.P.et al. (2012) Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 25, 1073&#x2013;1087 10.1002/nbm.2772</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2772</ArticleId><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallis, A., Ball, M., McKechnie, S., Butt, H., Lewis, D.P. and Bruck, D. (2017) Examining clinical similarities between myalgic encephalomyelitis/chronic fatigue syndrome and D-lactic acidosis: a systematic review. J. Transl. Med. 15, 129 10.1186/s12967-017-1229-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1229-1</ArticleId><ArticleId IdType="pmc">PMC5463382</ArticleId><ArticleId IdType="pubmed">28592308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali, A., Lacout, C., Ghali, M., Gury, A., Beucher, A.B., Lozac'h, P.et al. (2019) Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Sci. Rep. 9, 18817 10.1038/s41598-019-55473-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-55473-4</ArticleId><ArticleId IdType="pmc">PMC6906377</ArticleId><ArticleId IdType="pubmed">31827223</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien, K., Johansen, B., Veier&#xf8;d, M.B., Haslestad, A.S., B&#xf8;hn, S.K., Melsom, M.N.et al. (2019) Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiol. Rep. 7, e14138 10.14814/phy2.14138</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14138</ArticleId><ArticleId IdType="pmc">PMC6546966</ArticleId><ArticleId IdType="pubmed">31161646</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson, I., Palmer, J., Apostolou, E., Gottfries, C.G., Rizwan, M., Dahle, C.et al. (2020) Metabolic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome not due to anti-mitochondrial antibodies. Front. Med. (Lausanne) 7, 108 10.3389/fmed.2020.00108</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00108</ArticleId><ArticleId IdType="pmc">PMC7136523</ArticleId><ArticleId IdType="pubmed">32296708</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrough, J.W., Mao, X., Collins, K.A., Kelly, C., Andrade, G., Nestadt, P.et al. (2010) Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. NMR Biomed. 23, 643&#x2013;650 10.1002/nbm.1512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1512</ArticleId><ArticleId IdType="pubmed">20661876</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruno, R.R., Wernly, B., Flaatten, H., Fjolner, J., Artigas, A., Bollen Pinto, B.et al. (2021) Lactate is associated with mortality in very old intensive care patients suffering from COVID-19: results from an international observational study of 2860 patients. Ann. Intensive Care 11, 128 10.1186/s13613-021-00911-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-021-00911-8</ArticleId><ArticleId IdType="pmc">PMC8379577</ArticleId><ArticleId IdType="pubmed">34417919</ArticleId></ArticleIdList></Reference><Reference><Citation>Iepsen, U.W., Plovsing, R.R., Tjelle, K., Foss, N.B., Meyhoff, C.S., Ryrs&#xf8;, C.K.et al. (2021) The role of lactate in sepsis and COVID-19: perspective from contracting skeletal muscle metabolism. Exp. Physiol. 107, 665&#x2013;673 10.1113/EP089474</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089474</ArticleId><ArticleId IdType="pmc">PMC8239768</ArticleId><ArticleId IdType="pubmed">34058787</ArticleId></ArticleIdList></Reference><Reference><Citation>Velavan, T.P., Kieu Linh, L.T., Kreidenweiss, A., Gabor, J., Krishna, S. and Kremsner, P.G. (2021) Longitudinal monitoring of lactate in hospitalized and ambulatory COVID-19 patients. Am. J. Trop. Med. Hyg. 104, 1041&#x2013;1044 10.4269/ajtmh.20-1282</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-1282</ArticleId><ArticleId IdType="pmc">PMC7941812</ArticleId><ArticleId IdType="pubmed">33432902</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpen&#xe8;, G., Onorato, D., Nocini, R., Fortunato, G., Rizk, J.G., Henry, B.M.et al. (2022) Blood lactate concentration in COVID-19: a systematic literature review. Clin. Chem. Lab. Med. 60, 332&#x2013;337 10.1515/cclm-2021-1115</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1115</ArticleId><ArticleId IdType="pubmed">34856090</ArticleId></ArticleIdList></Reference><Reference><Citation>Santinelli, L., Laghi, L., Innocenti, G.P., Pinacchio, C., Vassalini, P., Celani, L.et al. (2021) Oral bacteriotherapy reduces the occurrence of chronic fatigue in COVID-19 patients. Front. Nutr. 8, 756177 10.3389/fnut.2021.756177</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.756177</ArticleId><ArticleId IdType="pmc">PMC8790565</ArticleId><ArticleId IdType="pubmed">35096923</ArticleId></ArticleIdList></Reference><Reference><Citation>Herce-Pagliai, C., Kotecha, S. and Shuker, D.E.G. (1998) Analytical methods for 3-nitrotyrosine as a marker of exposure to reactive nitrogen species: a review. Nitric Oxide-Biol. Chem. 2, 324&#x2013;336 10.1006/niox.1998.0192</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/niox.1998.0192</ArticleId><ArticleId IdType="pubmed">10100488</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian, K., Gao, Z., Weisbrodt, N. and Murad, F. (2003) The nature of heme/iron-induced protein tyrosine nitration. Proc. Natl Acad. Sci. U.S.A. 100, 5712&#x2013;5717 10.1073/pnas.0931291100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0931291100</ArticleId><ArticleId IdType="pmc">PMC156266</ArticleId><ArticleId IdType="pubmed">12709594</ArticleId></ArticleIdList></Reference><Reference><Citation>Duncan, M.W. (2003) A review of approaches to the analysis of 3-nitrotyrosine. Amino Acids 25, 351&#x2013;361 10.1007/s00726-003-0022-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-003-0022-z</ArticleId><ArticleId IdType="pubmed">14661096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg, H. and Caidahl, K. (2007) Chromatographic and mass spectrometric methods for quantitative determination of 3-nitrotyrosine in biological samples and their application to human samples. J. Chromatogr. B 851, 160&#x2013;171 10.1016/j.jchromb.2007.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchromb.2007.02.001</ArticleId><ArticleId IdType="pubmed">17344105</ArticleId></ArticleIdList></Reference><Reference><Citation>Campolo, N., Issoglio, F.M., Estrin, D.A., Bartesaghi, S. and Radi, R. (2020) 3-Nitrotyrosine and related derivatives in proteins: precursors, radical intermediates and impact in function. Essays Biochem. 64, 111&#x2013;133 10.1042/EBC20190052</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20190052</ArticleId><ArticleId IdType="pubmed">32016371</ArticleId></ArticleIdList></Reference><Reference><Citation>Janero, D.R. (1990) Malondialdehyde and thiobarbituric acid reactivity as diagnostic indexes of lipid peroxidation and peroxidative tissue injury. Free Radic. Biol. Med. 9, 515&#x2013;540 10.1016/0891-5849(90)90131-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0891-5849(90)90131-2</ArticleId><ArticleId IdType="pubmed">2079232</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio, D., Stewart, A.J. and Pellegrini, N. (2005) A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis. 15, 316&#x2013;328 10.1016/j.numecd.2005.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.numecd.2005.05.003</ArticleId><ArticleId IdType="pubmed">16054557</ArticleId></ArticleIdList></Reference><Reference><Citation>Aust, A.E. and Eveleigh, J.F. (1999) Mechanisms of DNA oxidation. Proc. Soc. Exp. Biol. Med. 222, 246&#x2013;252 10.1046/j.1525-1373.1999.d01-141.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1373.1999.d01-141.x</ArticleId><ArticleId IdType="pubmed">10601883</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooke, M.S., Lunec, J. and Evans, M.D. (2002) Progress in the analysis of urinary oxidative DNA damage. Free Radic. Biol. Med. 33, 1601&#x2013;1614 10.1016/S0891-5849(02)01146-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(02)01146-2</ArticleId><ArticleId IdType="pubmed">12488129</ArticleId></ArticleIdList></Reference><Reference><Citation>Dizdaroglu, M., Jaruga, P., Birincioglu, M. and Rodriguez, H. (2002) Free radical-induced damage to DNA: mechanisms and measurement. Free Radic. Biol. Med. 32, 1102&#x2013;1115 10.1016/S0891-5849(02)00826-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(02)00826-2</ArticleId><ArticleId IdType="pubmed">12031895</ArticleId></ArticleIdList></Reference><Reference><Citation>Neeley, W.L. and Essigmann, J.M. (2006) Mechanisms of formation, genotoxicity, and mutation of guanine oxidation products. Chem. Res. Toxicol. 19, 491&#x2013;505 10.1021/tx0600043</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/tx0600043</ArticleId><ArticleId IdType="pubmed">16608160</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang, E.S. and Bowen, P.E. (2007) DNA damage, a biomarker of carcinogenesis: its measurement and modulation by diet and environment. Crit. Rev. Food Sci. Nutr. 47, 27&#x2013;50 10.1080/10408390600550299</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408390600550299</ArticleId><ArticleId IdType="pubmed">17364694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kageyama, Y., Takahashi, M., Ichikawa, T., Torikai, E. and Nagano, A. (2008) Reduction of oxidative stress marker levels by anti-TNF-alpha antibody, infliximab, in patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 26, 73&#x2013;80</Citation><ArticleIdList><ArticleId IdType="pubmed">18328150</ArticleId></ArticleIdList></Reference><Reference><Citation>Pemberton, P.W., Ahmad, Y., Bodill, H., Lokko, D., Hider, S.L., Yates, A.P.et al. (2009) Biomarkers of oxidant stress, insulin sensitivity and endothelial activation in rheumatoid arthritis: a cross-sectional study of their association with accelerated atherosclerosis. BMC Res. Notes 2, 83 10.1186/1756-0500-2-83</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-0500-2-83</ArticleId><ArticleId IdType="pmc">PMC2687454</ArticleId><ArticleId IdType="pubmed">19426539</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu, J., Schoeman, J.C., Harms, A.C., van Wietmarschen, H.A., Vreeken, R.J., Berger, R.et al. (2016) Metabolomics profiling of the free and total oxidised lipids in urine by LC-MS/MS: application in patients with rheumatoid arthritis. Anal. Bioanal. Chem. 408, 6307&#x2013;6319 10.1007/s00216-016-9742-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-016-9742-2</ArticleId><ArticleId IdType="pmc">PMC5009176</ArticleId><ArticleId IdType="pubmed">27405874</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowers, I. and Subedi, B. (2021) Isoprostanes in wastewater as biomarkers of oxidative stress during COVID-19 pandemic. Chemosphere 271, 129489 10.1016/j.chemosphere.2020.129489</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemosphere.2020.129489</ArticleId><ArticleId IdType="pmc">PMC7778527</ArticleId><ArticleId IdType="pubmed">33434819</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossini, E., Concina, D., Rinaldi, C., Russotto, S., Garhwal, D., Zeppegno, P.et al. (2021) Association between plasma redox state/mitochondria function and a Flu-like syndrome/COVID-19 in the elderly admitted to a long-term care unit. Front. Physiol. 12, 707587 10.3389/fphys.2021.707587</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.707587</ArticleId><ArticleId IdType="pmc">PMC8715756</ArticleId><ArticleId IdType="pubmed">34975514</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, P., Osahon, O., Vides, D.B., Hanania, N., Minard, C.G. and Sekhar, R.V. (2022) Severe glutathione deficiency, oxidative stress and oxidant damage in adults hospitalized with COVID-19: implications for GlyNAC (glycine and N-acetylcysteine) supplementation. Antioxidants (Basel) 11, 50 10.3390/antiox11010050</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11010050</ArticleId><ArticleId IdType="pmc">PMC8773164</ArticleId><ArticleId IdType="pubmed">35052554</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto, M.E., Guarner-Lans, V., D&#xed;az-D&#xed;az, E., Manzano-Pech, L., Palacios-Chavarria, A., Valdez-V&#xe1;zquez, R.R.et al. (2022) Hyperglycemia and loss of redox homeostasis in COVID-19 patients. Cells 11, 932 10.3390/cells11060932</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11060932</ArticleId><ArticleId IdType="pmc">PMC8946177</ArticleId><ArticleId IdType="pubmed">35326383</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominic, P., Ahmad, J., Bhandari, R., Pardue, S., Solorzano, J., Jaisingh, K.et al. (2021) Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19. Redox Biol. 43, 101982 10.1016/j.redox.2021.101982</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.101982</ArticleId><ArticleId IdType="pmc">PMC8106525</ArticleId><ArticleId IdType="pubmed">34020311</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden, M.R. (2020) An immediate and long-term complication of COVID-19 May be type 2 diabetes mellitus: the central role of beta-cell dysfunction, apoptosis and exploration of possible mechanisms. Cells 9, 2475 10.3390/cells9112475</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112475</ArticleId><ArticleId IdType="pmc">PMC7697826</ArticleId><ArticleId IdType="pubmed">33202960</ArticleId></ArticleIdList></Reference><Reference><Citation>Misko, T.P., Radabaugh, M.R., Highkin, M., Abrams, M., Friese, O., Gallavan, R.et al. (2013) Characterization of nitrotyrosine as a biomarker for arthritis and joint injury. Osteoarthr. Cartil. 21, 151&#x2013;156 10.1016/j.joca.2012.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.joca.2012.09.005</ArticleId><ArticleId IdType="pubmed">23025928</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan, M.A., Alam, K., Zafaryab, M. and Rizvi, M.M.A. (2017) Peroxynitrite-modified histone as a pathophysiological biomarker in autoimmune diseases. Biochimie 140, 1&#x2013;9 10.1016/j.biochi.2017.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2017.06.006</ArticleId><ArticleId IdType="pubmed">28619676</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1; da Fonseca, L.J., Nunes-Souza, V., Goulart, M.O.F. and Rabelo, L.A. (2019) Oxidative Stress in Rheumatoid Arthritis: What the Future Might Hold regarding Novel Biomarkers and Add-On Therapies. Oxid. Med. Cell. Longev. 2019, 7536805 10.1155/2019/7536805</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7536805</ArticleId><ArticleId IdType="pmc">PMC6942903</ArticleId><ArticleId IdType="pubmed">31934269</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinz, M.M., Persson, M., Aresh, B., Olsson, K., Cheng, A.J., Ahlstrand, E.et al. (2019) Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis. JCI Insight 4, e126347 10.1172/jci.insight.126347</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.126347</ArticleId><ArticleId IdType="pmc">PMC6538353</ArticleId><ArticleId IdType="pubmed">30920392</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes, M., Mihaylova, I. and Leunis, J.C. (2006) Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol. Lett. 27, 615&#x2013;621</Citation><ArticleIdList><ArticleId IdType="pubmed">17159817</ArticleId></ArticleIdList></Reference><Reference><Citation>Veselinovic, M., Barudzic, N., Vuletic, M., Zivkovic, V., Tomic-Lucic, A., Djuric, D.et al. (2014) Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity. Mol. Cell. Biochem. 391, 225&#x2013;232 10.1007/s11010-014-2006-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-014-2006-6</ArticleId><ArticleId IdType="pubmed">24610042</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Gonz&#xe1;lez, A., Gaxiola-Robles, R. and Zenteno-Sav&#xed;n, T. (2015) Oxidative stress in patients with rheumatoid arthritis. Rev. Invest. Clin. 67, 46&#x2013;53</Citation><ArticleIdList><ArticleId IdType="pubmed">25857584</ArticleId></ArticleIdList></Reference><Reference><Citation>Mititelu, R.R., P&#x103;dureanu, R., B&#x103;c&#x103;noiu, M., P&#x103;dureanu, V., Docea, A.O., Calina, D.et al. (2020) Inflammatory and oxidative stress Markers-Mirror tools in rheumatoid arthritis. Biomedicines 8, 125 10.3390/biomedicines8050125</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8050125</ArticleId><ArticleId IdType="pmc">PMC7277871</ArticleId><ArticleId IdType="pubmed">32429264</ArticleId></ArticleIdList></Reference><Reference><Citation>Richards, R.S., Roberts, T.K., McGregor, N.R., Dunstan, R.H. and Butt, H.L. (2000) Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep. 5, 35&#x2013;41 10.1179/rer.2000.5.1.35</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/rer.2000.5.1.35</ArticleId><ArticleId IdType="pubmed">10905542</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes, Y., Steinberg, J.G. and Delliaux, S. (2013) Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins. Open J. Intern. Med. 272, 74&#x2013;84 10.1111/j.1365-2796.2011.02488.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02488.x</ArticleId><ArticleId IdType="pubmed">22112145</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenouillet, E., Vigouroux, A., Steinberg, J.G., Chagvardieff, A., Retornaz, F., Guieu, R.et al. (2016) Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. J. Transl. Med. 14, 251 10.1186/s12967-016-1010-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-1010-x</ArticleId><ArticleId IdType="pmc">PMC5006431</ArticleId><ArticleId IdType="pubmed">27580693</ArticleId></ArticleIdList></Reference><Reference><Citation>Brkic, S., Tomic, S., Maric, D., Novakov Mikic, A. and Turkulov, V. (2010) Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. Med. Sci. Monit. 16, CR628&#x2013;CR632</Citation><ArticleIdList><ArticleId IdType="pubmed">21119582</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, T., Zhang, L., Joo, D. and Sun, S.C. (2017) NF-kappaB signaling in inflammation. Signal. Transduct. Target. Ther 2, 17023 10.1038/sigtrans.2017.23</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sigtrans.2017.23</ArticleId><ArticleId IdType="pmc">PMC5661633</ArticleId><ArticleId IdType="pubmed">29158945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma, Q. (2013) Role of Nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53, 401&#x2013;426 10.1146/annurev-pharmtox-011112-140320</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-011112-140320</ArticleId><ArticleId IdType="pmc">PMC4680839</ArticleId><ArticleId IdType="pubmed">23294312</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerins, M.J. and Ooi, A. (2018) The roles of NRF2 in modulating cellular iron homeostasis. Antioxid. Redox Signal. 29, 1756&#x2013;1773 10.1089/ars.2017.7176</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7176</ArticleId><ArticleId IdType="pmc">PMC6208163</ArticleId><ArticleId IdType="pubmed">28793787</ArticleId></ArticleIdList></Reference><Reference><Citation>Schreck, R., Albermann, K. and Baeuerle, P.A. (1992) Nuclear factor kappa-B - an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad. Res. Commun. 17, 221&#x2013;237 10.3109/10715769209079515</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/10715769209079515</ArticleId><ArticleId IdType="pubmed">1473734</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ignazio, L. and Rocha, S. (2016) Hypoxia induced NF-kappaB. Cells 5, 10 10.3390/cells5010010</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells5010010</ArticleId><ArticleId IdType="pmc">PMC4810095</ArticleId><ArticleId IdType="pubmed">27005664</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, Y. and Oberley, L.W. (1996) Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21, 335&#x2013;348 10.1016/0891-5849(96)00109-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0891-5849(96)00109-8</ArticleId><ArticleId IdType="pubmed">8855444</ArticleId></ArticleIdList></Reference><Reference><Citation>Floh&#xe9;, L., Brigelius-Floh&#xe9;, R., Saliou, C., Traber, M.G. and Packer, L. (1997) Redox regulation of NF-kappa B activation. Free Radi. Biol. Med. 22, 1115&#x2013;1126 10.1016/S0891-5849(96)00501-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(96)00501-1</ArticleId><ArticleId IdType="pubmed">9034250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabe, Y., Ando, K., Hirao, S., Yoshida, M. and Handa, H. (2005) Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 7, 395&#x2013;403 10.1089/ars.2005.7.395</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2005.7.395</ArticleId><ArticleId IdType="pubmed">15706086</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidlin, C.J., Dodson, M.B., Madhavan, L. and Zhang, D.D. (2019) Redox regulation by NRF2 in aging and disease. Free Radic. Biol. Med. 134, 702&#x2013;707 10.1016/j.freeradbiomed.2019.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.01.016</ArticleId><ArticleId IdType="pmc">PMC6588470</ArticleId><ArticleId IdType="pubmed">30654017</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathee, P., Chaudhary, H., Rathee, S., Rathee, D., Kumar, V. and Kohli, K. (2009) Mechanism of action of flavonoids as anti-inflammatory agents: a review. Inflamm. Allergy Drug Targets 8, 229&#x2013;235 10.2174/187152809788681029</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152809788681029</ArticleId><ArticleId IdType="pubmed">19601883</ArticleId></ArticleIdList></Reference><Reference><Citation>Choy, K.W., Murugan, D., Leong, X.F., Abas, R., Alias, A. and Mustafa, M.R. (2019) Flavonoids as natural anti-inflammatory agents targeting nuclear factor-kappa B (NFkappaB) signaling in cardiovascular diseases: a mini review. Front. Pharmacol. 10, 1295 10.3389/fphar.2019.01295</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.01295</ArticleId><ArticleId IdType="pmc">PMC6842955</ArticleId><ArticleId IdType="pubmed">31749703</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ignazio, L., Bandarra, D. and Rocha, S. (2016) NF-kappaB and HIF crosstalk in immune responses. FEBS J. 283, 413&#x2013;424 10.1111/febs.13578</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13578</ArticleId><ArticleId IdType="pmc">PMC4864946</ArticleId><ArticleId IdType="pubmed">26513405</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Ignazio, L., Batie, M. and Rocha, S. (2017) Hypoxia and inflammation in cancer, focus on HIF and NF-kappaB. Biomedicines 5, 21 10.3390/biomedicines5020021</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines5020021</ArticleId><ArticleId IdType="pmc">PMC5489807</ArticleId><ArticleId IdType="pubmed">28536364</ArticleId></ArticleIdList></Reference><Reference><Citation>Biddlestone, J., Bandarra, D. and Rocha, S. (2015) The role of hypoxia in inflammatory disease (review). Int. J. Mol. Med. 35, 859&#x2013;869 10.3892/ijmm.2015.2079</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2015.2079</ArticleId><ArticleId IdType="pmc">PMC4356629</ArticleId><ArticleId IdType="pubmed">25625467</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson, D.E., Ihekwaba, A.E.C., Elliott, M., Gibney, C.A., Foreman, B.E., Nelson, G.et al. (2004) Oscillations in NF-&#x3ba;B signalling control the dynamics of gene expression. Science 306, 704&#x2013;708 10.1126/science.1099962</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1099962</ArticleId><ArticleId IdType="pubmed">15499023</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. (2006) Metabolomics, modelling and machine learning in systems biology: towards an understanding of the languages of cells. The 2005 Theodor B&#xfc;cher lecture. FEBS J. 273, 873&#x2013;894 10.1111/j.1742-4658.2006.05136.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2006.05136.x</ArticleId><ArticleId IdType="pubmed">16478464</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashall, L., Horton, C.A., Nelson, D.E., Paszek, P., Ryan, S., Sillitoe, K.et al. (2009) Pulsatile stimulation determines timing and specificity of NFkappa-B-dependent transcription. Science 324, 242&#x2013;246 10.1126/science.1164860</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1164860</ArticleId><ArticleId IdType="pmc">PMC2785900</ArticleId><ArticleId IdType="pubmed">19359585</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue, M., Momiji, H., Rabbani, N., Bretschneider, T., Rand, D.A. and Thornalley, P.J. (2015) Frequency modulated translocational oscillations of Nrf2, a transcription factor functioning like a wireless sensor. Biochem. Soc. Trans. 43, 669&#x2013;673 10.1042/BST20150060</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20150060</ArticleId><ArticleId IdType="pubmed">26551710</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue, M., Momiji, H., Rabbani, N., Barker, G., Bretschneider, T., Shmygol, A.et al. (2015) Frequency modulated translocational oscillations of Nrf2 mediate the antioxidant response element cytoprotective transcriptional response. Antioxid. Redox Signal. 23, 613&#x2013;629 10.1089/ars.2014.5962</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2014.5962</ArticleId><ArticleId IdType="pmc">PMC4556091</ArticleId><ArticleId IdType="pubmed">25178584</ArticleId></ArticleIdList></Reference><Reference><Citation>Frangogiannis, N.G., Smith, C.W. and Entman, M.L. (2002) The inflammatory response in myocardial infarction. Cardiovasc Res. 53, 31&#x2013;47 10.1016/S0008-6363(01)00434-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0008-6363(01)00434-5</ArticleId><ArticleId IdType="pubmed">11744011</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchant, D.J., Boyd, J.H., Lin, D.C., Granville, D.J., Garmaroudi, F.S. and McManus, B.M. (2012) Inflammation in myocardial diseases. Circ. Res. 110, 126&#x2013;144 10.1161/CIRCRESAHA.111.243170</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.111.243170</ArticleId><ArticleId IdType="pubmed">22223210</ArticleId></ArticleIdList></Reference><Reference><Citation>Slegtenhorst, B.R., Dor, F.J., Rodriguez, H., Voskuil, F.J. and Tullius, S.G. (2014) Ischemia/reperfusion injury and its consequences on immunity and inflammation. Curr. Transplant. Rep. 1, 147&#x2013;154 10.1007/s40472-014-0017-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40472-014-0017-6</ArticleId><ArticleId IdType="pmc">PMC4235532</ArticleId><ArticleId IdType="pubmed">25419507</ArticleId></ArticleIdList></Reference><Reference><Citation>Toldo, S., Mauro, A.G., Cutter, Z. and Abbate, A. (2018) Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 315, H1553&#x2013;H1568 10.1152/ajpheart.00158.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00158.2018</ArticleId><ArticleId IdType="pmc">PMC6336966</ArticleId><ArticleId IdType="pubmed">30168729</ArticleId></ArticleIdList></Reference><Reference><Citation>Soares, R.O.S., Losada, D.M., Jordani, M.C., &#xc9;vora, P. and Castro-E-Silva, O. (2019) Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies. Int. J. Mol. Sci 20, 5034 10.3390/ijms20205034</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205034</ArticleId><ArticleId IdType="pmc">PMC6834141</ArticleId><ArticleId IdType="pubmed">31614478</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Hern&#xe1;ndez, C.D., Torres-Alarc&#xf3;n, L.A., Gonz&#xe1;lez-Cort&#xe9;s, A. and Pe&#xf3;n, A.N. (2020) Ischemia/Reperfusion injury: pathophysiology, current clinical management, and potential preventive approaches. Mediat. Inflamm. 2020, 8405370 10.1155/2020/8405370</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/8405370</ArticleId><ArticleId IdType="pmc">PMC7204323</ArticleId><ArticleId IdType="pubmed">32410868</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin, L.B., Ackerley, M.B., Bluestein, L.S., Brewer, J.H., Brook, J.B., Buchanan, A.D.et al. (2021) Diagnosis of mast cell activation syndrome: a global "consensus-2". Diagnosis (Berl.) 8, 137&#x2013;152 10.1515/dx-2020-0005</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/dx-2020-0005</ArticleId><ArticleId IdType="pubmed">32324159</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti, P., Caraffa, A., Tete, G., Gallenga, C.E., Ross, R., Kritas, S.K.et al. (2020) Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. J. Biol. Regul. Homeost. Agents 34, 1629&#x2013;1632 10.1155/2019/7536805</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7536805</ArticleId><ArticleId IdType="pubmed">32945158</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides, T.C. and Conti, P. (2020) COVID-19 and multisystem inflammatory syndrome, or is it mast cell activation syndrome? J. Biol. Regul. Homeost. Agents 34, 1633&#x2013;1636 10.23812/20-EDIT3</Citation><ArticleIdList><ArticleId IdType="doi">10.23812/20-EDIT3</ArticleId><ArticleId IdType="pubmed">33023287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebremeskel, S., Schanin, J., Coyle, K.M., Butuci, M., Luu, T., Brock, E.C.et al. (2021) Mast cell and eosinophil activation are associated with COVID-19 and TLR-mediated viral inflammation: implications for an anti-Siglec-8 antibody. Front. Immunol. 12, 650331 10.3389/fimmu.2021.650331</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.650331</ArticleId><ArticleId IdType="pmc">PMC7988091</ArticleId><ArticleId IdType="pubmed">33777047</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin, L.B., Butterfield, J.H., Raithel, M. and Molderings, G.J. (2016) Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options. Ann. Med. 48, 190&#x2013;201 10.3109/07853890.2016.1161231</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/07853890.2016.1161231</ArticleId><ArticleId IdType="pubmed">27012973</ArticleId></ArticleIdList></Reference><Reference><Citation>Afrin, L.B., Weinstock, L.B. and Molderings, G.J. (2020) COVID-19 hyperinflammation and post-COVID-19 illness may be rooted in mast cell activation syndrome. Int. J. Infect. Dis. 100, 327&#x2013;332 10.1016/j.ijid.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7529115</ArticleId><ArticleId IdType="pubmed">32920235</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinstock, L.B., Brook, J.B., Walters, A.S., Goris, A., Afrin, L.B. and Molderings, G.J. (2021) Mast cell activation symptoms are prevalent in long-COVID. Int. J. Infect. Dis. 112, 217&#x2013;226 10.1016/j.ijid.2021.09.043</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.09.043</ArticleId><ArticleId IdType="pmc">PMC8459548</ArticleId><ArticleId IdType="pubmed">34563706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler, J.B., Butuci, M., Wong, A., Kamboj, A.P. and Youngblood, B.A. (2022) Mast cell activation is associated with post-acute COVID-19 syndrome. Allergy 77, 1288&#x2013;1291 10.1111/all.15188</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15188</ArticleId><ArticleId IdType="pmc">PMC9299596</ArticleId><ArticleId IdType="pubmed">34820848</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh, M. and Saini, H.K. (2003) Resident cardiac mast cells and ischemia-reperfusion injury. J. Cardiovasc. Pharmacol. Ther. 8, 135&#x2013;148 10.1177/107424840300800207</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/107424840300800207</ArticleId><ArticleId IdType="pubmed">12808487</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, M.Q., Ma, Y.Y., Tao, S.F., Ding, J., Rao, L.H., Jiang, H.et al. (2014) Mast cell degranulation promotes ischemia-reperfusion injury in rat liver. J. Surg. Res. 186, 170&#x2013;178 10.1016/j.jss.2013.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2013.08.021</ArticleId><ArticleId IdType="pubmed">24139633</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, M.Q., Ma, Y.Y., Ding, J. and Li, J.Y. (2014) The role of mast cells in ischemia and reperfusion injury. Inflamm. Res. 63, 899&#x2013;905 10.1007/s00011-014-0763-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0763-z</ArticleId><ArticleId IdType="pubmed">25108401</ArticleId></ArticleIdList></Reference><Reference><Citation>He, Z., Li, Y., Ma, S., Yang, M., Ma, Y., Ma, C.et al. (2018) Degranulation of gastrointestinal mast cells contributes to hepatic ischemia-reperfusion injury in mice. Clin. Sci. (Lond.) 132, 2241&#x2013;2259 10.1042/CS20180662</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20180662</ArticleId><ArticleId IdType="pmc">PMC6376614</ArticleId><ArticleId IdType="pubmed">30301760</ArticleId></ArticleIdList></Reference><Reference><Citation>He, Z., Ma, C., Yu, T., Song, J., Leng, J., Gu, X.et al. (2019) Activation mechanisms and multifaceted effects of mast cells in ischemia reperfusion injury. Exp Cell Res. 376, 227&#x2013;235 10.1016/j.yexcr.2019.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.01.022</ArticleId><ArticleId IdType="pubmed">30716302</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng, S., Sun, X., Juan, Z., Wang, M., Wang, R., Sun, L.et al. (2021) Clemastine fumarate attenuates myocardial ischemia reperfusion injury through inhibition of mast cell degranulation. Front. Pharmacol. 12, 704852 10.3389/fphar.2021.704852</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.704852</ArticleId><ArticleId IdType="pmc">PMC8430029</ArticleId><ArticleId IdType="pubmed">34512339</ArticleId></ArticleIdList></Reference><Reference><Citation>DeTurk, S., Reddy, S., Pellegrino, A.N. and Wilson, J. (2019) Anaphylactic shock. In Clinical Management of Shock - The Science and Art of Physiological Restoration (Stawicki, S.P. and Swaroop, M., eds), IntechOpen, London</Citation></Reference><Reference><Citation>Demopoulos, C., Antonopoulou, S. and Theoharides, T.C. (2020) COVID-19, microthromboses, inflammation, and platelet activating factor. Biofactors 46, 927&#x2013;933 10.1002/biof.1696</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1696</ArticleId><ArticleId IdType="pubmed">33296106</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj, D., Selvakumar, G.P., Ahmed, M.E., Raikwar, S.P., Thangavel, R., Khan, A.et al. (2020) COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist 26, 402&#x2013;414 10.1177/1073858420941476</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858420941476</ArticleId><ArticleId IdType="pubmed">32684080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaid, Y., Puhm, F., Allaeys, I., Naya, A., Oudghiri, M., Khalki, L.et al. (2020) Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19. Circ. Res. 1494&#x2013;1418 10.1161/CIRCRESAHA.120.317703</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.120.317703</ArticleId><ArticleId IdType="pmc">PMC7641188</ArticleId><ArticleId IdType="pubmed">32938299</ArticleId></ArticleIdList></Reference><Reference><Citation>Jevtic, S.D. and Nazy, I. (2022) The COVID complex: a review of platelet activation and immune complexes in COVID-19. Front. Immunol. 13, 807934 10.3389/fimmu.2022.807934</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.807934</ArticleId><ArticleId IdType="pmc">PMC8965558</ArticleId><ArticleId IdType="pubmed">35371058</ArticleId></ArticleIdList></Reference><Reference><Citation>Forde, R.C. and Fitzgerald, D.J. (1997) Reactive oxygen species and platelet activation in reperfusion injury. Circulation 95, 787&#x2013;789 10.1161/01.CIR.95.4.787</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.95.4.787</ArticleId><ArticleId IdType="pubmed">9054729</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy, G., Norris, G., Spence, V., McLaren, M. and Belch, J.J. (2006) Is chronic fatigue syndrome associated with platelet activation? Blood Coagul. Fibrinolysis 17, 89&#x2013;92 10.1097/01.mbc.0000214705.80997.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mbc.0000214705.80997.73</ArticleId><ArticleId IdType="pubmed">16479189</ArticleId></ArticleIdList></Reference><Reference><Citation>Bester, J. and Pretorius, E. (2016) Effects of IL-1beta, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Sci. Rep. 6, 32188 10.1038/srep32188</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep32188</ArticleId><ArticleId IdType="pmc">PMC4999875</ArticleId><ArticleId IdType="pubmed">27561337</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemetson, K.J., Clemetson, J.M., Proudfoot, A.E., Power, C.A., Baggiolini, M. and Wells, T.N. (2000) Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood 96, 4046&#x2013;4054 10.1182/blood.V96.13.4046</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V96.13.4046</ArticleId><ArticleId IdType="pubmed">11110672</ArticleId></ArticleIdList></Reference><Reference><Citation>Hottz, E.D., Bozza, F.A. and Bozza, P.T. (2018) Platelets in immune response to virus and immunopathology of viral infections. Front. Med. (Lausanne) 5, 121 10.3389/fmed.2018.00121</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2018.00121</ArticleId><ArticleId IdType="pmc">PMC5936789</ArticleId><ArticleId IdType="pubmed">29761104</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso, M.E. and Santagostino, E. (2017) Platelets: much more than bricks in a breached wall. Br. J. Haematol. 178, 209&#x2013;219 10.1111/bjh.14653</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.14653</ArticleId><ArticleId IdType="pubmed">28419428</ArticleId></ArticleIdList></Reference><Reference><Citation>Nevzorova, T.A., Mordakhanova, E.R., Daminova, A.G., Ponomareva, A.A., Andrianova, I.A., Le Minh, G.et al. (2019) Platelet factor 4-containing immune complexes induce platelet activation followed by calpain-dependent platelet death. Cell Death Discov. 5, 106 10.1038/s41420-019-0188-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-019-0188-0</ArticleId><ArticleId IdType="pmc">PMC6591288</ArticleId><ArticleId IdType="pubmed">31263574</ArticleId></ArticleIdList></Reference><Reference><Citation>Olumuyiwa-Akeredolu, O.O., Page, M.J., Soma, P. and Pretorius, E. (2019) Platelets: emerging facilitators of cellular crosstalk in rheumatoid arthritis. Nat. Rev. Rheumatol. 15, 237&#x2013;248 10.1038/s41584-019-0187-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-019-0187-9</ArticleId><ArticleId IdType="pubmed">30824879</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura, A., Vecchie, A., Dagna, L., Martinod, K., Dixon, D.L., Van Tassell, B.W.et al. (2021) Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319&#x2013;329 10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunch, C.M., Moore, E.E., Moore, H.B., Neal, M.D., Thomas, A.V., Zackariya, N.et al. (2022) Immuno-thrombotic complications of COVID-19: implications for timing of surgery and anticoagulation. Front. Surg. 9, 889999 10.3389/fsurg.2022.889999</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fsurg.2022.889999</ArticleId><ArticleId IdType="pmc">PMC9119324</ArticleId><ArticleId IdType="pubmed">35599794</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams, B., Nunes, J.M., Page, M.J., Roberts, T., Carr, J., Nell, T.A.et al. (2019) Parkinson's disease: a systemic inflammatory disease accompanied by bacterial inflammagens. Front. Aging Neurosci. 11, 210 10.3389/fnagi.2019.00210</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00210</ArticleId><ArticleId IdType="pmc">PMC6718721</ArticleId><ArticleId IdType="pubmed">31507404</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M.J., Bester, J. and Pretorius, E. (2018) The inflammatory effects of TNF-alpha and complement component 3 on coagulation. Sci. Rep. 8, 1812 10.1038/s41598-018-20220-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20220-8</ArticleId><ArticleId IdType="pmc">PMC5789054</ArticleId><ArticleId IdType="pubmed">29379088</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M.J. and Pretorius, E. (2020) A champion of host defense: a generic large-scale cause for platelet dysfunction and depletion in infection. Semin. Thromb. Hemost. 46, 302&#x2013;319 10.1055/s-0040-1708827</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1708827</ArticleId><ArticleId IdType="pmc">PMC7339151</ArticleId><ArticleId IdType="pubmed">32279287</ArticleId></ArticleIdList></Reference><Reference><Citation>Page, M.J. and Pretorius, E. (2022) Platelet behavior contributes to neuropathologies: a focus on Alzheimer's and Parkinson's disease. Semin. Thromb. Hemost. 48, 382&#x2013;404 10.1055/s-0041-1733960</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1733960</ArticleId><ArticleId IdType="pubmed">34624913</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E., Oberholzer, H.M., van der Spuy, W.J. and Meiring, J.H. (2009) Macrothrombocytopenia: investigating the ultrastructure of platelets and fibrin networks using scanning and transmission electron microscopy. Ultrastruct. Pathol. 33, 216&#x2013;221 10.3109/01913120903288587</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913120903288587</ArticleId><ArticleId IdType="pubmed">19895294</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. (2019) Platelets as potent signaling entities in type 2 diabetes mellitus. Trends Endocrinol. Metab. 30, 532&#x2013;545 10.1016/j.tem.2019.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2019.05.003</ArticleId><ArticleId IdType="pubmed">31196615</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius, E. (2021) Platelets in HIV: a guardian of host defence or transient reservoir of the virus? Front. Immunol. 12, 649465 10.3389/fimmu.2021.649465</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.649465</ArticleId><ArticleId IdType="pmc">PMC8102774</ArticleId><ArticleId IdType="pubmed">33968041</ArticleId></ArticleIdList></Reference><Reference><Citation>Soma, P., Swanepoel, A.C., du Plooy, J.N., Mqoco, T. and Pretorius, E. (2016) Flow cytometric analysis of platelets type 2 diabetes mellitus reveals 'angry' platelets. Cardiovasc. Diabetol. 15, 52 10.1186/s12933-016-0373-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-016-0373-x</ArticleId><ArticleId IdType="pmc">PMC4818425</ArticleId><ArticleId IdType="pubmed">27036108</ArticleId></ArticleIdList></Reference><Reference><Citation>Soma, P. and Pretorius, E. (2015) Interplay between ultrastructural findings and atherothrombotic complications in type 2 diabetes mellitus. Cardiovasc. Diabetol. 14, 96 10.1186/s12933-015-0261-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0261-9</ArticleId><ArticleId IdType="pmc">PMC4521497</ArticleId><ArticleId IdType="pubmed">26228646</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rooy, M.J. and Pretorius, E. (2015) Metabolic syndrome, platelet activation and the development of transient ischemic attack or thromboembolic stroke. Thromb. Res. 135, 434&#x2013;442 10.1016/j.thromres.2014.12.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2014.12.030</ArticleId><ArticleId IdType="pubmed">25601172</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rooy, M.J., Duim, W., Ehlers, R., Buys, A.V. and Pretorius, E. (2015) Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: a microscopy and thromboelastography study. Cardiovasc. Diabetol. 14, 86 10.1186/s12933-015-0249-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0249-5</ArticleId><ArticleId IdType="pmc">PMC4542104</ArticleId><ArticleId IdType="pubmed">26140921</ArticleId></ArticleIdList></Reference><Reference><Citation>Blann, A.D., Nadar, S.K. and Lip, G.Y. (2003) The adhesion molecule P-selectin and cardiovascular disease. Eur. Heart. J. 24, 2166&#x2013;2179 10.1016/j.ehj.2003.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ehj.2003.08.021</ArticleId><ArticleId IdType="pubmed">14659768</ArticleId></ArticleIdList></Reference><Reference><Citation>Perkins, L.A., Anderson, C.J. and Novelli, E.M. (2019) Targeting P-selectin adhesion molecule in molecular imaging: P-selectin expression as a valuable imaging biomarker of inflammation in cardiovascular disease. J. Nucl. Med. 60, 1691&#x2013;1697 10.2967/jnumed.118.225169</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.118.225169</ArticleId><ArticleId IdType="pmc">PMC6894375</ArticleId><ArticleId IdType="pubmed">31601694</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarasev, M., Mota, S., Gao, X., Ferranti, M., Zaidi, A.U., Hannan, B.et al. (2022) Possible role of P-selectin adhesion in long-COVID: a comparative analysis of a long-COVID case versus an asymptomatic post-COVID case. medRxiv 2022.2003.2009.22271297</Citation></Reference><Reference><Citation>Lee, J., Kang, Y., Chang, J., Song, J. and Kim, B.K. (2020) Determination of serotonin concentration in single human platelets through single-entity electrochemistry. ACS Sens. 5, 1943&#x2013;1948 10.1021/acssensors.0c00267</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acssensors.0c00267</ArticleId><ArticleId IdType="pubmed">32498511</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloutier, N., Allaeys, I., Marcoux, G., Machlus, K.R., Mailhot, B., Zufferey, A.et al. (2018) Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. Proc. Natl Acad. Sci. U.S.A. 115, E1550&#x2013;E1559 10.1073/pnas.1720553115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1720553115</ArticleId><ArticleId IdType="pmc">PMC5816207</ArticleId><ArticleId IdType="pubmed">29386381</ArticleId></ArticleIdList></Reference><Reference><Citation>Dale, G.L., Friese, P., Batar, P., Hamilton, S.F., Reed, G.L., Jackson, K.W.et al. (2002) Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 415, 175&#x2013;179 10.1038/415175a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/415175a</ArticleId><ArticleId IdType="pubmed">11805836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jalali, F., Rezaie, S., Rola, P. and Kyle-Sidell, C. (2021) COVID-19 Pathophysiology: Are Platelets and Serotonin hiding in plain sight? SSRN preprint, https://ssrn.com/abstract=3800402</Citation></Reference><Reference><Citation>Santos, A.P., Couto, C.F., Pereira, S.S. and Monteiro, M.P. (2022) Is serotonin the missing link between COVID-19 severity observed in patients with diabetes and obesity? Neuroendocrinology 1&#x2013;71 10.1159/000522115</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522115</ArticleId><ArticleId IdType="pmc">PMC9059061</ArticleId><ArticleId IdType="pubmed">35066497</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimering, M.B., Razzaki, T., Tsang, T. and Shin, J.J. (2020) Inverse association between serotonin 2A receptor antagonist medication use and mortality in severe COVID-19 infection. Endocrinol. Diabetes Metab. J. 4, 1&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7590925</ArticleId><ArticleId IdType="pubmed">33117497</ArticleId></ArticleIdList></Reference><Reference><Citation>Fert-Bober, J., Darrah, E. and Andrade, F. (2020) Insights into the study and origin of the citrullinome in rheumatoid arthritis. Immunol. Rev. 294, 133&#x2013;147 10.1111/imr.12834</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12834</ArticleId><ArticleId IdType="pmc">PMC8061312</ArticleId><ArticleId IdType="pubmed">31876028</ArticleId></ArticleIdList></Reference><Reference><Citation>Smatti, M.K., Cyprian, F.S., Nasrallah, G.K., Al Thani, A.A., Almishal, R.O. and Yassine, H.M. (2019) Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses 11, 762 10.3390/v11080762</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11080762</ArticleId><ArticleId IdType="pmc">PMC6723519</ArticleId><ArticleId IdType="pubmed">31430946</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas, M., Rodr&#xed;guez, Y., Acosta-Ampudia, Y., Monsalve, D.M., Zhu, C., Quan-Zhen, L.et al. (2022) Autoimmunity is a hallmark of post-COVID syndrome. J. Transl. Med. 20, 129 10.1186/s12967-022-03328-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03328-4</ArticleId><ArticleId IdType="pmc">PMC8924736</ArticleId><ArticleId IdType="pubmed">35296346</ArticleId></ArticleIdList></Reference><Reference><Citation>Winchester, N., Calabrese, C. and Calabrese, L.H. (2021) The intersection of COVID-19 and autoimmunity: what is our current understanding? Pathog. Immun. 6, 31&#x2013;54 10.20411/pai.v6i1.417</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v6i1.417</ArticleId><ArticleId IdType="pmc">PMC8097827</ArticleId><ArticleId IdType="pubmed">33969248</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik, H.I., Mir, A.R., Abidi, M., Habib, S., Khan, F.H. and Moinuddin (2020) Preferential recognition of epitopes on peroxynitrite-modified alpha-2-macroglobulin by circulating autoantibodies in rheumatoid arthritis patients. J. Biomol. Struct. Dyn. 38, 1984&#x2013;1994 10.1080/07391102.2019.1623073</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2019.1623073</ArticleId><ArticleId IdType="pubmed">31179888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny, F., Blanco, J., Capelli, E., Castro-Marrero, J., Steiner, S., Murovska, M.et al. (2018) Myalgic encephalomyelitis/chronic fatigue syndrome - evidence for an autoimmune disease. Autoimmun. Rev. 17, 601&#x2013;609 10.1016/j.autrev.2018.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemekasten, G., Petersen, F. and Heidecke, H. (2020) What makes antibodies against G protein-coupled receptors so special? A novel concept to understand chronic diseases. Front. Immunol. 11, 564526 10.3389/fimmu.2020.564526</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.564526</ArticleId><ArticleId IdType="pmc">PMC7770155</ArticleId><ArticleId IdType="pubmed">33384684</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Y., Ebinger, J.E., Mostafa, R., Budde, P., Gajewski, J., Walker, B.et al. (2021) Paradoxical sex-specific patterns of autoantibody response to SARS-CoV-2 infection. J. Transl. Med. 19, 524 10.1186/s12967-021-03184-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-03184-8</ArticleId><ArticleId IdType="pmc">PMC8716184</ArticleId><ArticleId IdType="pubmed">34965855</ArticleId></ArticleIdList></Reference><Reference><Citation>Charnley, M., Islam, S., Bindra, G.K., Engwirda, J., Ratcliffe, J., Zhou, J.et al. (2022) Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19. Nat. Commun. 13, 3387 10.1038/s41467-022-30932-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30932-1</ArticleId><ArticleId IdType="pmc">PMC9189797</ArticleId><ArticleId IdType="pubmed">35697699</ArticleId></ArticleIdList></Reference><Reference><Citation>Nystr&#xf6;m, S. and Hammarstr&#xf6;m, P. (2022) Amyloidogenesis of SARS-CoV-2 spike protein. J. Am. Chem. Soc. 144, 8945&#x2013;8950 10.1021/jacs.2c03925</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jacs.2c03925</ArticleId><ArticleId IdType="pmc">PMC9136918</ArticleId><ArticleId IdType="pubmed">35579205</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan, A., Zlitni, S., Brooks, E.F., Vance, S.E., Dahlen, A., Hedlin, H.et al. (2022) Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med 3, 371&#x2013;387.e9 10.1016/j.medj.2022.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs, J.J.L. (2021) Persistent SARS-2 infections contribute to long COVID-19. Med. Hypotheses 149, 110538 10.1016/j.mehy.2021.110538</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110538</ArticleId><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Swank, Z., Senussi, Y., Alter, G. and Walt, D.R. (2022) Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. medRxiv 2022.2006.2014.22276401</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Brogna, C., Brogna, B., Bisaccia, D.R., Lauritano, F., Marino, G., Montano, L.et al. (2022) Could SARS-CoV-2 have bacteriophage behavior or induce the activity of other bacteriophages? Vaccines (Basel) 10, 708 10.3390/vaccines10050708</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10050708</ArticleId><ArticleId IdType="pmc">PMC9143435</ArticleId><ArticleId IdType="pubmed">35632464</ArticleId></ArticleIdList></Reference><Reference><Citation>Velasquez-Manoff, M. (2015) Gut microbiome: the peacekeepers. Nature 518, S3&#x2013;11 10.1038/518S3a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/518S3a</ArticleId><ArticleId IdType="pubmed">25715278</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal, A.D. and Marshall, T.G. (2018) Re-framing the theory of autoimmunity in the era of the microbiome: persistent pathogens, autoantibodies, and molecular mimicry. Discov. Med. 140, 299&#x2013;308</Citation><ArticleIdList><ArticleId IdType="pubmed">30021103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamada, N., Seo, S.U., Chen, G.Y. and N&#xfa;&#xf1;ez, G. (2013) Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 13, 321&#x2013;335 10.1038/nri3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3430</ArticleId><ArticleId IdType="pubmed">23618829</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentile, C.L. and Weir, T.L. (2018) The gut microbiota at the intersection of diet and human health. Science 362, 776&#x2013;780 10.1126/science.aau5812</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aau5812</ArticleId><ArticleId IdType="pubmed">30442802</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier, L., Goemans, C.V., Wirbel, J., Kuhn, M., Eberl, C., Pruteanu, M.et al. (2021) Unravelling the collateral damage of antibiotics on gut bacteria. Nature 599, 120&#x2013;124 10.1038/s41586-021-03986-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03986-2</ArticleId><ArticleId IdType="pmc">PMC7612847</ArticleId><ArticleId IdType="pubmed">34646011</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier, L., Pruteanu, M., Kuhn, M., Zeller, G., Telzerow, A., Anderson, E.E.et al. (2018) Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623&#x2013;628 10.1038/nature25979</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25979</ArticleId><ArticleId IdType="pmc">PMC6108420</ArticleId><ArticleId IdType="pubmed">29555994</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira-Silva, S., Falony, G., Belda, E., Nielsen, T., Aron-Wisnewsky, J., Chakaroun, R.et al. (2020) Statin therapy is associated with lower prevalence of gut microbiota dysbiosis. Nature 581, 310&#x2013;315 10.1038/s41586-020-2269-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2269-x</ArticleId><ArticleId IdType="pubmed">32433607</ArticleId></ArticleIdList></Reference><Reference><Citation>Forslund, S.K., Chakaroun, R., Zimmermann-Kogadeeva, M., Mark&#xf3;, L., Aron-Wisnewsky, J., Nielsen, T.et al. (2021) Combinatorial, additive and dose-dependent drug-microbiome associations. Nature 600, 500&#x2013;505 10.1038/s41586-021-04177-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04177-9</ArticleId><ArticleId IdType="pubmed">34880489</ArticleId></ArticleIdList></Reference><Reference><Citation>Haran, J.P., Bradley, E., Zeamer, A.L., Cincotta, L., Salive, M.C., Dutta, P.et al. (2021) Inflammation-type dysbiosis of the oral microbiome associates with the duration of COVID-19 symptoms and long COVID. JCI Insight 6, e152346 10.1172/jci.insight.152346</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.152346</ArticleId><ArticleId IdType="pmc">PMC8564890</ArticleId><ArticleId IdType="pubmed">34403368</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh, Y.K., Zuo, T., Lui, G.C., Zhang, F., Liu, Q., Li, A.Y.et al. (2021) Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut 70, 698&#x2013;706 10.1136/gutjnl-2020-323020</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazan, S., Stollman, N., Bozkurt, H.S., Dave, S., Papoutsis, A.J., Daniels, J.et al. (2022) Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity. BMJ Open Gastroenterol. 9, e000871 10.1136/bmjgast-2022-000871</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgast-2022-000871</ArticleId><ArticleId IdType="pmc">PMC9051551</ArticleId><ArticleId IdType="pubmed">35483736</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Q., Mak, J.W.Y., Su, Q., Yeoh, Y.K., Lui, G.C., Ng, S.S.S.et al. (2022) Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71, 544&#x2013;552 10.1136/gutjnl-2021-325989</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, B., Zhang, L., Wang, Y., Dai, T., Qin, Z., Zhou, F.et al. (2022) Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions. Signal. Transduct. Target. Ther. 7, 143 10.1038/s41392-022-00986-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00986-0</ArticleId><ArticleId IdType="pmc">PMC9052735</ArticleId><ArticleId IdType="pubmed">35487886</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilpert, K. and Mikut, R. (2021) Is there a connection between Gut microbiome dysbiosis occurring in COVID-19 patients and post-COVID-19 symptoms? Front. Microbiol. 12, 732838 10.3389/fmicb.2021.732838</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.732838</ArticleId><ArticleId IdType="pmc">PMC8485028</ArticleId><ArticleId IdType="pubmed">34603261</ArticleId></ArticleIdList></Reference><Reference><Citation>Newsome, R.C., Gauthier, J., Hernandez, M.C., Abraham, G.E., Robinson, T.O., Williams, H.B.et al. (2021) The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut Microbes 13, 1&#x2013;15 10.1080/19490976.2021.1926840</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2021.1926840</ArticleId><ArticleId IdType="pmc">PMC8205023</ArticleId><ArticleId IdType="pubmed">34100340</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuentes-Mu&#xf1;oz, N., Dutch, R.E. and Cattaneo, R. (2018) Direct cell-to-cell transmission of respiratory viruses: the fast lanes. PLoS Pathog. 14, e1007015 10.1371/journal.ppat.1007015</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007015</ArticleId><ArticleId IdType="pmc">PMC6023113</ArticleId><ArticleId IdType="pubmed">29953542</ArticleId></ArticleIdList></Reference><Reference><Citation>Bang, L.M. and Keating, G.M. (2004) Adalimumab: a review of its use in rheumatoid arthritis. BioDrugs 18, 121&#x2013;139 10.2165/00063030-200418020-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00063030-200418020-00005</ArticleId><ArticleId IdType="pubmed">15046527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y.F., Jobanputra, P., Barton, P., Jowett, S., Bryan, S., Clark, W.et al. (2006) A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness. Health Technol. Assess. 10, iii&#x2013;iv, xi&#x2013;xiii, 1&#x2013;229</Citation><ArticleIdList><ArticleId IdType="pubmed">17049139</ArticleId></ArticleIdList></Reference><Reference><Citation>Cattaneo, M. (2015) P2y12 receptors: structure and function. J. Thromb. Haemost. 13, S10&#x2013;S16 10.1111/jth.12952</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12952</ArticleId><ArticleId IdType="pubmed">26149010</ArticleId></ArticleIdList></Reference><Reference><Citation>Eller, T., Busse, J., Dittrich, M., Flieder, T., Alban, S., Knabbe, C.et al. (2014) Dabigatran, rivaroxaban, apixaban, argatroban and fondaparinux and their effects on coagulation POC and platelet function tests. Clin. Chem. Lab. Med. 52, 835&#x2013;844 10.1515/cclm-2013-0936</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2013-0936</ArticleId><ArticleId IdType="pubmed">24406289</ArticleId></ArticleIdList></Reference><Reference><Citation>Scharf, R.E. (2012) Drugs that affect platelet function. Semin. Thromb. Hemost. 38, 865&#x2013;883 10.1055/s-0032-1328881</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1328881</ArticleId><ArticleId IdType="pubmed">23111864</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman, S., Morris, M.C., Broderick, G., Craddock, T.J.A., Klimas, N.G. and Fletcher, M.A. (2019) Pharmaceutical interventions in chronic fatigue syndrome: a literature-based commentary. Clin. Ther. 41, 798&#x2013;805 10.1016/j.clinthera.2019.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.02.011</ArticleId><ArticleId IdType="pmc">PMC6543846</ArticleId><ArticleId IdType="pubmed">30871727</ArticleId></ArticleIdList></Reference><Reference><Citation>Collatz, A., Johnston, S.C., Staines, D.R. and Marshall-Gradisnik, S.M. (2016) A systematic review of drug therapies for chronic fatigue syndrome/myalgic encephalomyelitis. Clin. Ther. 38, 1263&#x2013;1271.e1269 10.1016/j.clinthera.2016.04.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2016.04.038</ArticleId><ArticleId IdType="pubmed">27229907</ArticleId></ArticleIdList></Reference><Reference><Citation>Reis, G., Silva, E., Silva, D.C.M., Thabane, L., Milagres, A.C., Ferreira, T.S.et al. (2022) Effect of Early treatment with ivermectin among patients with COVID-19. N. Engl. J. Med . 386, 1721&#x2013;1731 10.1056/NEJMoa2115869</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2115869</ArticleId><ArticleId IdType="pmc">PMC9006771</ArticleId><ArticleId IdType="pubmed">35353979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhakuni, T., Ali, M.F., Ahmad, I., Bano, S., Ansari, S. and Jairajpuri, M.A. (2016) Role of heparin and non heparin binding serpins in coagulation and angiogenesis: a complex interplay. Arch. Biochem. Biophys. 604, 128&#x2013;142 10.1016/j.abb.2016.06.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2016.06.018</ArticleId><ArticleId IdType="pubmed">27372899</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsh, J. and Raschke, R. (2004) Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126, 188S&#x2013;203S 10.1378/chest.126.3_suppl.188S</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.126.3_suppl.188S</ArticleId><ArticleId IdType="pubmed">15383472</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie, A.R. and Giri, H. (2020) Anticoagulant and signaling functions of antithrombin. J. Thromb. Haemost. 18, 3142&#x2013;3153 10.1111/jth.15052</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.15052</ArticleId><ArticleId IdType="pmc">PMC7855051</ArticleId><ArticleId IdType="pubmed">32780936</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Zhang, M., Tan, L., Pan, N. and Zhang, L. (2019) The clinical use of fondaparinux: a synthetic heparin pentasaccharide. Prog. Mol. Biol. Transl. Sci. 163, 41&#x2013;53 10.1016/bs.pmbts.2019.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/bs.pmbts.2019.02.004</ArticleId><ArticleId IdType="pubmed">31030756</ArticleId></ArticleIdList></Reference><Reference><Citation>Marongiu, F. and Barcellona, D. (2020) Fondaparinux: should it be studied in patients with COVID-19 disease? TH Open 4, e300&#x2013;e302 10.1055/s-0040-1719232</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1719232</ArticleId><ArticleId IdType="pmc">PMC7567638</ArticleId><ArticleId IdType="pubmed">33083688</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawlowski, C., Venkatakrishnan, A.J., Kirkup, C., Berner, G., Puranik, A., O'Horo, J.C.et al. (2021) Enoxaparin is associated with lower rates of mortality than unfractionated heparin in hospitalized COVID-19 patients. EClinicalMedicine 33, 100774 10.1016/j.eclinm.2021.100774</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100774</ArticleId><ArticleId IdType="pmc">PMC7941023</ArticleId><ArticleId IdType="pubmed">33718845</ArticleId></ArticleIdList></Reference><Reference><Citation>Mycroft-West, C., Su, D., Elli, S., Li, Y., Guimond, S., Miller, G.et al. (2020) The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 receptor binding domain undergoes conformational change upon heparin binding. bioRxiv 2020.2002.2029.971093</Citation></Reference><Reference><Citation>Tree, J.A., Turnbull, J.E., Buttigieg, K.R., Elmore, M.J., Coombes, N., Hogwood, J.et al. (2021) Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations. Br. J. Pharmacol. 178, 626&#x2013;635 10.1111/bph.15304</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15304</ArticleId><ArticleId IdType="pmc">PMC9328389</ArticleId><ArticleId IdType="pubmed">33125711</ArticleId></ArticleIdList></Reference><Reference><Citation>Handy, A., Banerjee, A., Wood, A.M., Dale, C., Sudlow, C.L.M., Tomlinson, C.et al. (2022) Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort. Heart 108, 923&#x2013;931 10.1136/heartjnl-2021-320325</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2021-320325</ArticleId><ArticleId IdType="pmc">PMC8931797</ArticleId><ArticleId IdType="pubmed">35273122</ArticleId></ArticleIdList></Reference><Reference><Citation>Viecca, M., Radovanovic, D., Forleo, G.B. and Santus, P. (2020) Enhanced platelet inhibition treatment improves hypoxemia in patients with severe COVID-19 and hypercoagulability. A case control, proof of concept study. Pharmacol. Res. 158, 104950 10.1016/j.phrs.2020.104950</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2020.104950</ArticleId><ArticleId IdType="pmc">PMC7244436</ArticleId><ArticleId IdType="pubmed">32450344</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaetgens, B., Nagy, M. and Ten Cate, H. (2022) Antiplatelet therapy in patients with COVID-19-more is less? J. Am. Med. Assoc. 327, 223&#x2013;224 10.1001/jama.2021.23866</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.23866</ArticleId><ArticleId IdType="pubmed">35040901</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger, J.S., Kornblith, L.Z., Gong, M.N., Reynolds, H.R., Cushman, M., Cheng, Y.et al. (2022) Effect of P2Y12 inhibitors on survival free of organ support among non-critically Ill hospitalized patients with COVID-19: a randomized clinical trial. J. Am. Med. Assoc 327, 227&#x2013;236 10.1001/jama.2021.23605</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.23605</ArticleId><ArticleId IdType="pmc">PMC8767444</ArticleId><ArticleId IdType="pubmed">35040887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, S., Chadwick, L., Mysler, E. and Moots, R.J. (2018) Review of biosimilar trials and data on Adalimumab in rheumatoid arthritis. Curr. Rheumatol. Rep. 20, 57 10.1007/s11926-018-0769-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-018-0769-6</ArticleId><ArticleId IdType="pmc">PMC6097048</ArticleId><ArticleId IdType="pubmed">30094742</ArticleId></ArticleIdList></Reference><Reference><Citation>Huizinga, T.W.J., Torii, Y. and Muniz, R. (2021) Adalimumab biosimilars in the treatment of rheumatoid arthritis: a systematic review of the evidence for biosimilarity. Rheumatol. Ther. 8, 41&#x2013;61 10.1007/s40744-020-00259-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40744-020-00259-8</ArticleId><ArticleId IdType="pmc">PMC7991039</ArticleId><ArticleId IdType="pubmed">33263165</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, X., Hu, R., Peng, L., Liu, M. and Sun, Z. (2021) Efficacy and safety of Adalimumab biosimilars: current critical clinical data in rheumatoid arthritis. Front. Immunol. 12, 638444 10.3389/fimmu.2021.638444</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.638444</ArticleId><ArticleId IdType="pmc">PMC8055954</ArticleId><ArticleId IdType="pubmed">33889152</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson, M., Archer, R., Tosh, J., Simpson, E., Everson-Hock, E., Stevens, J.et al. (2016) Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and Abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation. Health Technol. Assess . 20, 1&#x2013;610</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4867425</ArticleId><ArticleId IdType="pubmed">27140438</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo, Y., Hu, K., Li, Y., Lu, C., Ling, K., Cai, C.et al. (2022) Targeting TNF-alpha for COVID-19: recent advanced and controversies. Front. Public Health 10, 833967 10.3389/fpubh.2022.833967</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.833967</ArticleId><ArticleId IdType="pmc">PMC8873570</ArticleId><ArticleId IdType="pubmed">35223745</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, P.C., Liew, D.F.L., Tanner, H.L., Grainger, J.R., Dwek, R.A., Reisler, R.B.et al. (2022) COVID-19 therapeutics: challenges and directions for the future. Proc. Natl Acad. Sci. U.S.A. 119, e2119893119 10.1073/pnas.2119893119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2119893119</ArticleId><ArticleId IdType="pmc">PMC9169797</ArticleId><ArticleId IdType="pubmed">35385354</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Veerdonk, F.L., Giamarellos-Bourboulis, E., Pickkers, P., Derde, L., Leavis, H., van Crevel, R.et al. (2022) A guide to immunotherapy for COVID-19. Nat. Med. 28, 39&#x2013;50 10.1038/s41591-021-01643-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01643-9</ArticleId><ArticleId IdType="pubmed">35064248</ArticleId></ArticleIdList></Reference><Reference><Citation>Littlefield, K.M., Watson, R.O., Schneider, J.M., Neff, C.P., Yamada, E., Zhang, M.et al. (2022) SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 18, e1010359 10.1371/journal.ppat.1010359</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010359</ArticleId><ArticleId IdType="pmc">PMC9176759</ArticleId><ArticleId IdType="pubmed">35617421</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford, H. (2022) Can drugs reduce the risk of long COVID? What scientists know so far. Nature 604, 20&#x2013;21 10.1038/d41586-022-00823-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00823-y</ArticleId><ArticleId IdType="pubmed">35338366</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero, J., S&#xe1;ez-Franc&#xe0;s, N., Santillo, D. and Alegre, J. (2017) Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. Br. J. Pharmacol. 174, 345&#x2013;369 10.1111/bph.13702</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker, M.B., Brumfield, S.A. and Lara Mejia, P.S. (2018) Neuroinflammation and cytokines in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a critical review of research methods. Front. Neurol. 9, 1033 10.3389/fneur.2018.01033</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01033</ArticleId><ArticleId IdType="pmc">PMC6335565</ArticleId><ArticleId IdType="pubmed">30687207</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris, M.C., Cooney, K.E., Sedghamiz, H., Abreu, M., Collado, F., Balbin, E.G.et al. (2019) Leveraging prior knowledge of endocrine immune regulation in the therapeutically relevant phenotyping of women with chronic fatigue syndrome. Clin. Ther. 41, 656&#x2013;674.e654 10.1016/j.clinthera.2019.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.03.002</ArticleId><ArticleId IdType="pmc">PMC6478538</ArticleId><ArticleId IdType="pubmed">30929860</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, T., Yang, Y., Wang, D., Li, C., Qu, Y., Guo, J.et al. (2019) The clinical value of cytokines in chronic fatigue syndrome. J. Transl. Med. 17, 213 10.1186/s12967-019-1948-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-1948-6</ArticleId><ArticleId IdType="pmc">PMC6599310</ArticleId><ArticleId IdType="pubmed">31253154</ArticleId></ArticleIdList></Reference><Reference><Citation>Druce, K.L., Jones, G.T., Macfarlane, G.J. and Basu, N. (2015) Patients receiving anti-TNF therapies experience clinically important improvements in RA-related fatigue: results from the British society for rheumatology biologics register for rheumatoid arthritis. Rheumatology (Oxford) 54, 964&#x2013;971 10.1093/rheumatology/keu390</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu390</ArticleId><ArticleId IdType="pubmed">25313148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes, M.I., Bonjorno, L.P., Giannini, M.C., Amaral, N.B., Menezes, P.I., Dib, S.M.et al. (2021) Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open 7, e001455 10.1136/rmdopen-2020-001455</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2020-001455</ArticleId><ArticleId IdType="pmc">PMC7868202</ArticleId><ArticleId IdType="pubmed">33542047</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbab, A.A.I., Lu, X., Abdalla, I.M., Idris, A.A., Chen, Z., Li, M.et al. (2021) Metformin inhibits lipoteichoic acid-induced oxidative stress and inflammation through AMPK/NRF2/NF-kappaB signaling pathway in bovine mammary epithelial cells. Front. Vet. Sci. 8, 661380 10.3389/fvets.2021.661380</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2021.661380</ArticleId><ArticleId IdType="pmc">PMC8274905</ArticleId><ArticleId IdType="pubmed">34262962</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamyshnyi, O., Matskevych, V., Lenchuk, T., Strilbytska, O., Storey, K. and Lushchak, O. (2021) Metformin to decrease COVID-19 severity and mortality: molecular mechanisms and therapeutic potential. Biomed. Pharmacother. 144, 112230 10.1016/j.biopha.2021.112230</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.112230</ArticleId><ArticleId IdType="pmc">PMC8492612</ArticleId><ArticleId IdType="pubmed">34628168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y., Yang, X., Yan, P., Sun, T., Zeng, Z. and Li, S. (2021) Metformin in patients with COVID-19: a systematic review and meta-Analysis. Front. Med. (Lausanne) 8, 704666 10.3389/fmed.2021.704666</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.704666</ArticleId><ArticleId IdType="pmc">PMC8416892</ArticleId><ArticleId IdType="pubmed">34490296</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukhari, I.A., Almotrefi, A.A., Mohamed, O.Y., Al-Masri, A.A. and Sheikh, S.A. (2018) Protective effect of fenofibrate against ischemia-/reperfusion-induced cardiac arrhythmias in isolated rat hearts. Fundam. Clin. Pharmacol. 32, 141&#x2013;146 10.1111/fcp.12342</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/fcp.12342</ArticleId><ArticleId IdType="pubmed">29290096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu, Q., He, G., Wang, J., Wang, Y. and Chen, W. (2016) Protective effects of fenofibrate against acute lung injury induced by intestinal ischemia/reperfusion in mice. Sci. Rep. 6, 22044 10.1038/srep22044</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep22044</ArticleId><ArticleId IdType="pmc">PMC4763198</ArticleId><ArticleId IdType="pubmed">26902261</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolton, M.J., Chapman, B.P. and Van Marwijk, H. (2020) Low-dose naltrexone as a treatment for chronic fatigue syndrome. BMJ Case Rep. 13, e232502 10.1136/bcr-2019-232502</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2019-232502</ArticleId><ArticleId IdType="pmc">PMC6954765</ArticleId><ArticleId IdType="pubmed">31911410</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabanas, H., Muraki, K., Eaton-Fitch, N., Staines, D.R. and Marshall-Gradisnik, S. (2021) Potential therapeutic benefit of low dose naltrexone in myalgic encephalomyelitis/chronic fatigue syndrome: role of transient receptor potential melastatin 3 ion channels in pathophysiology and treatment. Front. Immunol. 12, 687806 10.3389/fimmu.2021.687806</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.687806</ArticleId><ArticleId IdType="pmc">PMC8313851</ArticleId><ArticleId IdType="pubmed">34326841</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, P.S. and Fishman, M.A. (2020) Low-dose naltrexone for chronic pain: update and systemic review. Curr. Pain Headache Rep. 24, 64 10.1007/s11916-020-00898-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-020-00898-0</ArticleId><ArticleId IdType="pubmed">32845365</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, F., Hou, T., Shen, A., Jin, H., Xiao, Y., Yu, W.et al. (2021) Mechanism deconvolution of Qing Fei Pai Du decoction for treatment of coronavirus disease 2019 (COVID-19) by label-free integrative pharmacology assays. J. Ethnopharmacol. 280, 114488 10.1016/j.jep.2021.114488</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2021.114488</ArticleId><ArticleId IdType="pmc">PMC8329432</ArticleId><ArticleId IdType="pubmed">34358653</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Y., Li, B., Wang, P. and Wang, Q. (2021) Traditional Chinese medicine, Qingfei Paidu decoction and Xuanfei Baidu decoction, inhibited cytokine production via NF-kappaB signaling pathway in macrophages: implications for coronavirus disease 2019 (COVID-19) therapy. Front. Pharmacol. 12, 722126 10.3389/fphar.2021.722126</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.722126</ArticleId><ArticleId IdType="pmc">PMC8576273</ArticleId><ArticleId IdType="pubmed">34764867</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z.Y., Xie, Z.J., Li, H.C., Wang, J.J., Wen, X.H., Wu, S.Y.et al. (2021) Guidelines on the treatment with integrated traditional Chinese medicine and western medicine for severe coronavirus disease 2019. Pharmacol. Res. 174, 105955 10.1016/j.phrs.2021.105955</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105955</ArticleId><ArticleId IdType="pmc">PMC8553423</ArticleId><ArticleId IdType="pubmed">34715330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L.H., Zheng, X., Bai, X.K., Wang, Q., Chen, B.W., Wang, H.B.et al. (2021) Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: a national retrospective registry study. Phytomedicine 85, 153531 10.1016/j.phymed.2021.153531</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2021.153531</ArticleId><ArticleId IdType="pmc">PMC7914374</ArticleId><ArticleId IdType="pubmed">33799224</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, H., Xu, B., Zhang, Y., Duan, Y., Gao, R., He, H.et al. (2021) Efficacy and safety of traditional Chinese medicine in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Front. Pharmacol. 12, 609213 10.3389/fphar.2021.609213</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.609213</ArticleId><ArticleId IdType="pmc">PMC8379002</ArticleId><ArticleId IdType="pubmed">34421581</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, J., Dong, F. and Robinson, N. (2022) State-of-the-art evidence of traditional Chinese medicine for treating coronavirus disease 2019. J. Tradit. Chin. Med. Sci. 9, 2&#x2013;6 10.1016/j.jtcms.2022.01.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtcms.2022.01.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, J.B., Andrade-Cetto, A., Echeverria, J., Wardle, J., Yen, H.R. and Heinrich, M. (2021) Editorial: ethnopharmacological responses to the coronavirus disease 2019 pandemic. Front. Pharmacol. 12, 798674 10.3389/fphar.2021.798674</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.798674</ArticleId><ArticleId IdType="pmc">PMC8678406</ArticleId><ArticleId IdType="pubmed">34925048</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang, W., Yang, F., Zhao, Y., Dai, E., Feng, J., Huang, Y.et al. (2022) Qingjin Yiqi granules for post-COVID-19 condition: a randomized clinical trial. J. Evid. Based Med. 15, 30&#x2013;38 10.1111/jebm.12465</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jebm.12465</ArticleId><ArticleId IdType="pmc">PMC9114922</ArticleId><ArticleId IdType="pubmed">35416437</ArticleId></ArticleIdList></Reference><Reference><Citation>Derosa, G., Maffioli, P., D'Angelo, A. and Di Pierro, F. (2021) Nutraceutical approach to preventing coronavirus disease 2019 and related complications. Front. Immunol. 12, 582556 10.3389/fimmu.2021.582556</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.582556</ArticleId><ArticleId IdType="pmc">PMC8273380</ArticleId><ArticleId IdType="pubmed">34262553</ArticleId></ArticleIdList></Reference><Reference><Citation>Alesci, A., Aragona, M., Cicero, N. and Lauriano, E.R. (2021) Can nutraceuticals assist treatment and improve COVID-19 symptoms? Nat. Prod. Res. 1&#x2013;20 36, 2672&#x2013;2691 10.1080/14786419.2021.1914032</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14786419.2021.1914032</ArticleId><ArticleId IdType="pubmed">33949266</ArticleId></ArticleIdList></Reference><Reference><Citation>Savant, S., Srinivasan, S. and Kruthiventi, A.K. (2021) Potential nutraceuticals for COVID-19. Nutr. Dietary Suppl. 13, 25&#x2013;51 10.2147/NDS.S294231</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDS.S294231</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, R.J. (1956) Biochemical Individuality, John Wiley, New York</Citation></Reference><Reference><Citation>Cuzzocrea, S., Riley, D.P., Caputi, A.P. and Salvemini, D. (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53, 135&#x2013;159</Citation><ArticleIdList><ArticleId IdType="pubmed">11171943</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, K., Zhao, G.M., Wu, D., Soong, Y., Birk, A.V., Schiller, P.W.et al. (2004) Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J. Biol. Chem. 279, 34682&#x2013;34690 10.1074/jbc.M402999200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M402999200</ArticleId><ArticleId IdType="pubmed">15178689</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori, K., Lee, H.T., Rapoport, D., Drexler, I.R., Foster, K., Yang, J.et al. (2005) Endocytic delivery of lipoccalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J. Clin. Investig. 115, 610&#x2013;621 10.1172/JCI23056</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI23056</ArticleId><ArticleId IdType="pmc">PMC548316</ArticleId><ArticleId IdType="pubmed">15711640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelsey, N.A., Wilkins, H.M. and Linseman, D.A. (2010) Nutraceutical antioxidants as novel neuroprotective agents. Molecules 15, 7792&#x2013;7814 10.3390/molecules15117792</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules15117792</ArticleId><ArticleId IdType="pmc">PMC4697862</ArticleId><ArticleId IdType="pubmed">21060289</ArticleId></ArticleIdList></Reference><Reference><Citation>Tardiolo, G., Bramanti, P. and Mazzon, E. (2018) Overview on the effects of N-acetylcysteine in neurodegenerative diseases. Molecules 23, 3305 10.3390/molecules23123305</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules23123305</ArticleId><ArticleId IdType="pmc">PMC6320789</ArticleId><ArticleId IdType="pubmed">30551603</ArticleId></ArticleIdList></Reference><Reference><Citation>dos Santos Ten&#xf3;rio, M.C., Graciliano, N.G., Moura, F.A., de Oliveira, M. and Goulart, M.O.F. (2021) N-acetylcysteine (NAC): impacts on human health. Antioxidants (Basel) 10, 967 10.3390/antiox10060967</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10060967</ArticleId><ArticleId IdType="pmc">PMC8234027</ArticleId><ArticleId IdType="pubmed">34208683</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwalfenberg, G.K. (2021) N-acetylcysteine: a review of clinical usefulness (an old drug with new tricks). J. Nutr. Metab. 2021, 9949453 10.1155/2021/9949453</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9949453</ArticleId><ArticleId IdType="pmc">PMC8211525</ArticleId><ArticleId IdType="pubmed">34221501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye, M., Lin, W., Zheng, J. and Lin, S. (2021) N-acetylcysteine for chronic kidney disease: a systematic review and meta-analysis. Am. J. Transl. Res. 13, 2472&#x2013;2485</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129408</ArticleId><ArticleId IdType="pubmed">34017406</ArticleId></ArticleIdList></Reference><Reference><Citation>Batooei, M., Tahamoli-Roudsari, A., Basiri, Z., Yasrebifar, F., Shahdoust, M., Eshraghi, A.et al. (2018) Evaluating the effect of oral N-acetylcysteine as an adjuvant treatment on clinical outcomes of patients with rheumatoid arthritis: a randomized, double blind clinical trial. Rev. Recent Clin. Trials 13, 132&#x2013;138 10.2174/1574887113666180307151937</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1574887113666180307151937</ArticleId><ArticleId IdType="pubmed">29521247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H.R., Kim, K.W., Kim, B.M., Lee, K.A. and Lee, S.H. (2019) N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL production in rheumatoid arthritis. Korean J. Intern. Med. 34, 210&#x2013;219 10.3904/kjim.2016.329</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2016.329</ArticleId><ArticleId IdType="pmc">PMC6325425</ArticleId><ArticleId IdType="pubmed">28286938</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamali, F., Ahmadzadeh, A., Sahraei, Z. and Salamzadeh, J. (2021) Study of the effects of N-acetylcysteine on inflammatory biomarkers and disease activity score in patients with rheumatoid arthritis. Iran. J. Allergy Asthma Immunol. 20, 574&#x2013;583 10.18502/ijaai.v20i5.7407</Citation><ArticleIdList><ArticleId IdType="doi">10.18502/ijaai.v20i5.7407</ArticleId><ArticleId IdType="pubmed">34664816</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer, J., Scorza, F.A., Scorza, C.A. and Fiorini, A.C. (2022) Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19. World J. Virol. 11, 82&#x2013;84 10.5501/wjv.v11.i1.82</Citation><ArticleIdList><ArticleId IdType="doi">10.5501/wjv.v11.i1.82</ArticleId><ArticleId IdType="pmc">PMC8788215</ArticleId><ArticleId IdType="pubmed">35117973</ArticleId></ArticleIdList></Reference><Reference><Citation>Assimakopoulos, S.F., Aretha, D., Komninos, D., Dimitropoulou, D., Lagadinou, M., Leonidou, L.et al. (2021) N-acetyl-cysteine reduces the risk for mechanical ventilation and mortality in patients with COVID-19 pneumonia: a two-center retrospective cohort study. Infect. Dis. (Lond.) 53, 847&#x2013;854 10.1080/23744235.2021.1945675</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1945675</ArticleId><ArticleId IdType="pubmed">34182881</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty, R.R., Padhy, B.M., Das, S. and Meher, B.R. (2021) Therapeutic potential of N-acetyl cysteine (NAC) in preventing cytokine storm in COVID-19: review of current evidence. Eur. Rev. Med. Pharmacol. Sci. 25, 2802&#x2013;2807 10.26355/eurrev_202103_25442</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202103_25442</ArticleId><ArticleId IdType="pubmed">33829465</ArticleId></ArticleIdList></Reference><Reference><Citation>Reyes-Gordillo, K., Segovia, J., Shibayama, M., Vergara, P., Moreno, M.G. and Muriel, P. (2007) Curcumin protects against acute liver damage in the rat by inhibiting NF-kappaB, proinflammatory cytokines production and oxidative stress. Biochim. Biophys. Acta 1770, 989&#x2013;996 10.1016/j.bbagen.2007.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2007.02.004</ArticleId><ArticleId IdType="pubmed">17383825</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu, Y., Zheng, S., Lin, J., Ryerse, J. and Chen, A. (2008) Curcumin protects the rat liver from CCl4-caused injury and fibrogenesis by attenuating oxidative stress and suppressing inflammation. Mol. Pharmacol. 73, 399&#x2013;409 10.1124/mol.107.039818</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.107.039818</ArticleId><ArticleId IdType="pubmed">18006644</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, J., Pan, X.Y., Xu, Y., Xiao, Y., An, Y., Tie, L.et al. (2012) Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy 8, 812&#x2013;825 10.4161/auto.19471</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.19471</ArticleId><ArticleId IdType="pubmed">22622204</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharajalu, R., Garige, M., Leckey, L.C., Reyes-Gordillo, K., Shah, R. and Lakshman, M.R. (2016) Protective role of dietary curcumin in the prevention of the oxidative stress induced by chronic alcohol with respect to hepatic injury and antiatherogenic markers. Oxidative Med. Cell. Longev. 2016, 5017460 10.1155/2016/5017460</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5017460</ArticleId><ArticleId IdType="pmc">PMC4736425</ArticleId><ArticleId IdType="pubmed">26881029</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Z. and Ying, Y. (2020) The inhibitory effect of curcumin on virus-induced cytokine storm and its potential use in the associated severe pneumonia. Front Cell Dev. Biol. 8, 479 10.3389/fcell.2020.00479</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2020.00479</ArticleId><ArticleId IdType="pmc">PMC7303286</ArticleId><ArticleId IdType="pubmed">32596244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattis, B.A.C., Ramos, S.G. and Celes, M.R.N. (2021) Curcumin as a potential treatment for COVID-19. Front. Pharmacol. 12, 675287 10.3389/fphar.2021.675287</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.675287</ArticleId><ArticleId IdType="pmc">PMC8138567</ArticleId><ArticleId IdType="pubmed">34025433</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris, G., Puri, B.K., Walker, A.J., Maes, M., Carvalho, A.F., Walder, K.et al. (2019) Myalgic encephalomyelitis/chronic fatigue syndrome: from pathophysiological insights to novel therapeutic opportunities. Pharmacol. Res. 148, 104450 10.1016/j.phrs.2019.104450</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2019.104450</ArticleId><ArticleId IdType="pubmed">31509764</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed, S., Anuntiyo, J., Malemud, C.J. and Haqqi, T.M. (2005) Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid. Based Complement. Alternat. Med. 2, 301&#x2013;308 10.1093/ecam/neh117</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecam/neh117</ArticleId><ArticleId IdType="pmc">PMC1193557</ArticleId><ArticleId IdType="pubmed">16136208</ArticleId></ArticleIdList></Reference><Reference><Citation>Aravilli, R.K., Vikram, S.L. and Kohila, V. (2017) Phytochemicals as potential antidotes for targeting NF-kappa B in rheumatoid arthritis. 3 Biotech 7, 253 10.1007/s13205-017-0888-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13205-017-0888-1</ArticleId><ArticleId IdType="pmc">PMC5515733</ArticleId><ArticleId IdType="pubmed">28721679</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl, T., Mehta, K., Sehgal, A., Singh, S., Sharma, N., Ahmadi, A.et al. (2022) Exploring the role of polyphenols in rheumatoid arthritis. Crit Rev Food Sci Nutr. 62, 5372&#x2013;5393 10.1080/10408398.2021.1924613</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2021.1924613</ArticleId><ArticleId IdType="pubmed">33998910</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadian Haftcheshmeh, S., Khosrojerdi, A., Aliabadi, A., Lotfi, S., Mohammadi, A. and Momtazi-Borojeni, A.A. (2021) Immunomodulatory effects of curcumin in rheumatoid arthritis: evidence from molecular mechanisms to clinical outcomes. Rev. Physiol. Biochem. Pharmacol. 179, 1&#x2013;29 10.1007/112_2020_54</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/112_2020_54</ArticleId><ArticleId IdType="pubmed">33404796</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourhabibi-Zarandi, F., Shojaei-Zarghani, S. and Rafraf, M. (2021) Curcumin and rheumatoid arthritis: a systematic review of literature. Int. J. Clin. Pract. 75, e14280 10.1111/ijcp.14280</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijcp.14280</ArticleId><ArticleId IdType="pubmed">33914984</ArticleId></ArticleIdList></Reference><Reference><Citation>Jena, A.B., Kanungo, N., Nayak, V., Chainy, G.B.N. and Dandapat, J. (2021) Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies. Sci. Rep. 11, 2043 10.1038/s41598-021-81462-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81462-7</ArticleId><ArticleId IdType="pmc">PMC7820253</ArticleId><ArticleId IdType="pubmed">33479401</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahedian-Azimi, A., Abbasifard, M., Rahimi-Bashar, F., Guest, P.C., Majeed, M., Mohammadi, A.et al. (2022) Effectiveness of curcumin on outcomes of hospitalized COVID-19 patients: a systematic review of clinical trials. Nutrients 14, 256 10.3390/nu14020256</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020256</ArticleId><ArticleId IdType="pmc">PMC8779570</ArticleId><ArticleId IdType="pubmed">35057437</ArticleId></ArticleIdList></Reference><Reference><Citation>Bousquet, J., Haahtela, T., Blain, H., Czarlewski, W., Zuberbier, T., Bedbrook, A.et al. (2022) Available and affordable complementary treatments for COVID-19: from hypothesis to pilot studies and the need for implementation. Clin. Transl. Allergy 12, e12127 10.1002/clt2.12127</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/clt2.12127</ArticleId><ArticleId IdType="pmc">PMC8967265</ArticleId><ArticleId IdType="pubmed">35344297</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava, K.C., Bordia, A. and Verma, S.K. (1995) Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot. Essent. Fat. Acids 52, 223&#x2013;227 10.1016/0952-3278(95)90040-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0952-3278(95)90040-3</ArticleId><ArticleId IdType="pubmed">7784468</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, B.H., Nawaz, Z., Pertani, S.A., Roomi, A., Mahmood, H., Saeed, S.A.et al. (1999) Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem. Pharmacol. 58, 1167&#x2013;1172 10.1016/S0006-2952(99)00206-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-2952(99)00206-3</ArticleId><ArticleId IdType="pubmed">10484074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, K. and Park, K.I. (2019) A review of antiplatelet activity of traditional medicinal herbs on integrative medicine studies. Evid. Based Complement. Alternat. Med. 2019, 7125162 10.1155/2019/7125162</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/7125162</ArticleId><ArticleId IdType="pmc">PMC6335729</ArticleId><ArticleId IdType="pubmed">30719065</ArticleId></ArticleIdList></Reference><Reference><Citation>Borodina, I., Kenny, L.C., McCarthy, C.M., Paramasivan, K., Pretorius, R., Roberts, T.J.et al. (2020) The biology of ergothioneine, an antioxidant nutraceutical. Nutr. Res. Rev. 33, 190&#x2013;217 10.1017/S0954422419000301</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0954422419000301</ArticleId><ArticleId IdType="pmc">PMC7653990</ArticleId><ArticleId IdType="pubmed">32051057</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheah, I.K. and Halliwell, B. (2021) Ergothioneine, recent developments. Redox Biol. 42, 101868 10.1016/j.redox.2021.101868</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2021.101868</ArticleId><ArticleId IdType="pmc">PMC8113028</ArticleId><ArticleId IdType="pubmed">33558182</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell, B., Cheah, I.K. and Drum, C.L. (2016) Ergothioneine, an adaptive antioxidant for the protection of injured tissues? A hypothesis. Biochem. Biophys. Res. Commun. 470, 245&#x2013;250 10.1016/j.bbrc.2015.12.124</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2015.12.124</ArticleId><ArticleId IdType="pubmed">26772879</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell, B., Cheah, I.K. and Tang, R.M.Y. (2018) Ergothioneine - a diet-derived antioxidant with therapeutic potential. FEBS Lett. 592, 3357&#x2013;3366 10.1002/1873-3468.13123</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.13123</ArticleId><ArticleId IdType="pubmed">29851075</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul, B.D. and Snyder, S.H. (2010) The unusual amino acid L-ergothioneine is a physiologic cytoprotectant. Cell Death Differ. 17, 1134&#x2013;1140 10.1038/cdd.2009.163</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2009.163</ArticleId><ArticleId IdType="pmc">PMC2885499</ArticleId><ArticleId IdType="pubmed">19911007</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul, B.D. (2021) Ergothioneine: a stress vitamin with anti-aging, vascular and neuroprotective roles? Antioxid. Redox Signal. 36, 1306&#x2013;1317 10.1089/ars.2021.0043</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2021.0043</ArticleId><ArticleId IdType="pmc">PMC9221166</ArticleId><ArticleId IdType="pubmed">34619979</ArticleId></ArticleIdList></Reference><Reference><Citation>Servillo, L., D'Onofrio, N. and Balestrieri, M.L. (2017) Ergothioneine antioxidant function: from chemistry to cardiovascular therapeutic potential. J. Cardiovasc. Pharmacol. 69, 183&#x2013;191 10.1097/FJC.0000000000000464</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/FJC.0000000000000464</ArticleId><ArticleId IdType="pubmed">28375902</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu, T.T. and Shen, L. (2022) Ergothioneine as a natural antioxidant against oxidative stress-related diseases. Front. Pharmacol. 13, 850813 10.3389/fphar.2022.850813</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.850813</ArticleId><ArticleId IdType="pmc">PMC8971627</ArticleId><ArticleId IdType="pubmed">35370675</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;ndemann, D., Harlfinger, S., Golz, S., Geerts, A., Lazar, A., Berkels, R.et al. (2005) Discovery of the ergothioneine transporter. Proc Natl Acad Sci. USA 102, 5256&#x2013;5261 10.1073/pnas.0408624102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0408624102</ArticleId><ArticleId IdType="pmc">PMC555966</ArticleId><ArticleId IdType="pubmed">15795384</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;ndemann, D. (2012) The ergothioneine transporter controls and indicates ergothioneine activity--a review. Prev. Med. 54, S71&#x2013;S74 10.1016/j.ypmed.2011.12.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ypmed.2011.12.001</ArticleId><ArticleId IdType="pubmed">22182480</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xfc;ndemann, D., Hartmann, L. and Fl&#xf6;gel, S. (2021) The ergothioneine transporter (ETT): substrates and locations, an inventory. FEBS Lett. 596, 1252&#x2013;1269 10.1002/1873-3468.14269</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14269</ArticleId><ArticleId IdType="pubmed">34958679</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerley, R.N., McCarthy, C., Kell, D.B. and Kenny, L.C. (2018) The potential therapeutic effects of ergothioneine in pre-eclampsia. Free Radic. Biol. Med. 117, 145&#x2013;157 10.1016/j.freeradbiomed.2017.12.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.12.030</ArticleId><ArticleId IdType="pubmed">29284116</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson, R.D., McCarthy, F.P., Manna, S., Groarke, E., Kell, D.B., Kenny, L.C.et al. (2020) L-(+)-Ergothioneine significantly improves the clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension 75, 561&#x2013;568 10.1161/HYPERTENSIONAHA.119.13929</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.119.13929</ArticleId><ArticleId IdType="pubmed">31865793</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith, E., Ottosson, F., Hellstrand, S., Ericson, U., Orho-Melander, M., Fernandez, C.et al. (2020) Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease. Heart 106, 691&#x2013;697 10.1136/heartjnl-2019-315485</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heartjnl-2019-315485</ArticleId><ArticleId IdType="pmc">PMC7229907</ArticleId><ArticleId IdType="pubmed">31672783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedirli, A., Sakrak, O., Muhtaroglu, S., Soyuer, I., Guler, I., Erdogan, A.R.et al. (2004) Ergothioneine pretreatment protects the liver from ischemia-reperfusion injury caused by increasing hepatic heat shock protein 70. J. Surg. Res. 122, 96&#x2013;102 10.1016/j.jss.2004.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2004.06.016</ArticleId><ArticleId IdType="pubmed">15522321</ArticleId></ArticleIdList></Reference><Reference><Citation>Deiana, M., Rosa, A., Casu, V., Piga, R., Dessi, M.A. and Aruoma, O.I. (2004) L-Ergothioneine modulates oxidative damage in the kidney and liver of rats in vivo: studies upon the profile of polyunsaturated fatty acids. Clin. Nutr. 23, 183&#x2013;193 10.1016/S0261-5614(03)00108-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0261-5614(03)00108-0</ArticleId><ArticleId IdType="pubmed">15030958</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, T.Y., Chen, C.L., Liao, J.W., Ou, H.C. and Tsai, M.S. (2010) Ergothioneine protects against neuronal injury induced by cisplatin both in vitro and in vivo. Food Chem. Toxicol. 48, 3492&#x2013;3499 10.1016/j.fct.2010.09.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2010.09.030</ArticleId><ArticleId IdType="pubmed">20932872</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, N.C., Lin, H.C., Wu, J.H., Ou, H.C., Chai, Y.C., Tseng, C.Y.et al. (2012) Ergothioneine protects against neuronal injury induced by beta-amyloid in mice. Food Chem. Toxicol. 50, 3902&#x2013;3911 10.1016/j.fct.2012.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2012.08.021</ArticleId><ArticleId IdType="pubmed">22921351</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakrak, O., Kerem, M., Bedirli, A., Pasaoglu, H., Akyurek, N., Ofluoglu, E.et al. (2008) Ergothioneine modulates proinflammatory cytokines and heat shock protein 70 in mesenteric ischemia and reperfusion injury. J. Surg. Res. 144, 36&#x2013;42 10.1016/j.jss.2007.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jss.2007.04.020</ArticleId><ArticleId IdType="pubmed">17603080</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheah, I.K. and Halliwell, B. (2020) Could ergothioneine aid in the treatment of coronavirus patients? Antioxidants (Basel) 9, 595 10.3390/antiox9070595</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9070595</ArticleId><ArticleId IdType="pmc">PMC7402156</ArticleId><ArticleId IdType="pubmed">32646061</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, R.M.Y., Cheah, I.K., Yew, T.S.K. and Halliwell, B. (2018) Distribution and accumulation of dietary ergothioneine and its metabolites in mouse tissues. Sci. Rep. 8, 1601 10.1038/s41598-018-20021-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-20021-z</ArticleId><ArticleId IdType="pmc">PMC5785509</ArticleId><ArticleId IdType="pubmed">29371632</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hoek, S.A., Darbani, B., Zugaj, K., Prabhala, B.K., Biron, M.B., Randelovic, M.et al. (2019) Engineering the yeast Saccharomyces cerevisiae for the production of L-(+)-ergothioneine. Front. Bioeng. Biotechnol. 7, 262 10.3389/fbioe.2019.00262</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2019.00262</ArticleId><ArticleId IdType="pmc">PMC6797849</ArticleId><ArticleId IdType="pubmed">31681742</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hoek, S.A., Rusn&#xe1;k, M., Jacobsen, I.H., Mart&#xed;nez, J.L., Kell, D.B. and Borodina, I. (2022) Engineering ergothioneine production in Yarrowia lipolytica FEBS lett 596, 1356&#x2013;1364 10.1002/1873-3468.14239</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.14239</ArticleId><ArticleId IdType="pmc">PMC9299812</ArticleId><ArticleId IdType="pubmed">34817066</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Hoek, S.A., Rusn&#xe1;k, M., Wang, G., Stanchev, L.D., de F&#xe1;tima Alvez, L., Jessop-Fabre, M.M.et al. (2022) Engineering precursor supply for the high-level production of ergothioneine in Saccharomyces cerevisiae. Metab. Eng. 70, 129&#x2013;142 10.1016/j.ymben.2022.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymben.2022.01.012</ArticleId><ArticleId IdType="pubmed">35085780</ArticleId></ArticleIdList></Reference><Reference><Citation>Alamgir, K.M., Masuda, S., Fujitani, Y., Fukuda, F. and Tani, A. (2015) Production of ergothioneine by Methylobacterium species. Front. Microbiol. 6, 1185 10.3389/fmicb.2015.01185</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2015.01185</ArticleId><ArticleId IdType="pmc">PMC4621440</ArticleId><ArticleId IdType="pubmed">26579093</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujitani, Y., Alamgir, K.M. and Tani, A. (2018) Ergothioneine production using Methylobacterium species, yeast, and fungi. J. Biosci. Bioeng. 126, 715&#x2013;722 10.1016/j.jbiosc.2018.05.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbiosc.2018.05.021</ArticleId><ArticleId IdType="pubmed">29910189</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Y., Tang, X., Zhang, Y., Hu, X. and Ren, L.J. (2021) The current status of biotechnological production and the application of a novel antioxidant ergothioneine. Crit. Rev. Biotechnol. 41, 580&#x2013;593 10.1080/07388551.2020.1869692</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07388551.2020.1869692</ArticleId><ArticleId IdType="pubmed">33550854</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamide, T., Takusagawa, S., Tanaka, N., Ogasawara, Y., Kawano, Y., Ohtsu, I.et al. (2020) High production of ergothioneine in Escherichia coli using the sulfoxide synthase from Methylobacterium strains. J. Agric. Food Chem. 68, 6390&#x2013;6394 10.1021/acs.jafc.0c01846</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.0c01846</ArticleId><ArticleId IdType="pubmed">32436380</ArticleId></ArticleIdList></Reference><Reference><Citation>Osawa, R., Kamide, T., Satoh, Y., Kawano, Y., Ohtsu, I. and Dairi, T. (2018) Heterologous and high production of ergothioneine in Escherichia coli. J. Agric. Food Chem. 66, 1191&#x2013;1196 10.1021/acs.jafc.7b04924</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.7b04924</ArticleId><ArticleId IdType="pubmed">29276826</ArticleId></ArticleIdList></Reference><Reference><Citation>Takusagawa, S., Satoh, Y., Ohtsu, I. and Dairi, T. (2019) Ergothioneine production with Aspergillus oryzae. Biosci. Biotechnol. Biochem. 83, 181&#x2013;184 10.1080/09168451.2018.1527210</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09168451.2018.1527210</ArticleId><ArticleId IdType="pubmed">30286703</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L., Wang, Y., Li, J., Du, G. and Kang, Z. (2022) [Construction and optimization of ergothioneine-producing Escherichia coli]. Sheng Wu Gong Cheng Xue Bao. 38, 796&#x2013;806 10.13345/j.cjb.210166</Citation><ArticleIdList><ArticleId IdType="doi">10.13345/j.cjb.210166</ArticleId><ArticleId IdType="pubmed">35234399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubost, N.J., Ou, B. and Beelman, R.B. (2007) Quantification of polyphenols and ergothioneine in cultivated mushrooms and correlation to total antioxidant capacity. Food Chem. 105, 727&#x2013;735 10.1016/j.foodchem.2007.01.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2007.01.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ey, J., Sch&#xf6;mig, E. and Taubert, D. (2007) Dietary sources and antioxidant effects of ergothioneine. J. Agric. Food Chem. 55, 6466&#x2013;6474 10.1021/jf071328f</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf071328f</ArticleId><ArticleId IdType="pubmed">17616140</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalaras, M.D., Richie, J.P., Calcagnotto, A. and Beelman, R.B. (2017) Mushrooms: a rich source of the antioxidants ergothioneine and glutathione. Food Chem. 233, 429&#x2013;433 10.1016/j.foodchem.2017.04.109</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2017.04.109</ArticleId><ArticleId IdType="pubmed">28530594</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng, L., Cheah, I.K., Ng, M.M., Li, J., Chan, S.M., Lim, S.L.et al. (2019) The association between mushroom consumption and mild cognitive impairment: a community-based cross-sectional study in Singapore. J. Alzheimers Dis. 68, 197&#x2013;203 10.3233/JAD-180959</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-180959</ArticleId><ArticleId IdType="pubmed">30775990</ArticleId></ArticleIdList></Reference><Reference><Citation>Slomski, A. (2021) Trials test mushrooms and herbs as anti-COVID-19 agents. J. Am. Med. Assoc 326, 1997&#x2013;1999 10.1001/jama.2021.19388</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.19388</ArticleId><ArticleId IdType="pubmed">34730783</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips, J.M., Ooi, S.L. and Pak, S.C. (2022) Health-promoting properties of medicinal mushrooms and their bioactive compounds for the COVID-19 era-an appraisal: do the pro-health claims measure up? Molecules 27, 2302 10.3390/molecules27072302</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27072302</ArticleId><ArticleId IdType="pmc">PMC9000601</ArticleId><ArticleId IdType="pubmed">35408701</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain, T., Tan, B., Yin, Y.L., Blachier, F., Tossou, M.C.B. and Rahu, N. (2016) Oxidative stress and inflammation: what polyphenols can do for US? Oxidative Med. Cell. Longev. 2016, 7432797 10.1155/2016/7432797</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/7432797</ArticleId><ArticleId IdType="pmc">PMC5055983</ArticleId><ArticleId IdType="pubmed">27738491</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton, E., Kandaswami, C. and Theoharides, T.C. (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52, 673&#x2013;751</Citation><ArticleIdList><ArticleId IdType="pubmed">11121513</ArticleId></ArticleIdList></Reference><Reference><Citation>Havsteen, B.H. (2002) The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 96, 67&#x2013;202 10.1016/S0163-7258(02)00298-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-7258(02)00298-X</ArticleId><ArticleId IdType="pubmed">12453566</ArticleId></ArticleIdList></Reference><Reference><Citation>Passamonti, S., Terdoslavich, M., Franca, R., Vanzo, A., Tramer, F., Braidot, E.et al. (2009) Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr. Drug Metab. 10, 369&#x2013;394 10.2174/138920009788498950</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/138920009788498950</ArticleId><ArticleId IdType="pubmed">19519345</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Bo', C., Bernardi, S., Marino, M., Porrini, M., Tucci, M., Guglielmetti, S.et al. (2019) Systematic review on polyphenol intake and health outcomes: is there sufficient evidence to define a health-promoting polyphenol-rich dietary pattern? Nutrients 11, 1355 10.3390/nu11020391</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11020391</ArticleId><ArticleId IdType="pmc">PMC6627994</ArticleId><ArticleId IdType="pubmed">31208133</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayat, P., Farshchi, M., Yousefian, M., Mahmoudi, M. and Yazdian-Robati, R. (2021) Flavonoids, the compounds with anti-inflammatory and immunomodulatory properties, as promising tools in multiple sclerosis (MS) therapy: a systematic review of preclinical evidence. Int. Immunopharmacol. 95, 107562 10.1016/j.intimp.2021.107562</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107562</ArticleId><ArticleId IdType="pubmed">33770729</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamsalakshmi, A., Arehally Marappa, A.M., Joghee, M., and Chidambaram, S. and B, S. (2022) Therapeutic benefits of flavonoids against neuroinflammation: a systematic review. Inflammopharmacology 30, 111&#x2013;136 10.1007/s10787-021-00895-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00895-8</ArticleId><ArticleId IdType="pubmed">35031904</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeedi-Boroujeni, A. and Mahmoudian-Sani, M.R. (2021) Anti-inflammatory potential of quercetin in COVID-19 treatment. J. Inflamm. (Lond.) 18, 3 10.1186/s12950-021-00268-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12950-021-00268-6</ArticleId><ArticleId IdType="pmc">PMC7840793</ArticleId><ArticleId IdType="pubmed">33509217</ArticleId></ArticleIdList></Reference><Reference><Citation>Aucoin, M., Cooley, K., Saunders, P.R., Cardozo, V., Remy, D., Cramer, H.et al. (2020) The effect of quercetin on the prevention or treatment of COVID-19 and other respiratory tract infections in humans: a rapid review. Adv. Integr. Med. 7, 247&#x2013;251 10.1016/j.aimed.2020.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aimed.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7392107</ArticleId><ArticleId IdType="pubmed">32837891</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell, D.B. (2021) The transporter-mediated cellular uptake and efflux of pharmaceutical drugs and biotechnology products: how and why phospholipid bilayer transport is negligible in real biomembranes. Molecules 26, 5629 10.3390/molecules26185629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26185629</ArticleId><ArticleId IdType="pmc">PMC8470029</ArticleId><ArticleId IdType="pubmed">34577099</ArticleId></ArticleIdList></Reference><Reference><Citation>Ami&#x107;, D., Davidovi&#x107;-Ami&#x107;, D., Be&#x161;lo, D., Rastija, V., Lu&#x10d;i&#x107;, B. and Trinajsti&#x107;, N. (2007) SAR and QSAR of the antioxidant activity of flavonoids. Curr. Med. Chem. 14, 827&#x2013;845 10.2174/092986707780090954</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986707780090954</ArticleId><ArticleId IdType="pubmed">17346166</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, J.H. and Kim, G.H. (2010) Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis. J. Food Sci. 75, H212&#x2013;H217 10.1111/j.1750-3841.2010.01755.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3841.2010.01755.x</ArticleId><ArticleId IdType="pubmed">21535545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lahiri, M., Morgan, C., Symmons, D.P.M. and Bruce, I.N. (2012) Modifiable risk factors for RA: prevention, better than cure? Rheumatology 51, 499&#x2013;512 10.1093/rheumatology/ker299</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker299</ArticleId><ArticleId IdType="pmc">PMC3281496</ArticleId><ArticleId IdType="pubmed">22120459</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes, S.D., Ketheesan, N. and Haleagrahara, N. (2017) The therapeutic potential of plant flavonoids on rheumatoid arthritis. Crit. Rev. Food Sci. 57, 3601&#x2013;3613 10.1080/10408398.2016.1246413</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408398.2016.1246413</ArticleId><ArticleId IdType="pubmed">27874281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H.R., Kim, B.M., Won, J.Y., Lee, K.A., Ko, H.M., Kang, Y.S.et al. (2019) Quercetin, a plant polyphenol, has potential for the prevention of bone destruction in rheumatoid arthritis. J. Med. Food. 22, 152&#x2013;161 10.1089/jmf.2018.4259</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jmf.2018.4259</ArticleId><ArticleId IdType="pubmed">30596535</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung, S., Kwon, D., Um, E. and Kim, B. (2019) Could polyphenols help in the control of rheumatoid arthritis? Molecules 24, 1286 10.3390/molecules24081589</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081589</ArticleId><ArticleId IdType="pmc">PMC6515230</ArticleId><ArticleId IdType="pubmed">31013659</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateen, S., Moin, S., Zafar, A. and Khan, A.Q. (2016) Redox signaling in rheumatoid arthritis and the preventive role of polyphenols. Clin. Chim. Acta 463, 4&#x2013;10 10.1016/j.cca.2016.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2016.10.007</ArticleId><ArticleId IdType="pubmed">27720800</ArticleId></ArticleIdList></Reference><Reference><Citation>Christman, L.M. and Gu, L.W. (2020) Efficacy and mechanisms of dietary polyphenols in mitigating rheumatoid arthritis. J. Funct. Foods 71, 104003 10.1016/j.jff.2020.104003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2020.104003</ArticleId></ArticleIdList></Reference><Reference><Citation>Behl, T., Upadhyay, T., Singh, S., Chigurupati, S., Alsubayiel, A.M., Mani, V.et al. (2021) Polyphenols targeting MAPK mediated oxidative stress and inflammation in rheumatoid arthritis. Molecules 26, 6570 10.3390/molecules26216570</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26216570</ArticleId><ArticleId IdType="pmc">PMC8588006</ArticleId><ArticleId IdType="pubmed">34770980</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo, Y.H., Tsai, W.J., Loke, S.H., Wu, T.S. and Chiou, W.F. (2009) Astragalus membranaceus flavonoids (AMF) ameliorate chronic fatigue syndrome induced by food intake restriction plus forced swimming. J. Ethnopharmacol. 122, 28&#x2013;34 10.1016/j.jep.2008.11.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2008.11.025</ArticleId><ArticleId IdType="pubmed">19103273</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathyapalan, T., Beckett, S., Rigby, A.S., Mellor, D.D. and Atkin, S.L. (2010) High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome. Nutr. J. 9, 55 10.1186/1475-2891-9-55</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2891-9-55</ArticleId><ArticleId IdType="pmc">PMC3001690</ArticleId><ArticleId IdType="pubmed">21092175</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, M&#xc1; and Ramos, S. (2021) Impact of cocoa flavanols on human health. Food Chem. Toxicol. 151, 112121 10.1016/j.fct.2021.112121</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2021.112121</ArticleId><ArticleId IdType="pubmed">33722594</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo, M., Moccia, S., Spagnuolo, C., Tedesco, I. and Russo, G.L. (2020) Roles of flavonoids against coronavirus infection. Chem. Biol. Interact. 328, 109211 10.1016/j.cbi.2020.109211</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cbi.2020.109211</ArticleId><ArticleId IdType="pmc">PMC7385538</ArticleId><ArticleId IdType="pubmed">32735799</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo, S., Kim, S., Kim, D.Y., Kim, M.S. and Shin, D.H. (2020) Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. J. Enzyme Inhib. Med. Chem. 35, 1539&#x2013;1544 10.1080/14756366.2020.1801672</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2020.1801672</ArticleId><ArticleId IdType="pmc">PMC7470085</ArticleId><ArticleId IdType="pubmed">32746637</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari, A., Rajput, V.S., Nagpal, P., Kukrety, H., Grover, S. and Grover, A. (2020) Dual inhibition of SARS-CoV-2 spike and main protease through a repurposed drug, rutin. J. Biomol. Struct. Dyn. 40, 4987&#x2013;4999 10.1080/07391102.2020.1864476</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1864476</ArticleId><ArticleId IdType="pmc">PMC7784834</ArticleId><ArticleId IdType="pubmed">33357073</ArticleId></ArticleIdList></Reference><Reference><Citation>Udrea, A.M., Mernea, M., Buiu, C. and Avram, S. (2020) Scutellaria baicalensis flavones as potent drugs against acute respiratory injury during SARS-CoV-2 infection: structural biology approaches. Processes 8, 1468 10.3390/pr8111468</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pr8111468</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, J., Zhang, L., Xu, Y., Yang, D., Zhang, L., Yang, S.et al. (2021) The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro. Biochem. Pharmacol. 183, 114302 10.1016/j.bcp.2020.114302</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2020.114302</ArticleId><ArticleId IdType="pmc">PMC7588320</ArticleId><ArticleId IdType="pubmed">33121927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandi, K., Musall, K., Oo, A., Cao, D., Liang, B., Hassandarvish, P.et al. (2021) Baicalein and baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase. Microorganisms 9, 893 10.3390/microorganisms9050893</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9050893</ArticleId><ArticleId IdType="pmc">PMC8143456</ArticleId><ArticleId IdType="pubmed">33921971</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzaabi, M.M., Hamdy, R., Ashmawy, N.S., Hamoda, A.M., Alkhayat, F., Khademi, N.N.et al. (2022) Flavonoids are promising safe therapy against COVID-19. Phytochem. Rev. 21, 291&#x2013;312 10.1007/s11101-021-09759-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11101-021-09759-z</ArticleId><ArticleId IdType="pmc">PMC8139868</ArticleId><ArticleId IdType="pubmed">34054380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul, R., Paul, P., Kumar, S., Busselberg, D., Dwivedi, V.D. and Chaari, A. (2021) Promising antiviral activities of natural flavonoids against SARS-CoV-2 targets: systematic review. Int. J. Mol. Sci 22, 11069 10.3390/ijms222011069</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222011069</ArticleId><ArticleId IdType="pmc">PMC8539743</ArticleId><ArticleId IdType="pubmed">34681727</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, S., Paul, P., Yadav, P., Kaul, R., Maitra, S.S., Jha, S.K.et al. (2022) A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle. Comput. Biol. Med. 142, 105231 10.1016/j.compbiomed.2022.105231</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.compbiomed.2022.105231</ArticleId><ArticleId IdType="pmc">PMC8750703</ArticleId><ArticleId IdType="pubmed">35032740</ArticleId></ArticleIdList></Reference><Reference><Citation>Santana, F.P.R., Thevenard, F., Gomes, K.S., Taguchi, L., C&#xe2;mara, N.O.S., Stilhano, R.S.et al. (2021) New perspectives on natural flavonoids on COVID-19-induced lung injuries. Phytother. Res. 35, 4988&#x2013;5006 10.1002/ptr.7131</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.7131</ArticleId><ArticleId IdType="pmc">PMC8242604</ArticleId><ArticleId IdType="pubmed">33928690</ArticleId></ArticleIdList></Reference><Reference><Citation>Liskova, A., Samec, M., Koklesova, L., Samuel, S.M., Zhai, K., Al-Ishaq, R.K.et al. (2021) Flavonoids against the SARS-CoV-2 induced inflammatory storm. Biomed. Pharmacother. 138, 111430 10.1016/j.biopha.2021.111430</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111430</ArticleId><ArticleId IdType="pmc">PMC7906511</ArticleId><ArticleId IdType="pubmed">33662680</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal, P.K., Agrawal, C. and Blunden, G. (2021) Pharmacological significance of hesperidin and hesperetin, two citrus flavonoids, as promising antiviral compounds for prophylaxis against and combating COVID-19. Nat. Prod. Commun. 16, 1&#x2013;15 10.1177/1934578X211042540</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1934578X211042540</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakshit, G., Dagur, P., Satpathy, S., Patra, A., Jain, A. and Ghosh, M. (2021) Flavonoids as potential therapeutics against novel coronavirus disease-2019 (nCOVID-19). J. Biomol. Struct. Dyn. 1&#x2013;13 10.1080/07391102.2021.1892529</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2021.1892529</ArticleId><ArticleId IdType="pubmed">33682606</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides, T.C., Cholevas, C., Polyzoidis, K. and Politis, A. (2021) Long-COVID syndrome-associated brain fog and chemofog: luteolin to the rescue. Biofactors 47, 232&#x2013;241 10.1002/biof.1726</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/biof.1726</ArticleId><ArticleId IdType="pmc">PMC8250989</ArticleId><ArticleId IdType="pubmed">33847020</ArticleId></ArticleIdList></Reference><Reference><Citation>Edeas, M., Saleh, J. and Peyssonnaux, C. (2020) Iron: innocent bystander or vicious culprit in COVID-19 pathogenesis? Int. J. Infect. Dis. 97, 303&#x2013;305 10.1016/j.ijid.2020.05.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.05.110</ArticleId><ArticleId IdType="pmc">PMC7264936</ArticleId><ArticleId IdType="pubmed">32497811</ArticleId></ArticleIdList></Reference><Reference><Citation>Perricone, C., Bartoloni, E., Bursi, R., Cafaro, G., Guidelli, G.M., Shoenfeld, Y.et al. (2020) COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol. Res. 68, 213&#x2013;224 10.1007/s12026-020-09145-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-020-09145-5</ArticleId><ArticleId IdType="pmc">PMC7366458</ArticleId><ArticleId IdType="pubmed">32681497</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastin, A., Shiri, H., Zanganeh, S., Fooladi, S., Momeni Moghaddam, M.A., Mehrabani, M.et al. (2021) Iron Chelator or iron supplement consumption in COVID-19? The Role of iron with severity infection. Biol. Trace Elem. Res .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8614629</ArticleId><ArticleId IdType="pubmed">34825316</ArticleId></ArticleIdList></Reference><Reference><Citation>Girelli, D., Marchi, G., Busti, F. and Vianello, A. (2021) Iron metabolism in infections: focus on COVID-19. Semin. Hematol. 58, 182&#x2013;187 10.1053/j.seminhematol.2021.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminhematol.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8305218</ArticleId><ArticleId IdType="pubmed">34389110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahroum, N., Alghory, A., Kiyak, Z., Alwani, A., Seida, R., Alrais, M.et al. (2022) Ferritin - from iron, through inflammation and autoimmunity, to COVID-19. J. Autoimmun. 126, 102778 10.1016/j.jaut.2021.102778</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102778</ArticleId><ArticleId IdType="pmc">PMC8647584</ArticleId><ArticleId IdType="pubmed">34883281</ArticleId></ArticleIdList></Reference><Reference><Citation>Poonkuzhi Naseef, P., Elayadeth-Meethal, M., Salim, K.T.M., Anjana, A., Muhas, C., Vajid, K.A.et al. (2022) Therapeutic potential of induced iron depletion using iron chelators in COVID-19. Saudi J. Biol. Sci 20, 1947&#x2013;1956 10.1016/j.sjbs.2021.11.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2021.11.061</ArticleId><ArticleId IdType="pmc">PMC8666385</ArticleId><ArticleId IdType="pubmed">34924800</ArticleId></ArticleIdList></Reference><Reference><Citation>Taneri, P.E., G&#xf3;mez-Ochoa, S.A., Llanaj, E., Raguindin, P.F., Rojas, L.Z., Roa-D&#xed;az, Z.M.et al. (2020) Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur. J. Epidemiol. 35, 763&#x2013;773 10.1007/s10654-020-00678-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-020-00678-5</ArticleId><ArticleId IdType="pmc">PMC7438401</ArticleId><ArticleId IdType="pubmed">32816244</ArticleId></ArticleIdList></Reference><Reference><Citation>Birlutiu, V., Birlutiu, R.M. and Chicea, L. (2021) Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: a single center experience. Medicine (Baltimore) 100, e25832 10.1097/MD.0000000000025832</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000025832</ArticleId><ArticleId IdType="pmc">PMC8104262</ArticleId><ArticleId IdType="pubmed">33950993</ArticleId></ArticleIdList></Reference><Reference><Citation>Carota, G., Ronsisvalle, S., Panarello, F., Tibullo, D., Nicolosi, A. and Li Volti, G. (2021) Role of iron chelation and protease inhibition of natural products on COVID-19 infection. J. Clin. Med. 10, 2306 10.3390/jcm10112306</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10112306</ArticleId><ArticleId IdType="pmc">PMC8198259</ArticleId><ArticleId IdType="pubmed">34070628</ArticleId></ArticleIdList></Reference><Reference><Citation>Habib, H.M., Ibrahim, S., Zaim, A. and Ibrahim, W.H. (2021) The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators. Biomed. Pharmacother. 136, 111228 10.1016/j.biopha.2021.111228</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2021.111228</ArticleId><ArticleId IdType="pmc">PMC7836924</ArticleId><ArticleId IdType="pubmed">33454595</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlahakos, V.D., Marathias, K.P., Arkadopoulos, N. and Vlahakos, D.V. (2021) Hyperferritinemia in patients with COVID-19: an opportunity for iron chelation? Artif. Organs 45, 163&#x2013;167 10.1111/aor.13812</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aor.13812</ArticleId><ArticleId IdType="pubmed">32882061</ArticleId></ArticleIdList></Reference><Reference><Citation>Henss, L., Auste, A., Schurmann, C., Schmidt, C., von Rhein, C., Muhlebach, M.D.et al. (2021) The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection. J. Gen. Virol 102, 001574 10.1099/jgv.0.001574</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.001574</ArticleId><ArticleId IdType="pmc">PMC8290267</ArticleId><ArticleId IdType="pubmed">33830908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel, S., Weinreb, O., Reznichenko, L., Kalfon, L. and Amit, T. (2006) Green tea catechins as brain-permeable, non toxic iron chelators to "iron out iron" from the brain. J. Neural Transm.-Suppl. 50, 229&#x2013;234 10.1007/978-3-211-33328-0_26</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-211-33328-0_26</ArticleId><ArticleId IdType="pubmed">17447435</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandel, S., Amit, T., Reznichenko, L., Weinreb, O. and Youdim, M.B.H. (2006) Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol. Nutr. Food Res. 50, 229&#x2013;234 10.1002/mnfr.200500156</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200500156</ArticleId><ArticleId IdType="pubmed">16470637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatcher, H.C., Singh, R.N., Torti, F.M. and Torti, S.V. (2009) Synthetic and natural iron chelators: therapeutic potential and clinical use. Future Med. Chem. 1, 1643&#x2013;1670 10.4155/fmc.09.121</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/fmc.09.121</ArticleId><ArticleId IdType="pmc">PMC3821171</ArticleId><ArticleId IdType="pubmed">21425984</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreb, O., Amit, T., Mandel, S. and Youdim, M.B. (2009) Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. 4, 283&#x2013;296 10.1007/s12263-009-0143-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12263-009-0143-4</ArticleId><ArticleId IdType="pmc">PMC2775893</ArticleId><ArticleId IdType="pubmed">19756809</ArticleId></ArticleIdList></Reference><Reference><Citation>Riegsecker, S., Wiczynski, D., Kaplan, M.J. and Ahmed, S. (2013) Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci. 93, 307&#x2013;312 10.1016/j.lfs.2013.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2013.07.006</ArticleId><ArticleId IdType="pmc">PMC3768132</ArticleId><ArticleId IdType="pubmed">23871988</ArticleId></ArticleIdList></Reference><Reference><Citation>Che, F., Wang, G., Yu, J., Wang, X., Lu, Y., Fu, Q.et al. (2017) Effects of epigallocatechin-3-gallate on iron metabolism in spinal cord motor neurons. Mol. Med. Rep. 16, 3010&#x2013;3014 10.3892/mmr.2017.6919</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2017.6919</ArticleId><ArticleId IdType="pubmed">28677731</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, J., Xu, L., Liang, Q., Sun, Q., Chen, C., Zhang, Y.et al. (2017) Metal chelator EGCG attenuates Fe(III)-induced conformational transition of alpha-synuclein and protects AS-PC12 cells against Fe(III)-induced death. J. Neurochem. 143, 136&#x2013;146 10.1111/jnc.14142</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.14142</ArticleId><ArticleId IdType="pubmed">28792609</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Q., Langley, M., Kanthasamy, A.G. and Reddy, M.B. (2017) Epigallocatechin gallate has a neurorescue effect in a mouse model of Parkinson disease. J. Nutr. 147, 1926&#x2013;1931 10.3945/jn.117.255034</Citation><ArticleIdList><ArticleId IdType="doi">10.3945/jn.117.255034</ArticleId><ArticleId IdType="pmc">PMC5610551</ArticleId><ArticleId IdType="pubmed">28835392</ArticleId></ArticleIdList></Reference><Reference><Citation>Koonyosying, P., Tantiworawit, A., Hantrakool, S., Utama-Ang, N., Cresswell, M., Fucharoen, S.et al. (2020) Consumption of a green tea extract-curcumin drink decreases blood urea nitrogen and redox iron in beta-thalassemia patients. Food Funct. 11, 932&#x2013;943 10.1039/C9FO02424G</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C9FO02424G</ArticleId><ArticleId IdType="pubmed">31950948</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhatre, S., Srivastava, T., Naik, S. and Patravale, V. (2021) Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: a review. Phytomedicine 85, 153286 10.1016/j.phymed.2020.153286</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2020.153286</ArticleId><ArticleId IdType="pmc">PMC7367004</ArticleId><ArticleId IdType="pubmed">32741697</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione, E., Cosio, T., Rosa, L., Lanna, C., Di Girolamo, S., Gaziano, R.et al. (2020) Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation. Int. J. Mol. Sci. 21, 4903 10.3390/ijms21144903</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21144903</ArticleId><ArticleId IdType="pmc">PMC7402319</ArticleId><ArticleId IdType="pubmed">32664543</ArticleId></ArticleIdList></Reference><Reference><Citation>Cegolon, L., Javanbakht, M. and Mastrangelo, G. (2020) Nasal disinfection for the prevention and control of COVID-19: a scoping review on potential chemo-preventive agents. Int. J. Hyg. Environ. Health 230, 113605 10.1016/j.ijheh.2020.113605</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijheh.2020.113605</ArticleId><ArticleId IdType="pmc">PMC7434367</ArticleId><ArticleId IdType="pubmed">32898838</ArticleId></ArticleIdList></Reference><Reference><Citation>AlKhazindar, M. and Elnagdy, S.M. (2020) Can lactoferrin boost human immunity against COVID-19? Pathog. Glob. Health 114, :234-&#x2013;:2235 10.1080/20477724.2020.1779514</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/20477724.2020.1779514</ArticleId><ArticleId IdType="pmc">PMC7480455</ArticleId><ArticleId IdType="pubmed">32529963</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho, M., da Rocha Matos, C.A., Caetano, A., de Sousa Junior, B.C., da Costa Campos, I.P., Geraldino, S.P.et al. (2020) In vitro inhibition of SARS-CoV-2 infection by bovine lactoferrin. bioRxiv 2020.2005.2013.093781</Citation></Reference><Reference><Citation>Wang, Y., Wang, P., Wang, H., Luo, Y., Wan, L., Jiang, M.et al. (2020) Lactoferrin for the treatment of COVID-19 (review). Exp. Ther. Med. 20, 272 10.3892/etm.2020.94021</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2020.94021</ArticleId><ArticleId IdType="pmc">PMC7664603</ArticleId><ArticleId IdType="pubmed">33199997</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang, R., Ng, T.B. and Sun, W.Z. (2020) Lactoferrin as potential preventative and adjunct treatment for COVID-19. Int. J. Antimicrob. Agents 56, 106118, 10.1016/j.ijantimicag.2020.106118</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106118</ArticleId><ArticleId IdType="pmc">PMC7390755</ArticleId><ArticleId IdType="pubmed">32738305</ArticleId></ArticleIdList></Reference><Reference><Citation>Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M.P., Iacovelli, F.et al. (2021) Lactoferrin as antiviral treatment in COVID-19 management: preliminary evidence. Int. J. Environ. Res. Public Health 18, 10985 10.3390/ijerph182010985</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182010985</ArticleId><ArticleId IdType="pmc">PMC8535893</ArticleId><ArticleId IdType="pubmed">34682731</ArticleId></ArticleIdList></Reference><Reference><Citation>Kucia, M., Wietrak, E., Szymczak, M., Majchrzak, M. and Kowalczyk, P. (2021) Protective action of L. salivarius SGL03 and lactoferrin against COVID-19 infections in human nasopharynx. Materials (Basel) 14, 3086 10.3390/ma14113086</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ma14113086</ArticleId><ArticleId IdType="pmc">PMC8200234</ArticleId><ArticleId IdType="pubmed">34200055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa, L., Tripepi, G., Naldi, E., Aimati, M., Santangeli, S., Venditto, F.et al. (2021) Ambulatory COVID-19 patients treated with lactoferrin as a supplementary antiviral agent: a preliminary study. J. Clin. Med. 10, 4276 10.3390/jcm10184276</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184276</ArticleId><ArticleId IdType="pmc">PMC8469309</ArticleId><ArticleId IdType="pubmed">34575388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wotring, J.W., Fursmidt, R., Ward, L. and Sexton, J.Z. (2022) Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern. J. Dairy Sci. 105, 2791&#x2013;2802 10.3168/jds.2021-21247</Citation><ArticleIdList><ArticleId IdType="doi">10.3168/jds.2021-21247</ArticleId><ArticleId IdType="pmc">PMC8872794</ArticleId><ArticleId IdType="pubmed">35221061</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimecki, M., Actor, J.K. and Kruzel, M.L. (2021) The potential for lactoferrin to reduce SARS-CoV-2 induced cytokine storm. Int. Immunopharmacol. 95, 107571 10.1016/j.intimp.2021.107571</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107571</ArticleId><ArticleId IdType="pmc">PMC7953442</ArticleId><ArticleId IdType="pubmed">33765614</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo, V., Giansanti, F., Arienzo, A. and Antonini, G. (2022) Antiviral properties of whey proteins and their activity against SARS-CoV-2 infection. J. Funct. Foods 89, 104932 10.1016/j.jff.2022.104932</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2022.104932</ArticleId><ArticleId IdType="pmc">PMC8723829</ArticleId><ArticleId IdType="pubmed">35003332</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafqat, F., Ur Rehman, S. and Niaz, K. (2022) Lactoferrin can attenuate SARS-CoV-2: an analysis of evidential relations. Biomed. Res. Ther. 9, 4901&#x2013;4919 10.15419/bmrat.v9i2.727</Citation><ArticleIdList><ArticleId IdType="doi">10.15419/bmrat.v9i2.727</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian, J., Tang, L., Liu, X., Li, Y., Chen, J., Huang, W.et al. (2022) Populations in Low-Magnesium areas were associated with higher risk of infection in COVID-19's early transmission: a nationwide retrospective cohort study in the United States. Nutrients 14, 909 10.3390/nu14040909</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14040909</ArticleId><ArticleId IdType="pmc">PMC8875017</ArticleId><ArticleId IdType="pubmed">35215558</ArticleId></ArticleIdList></Reference><Reference><Citation>DiNicolantonio, J.J. and O'Keefe, J.H. (2021) Magnesium and vitamin D deficiency as a potential cause of immune dysfunction, cytokine storm and disseminated intravascular coagulation in COVID-19 patients. Mo Med. 118, 68&#x2013;73</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7861592</ArticleId><ArticleId IdType="pubmed">33551489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox, I.M., Campbell, M.J. and Dowson, D. (1991) Red blood cell magnesium and chronic fatigue syndrome. Lancet 337, 757&#x2013;760 10.1016/0140-6736(91)91371-Z</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0140-6736(91)91371-Z</ArticleId><ArticleId IdType="pubmed">1672392</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier, J.A.M., Malpuech-Brug&#xe8;re, C., Zimowska, W., Rayssiguier, Y. and Mazur, A. (2004) Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim. Biophys. Acta 1689, 13&#x2013;21 10.1016/j.bbadis.2004.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2004.01.002</ArticleId><ArticleId IdType="pubmed">15158909</ArticleId></ArticleIdList></Reference><Reference><Citation>Claustrat, B., Brun, J. and Chazot, G. (2005) The basic physiology and pathophysiology of melatonin. Sleep Med. Rev. 9, 11&#x2013;24 10.1016/j.smrv.2004.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2004.08.001</ArticleId><ArticleId IdType="pubmed">15649735</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter, R.J. (1998) Oxidative damage in the central nervous system: protection by melatonin. Progr. Neurobiol. 56, 359&#x2013;384 10.1016/S0301-0082(98)00052-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0301-0082(98)00052-5</ArticleId><ArticleId IdType="pubmed">9770244</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter, R.J., Paredes, S.D., Manchester, L.C. and Tan, D.X. (2009) Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit. Rev. Biochem. Mol. Biol. 44, 175&#x2013;200 10.1080/10409230903044914</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409230903044914</ArticleId><ArticleId IdType="pubmed">19635037</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter, R.J., Rosales-Corral, S., Tan, D.X., Jou, M.J., Galano, A. and Xu, B. (2017) Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas. Cell. Mol. Life Sci. 74, 3863&#x2013;3881 10.1007/s00018-017-2609-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-017-2609-7</ArticleId><ArticleId IdType="pmc">PMC11107735</ArticleId><ArticleId IdType="pubmed">28864909</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, G.M., Pandi-Perumal, S.R., Pupko, H., Kennedy, J.L. and Cardinali, D.P. (2021) Melatonin as an add-on treatment of COVID-19 infection: current status. Diseases 9, 64 10.3390/diseases9030064</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diseases9030064</ArticleId><ArticleId IdType="pmc">PMC8482145</ArticleId><ArticleId IdType="pubmed">34562971</ArticleId></ArticleIdList></Reference><Reference><Citation>Loh, D. (2020) The potential of melatonin in the prevention and attenuation of oxidative hemolysis and myocardial injury from cd147 SARS-CoV-2 spike protein receptor binding. Melatonin Res. 3, 380&#x2013;416 10.32794/mr11250069</Citation><ArticleIdList><ArticleId IdType="doi">10.32794/mr11250069</ArticleId></ArticleIdList></Reference><Reference><Citation>Camp, O.G., Bai, D., Gonullu, D.C., Nayak, N. and Abu-Soud, H.M. (2021) Melatonin interferes with COVID-19 at several distinct ROS-related steps. J. Inorg. Biochem. 223, 111546 10.1016/j.jinorgbio.2021.111546</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinorgbio.2021.111546</ArticleId><ArticleId IdType="pmc">PMC8285369</ArticleId><ArticleId IdType="pubmed">34304092</ArticleId></ArticleIdList></Reference><Reference><Citation>Castle, R.D., Williams, M.A., Bushell, W.C., Rindfleisch, J.A., Peterson, C.T., Marzolf, J.et al. (2021) Implications for systemic approaches to COVID-19: effect sizes of remdesivir, tocilizumab, melatonin, vitamin D3, and meditation. J. Inflamm. Res. 14, 4859&#x2013;4876 10.2147/JIR.S323356</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S323356</ArticleId><ArticleId IdType="pmc">PMC8473718</ArticleId><ArticleId IdType="pubmed">34588793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos, E., L&#xf3;pez-Mu&#xf1;oz, F., Gil-Martin, E., Egea, J., &#xc1;lvarez-Merz, I., Painuli, S.et al. (2021) The coronavirus disease 2019 (COVID-19): key emphasis on melatonin safety and therapeutic efficacy. Antioxidants (Basel) 10, 1152 10.3390/antiox10071152</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox10071152</ArticleId><ArticleId IdType="pmc">PMC8301107</ArticleId><ArticleId IdType="pubmed">34356384</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter, R.J., Abreu-Gonzalez, P., Marik, P.E. and Dominguez-Rodriguez, A. (2020) Therapeutic algorithm for use of melatonin in patients with COVID-19. Front. Med. (Lausanne) 7, 226 10.3389/fmed.2020.00226</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00226</ArticleId><ArticleId IdType="pmc">PMC7242729</ArticleId><ArticleId IdType="pubmed">32574327</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan, S.H., Lee, H.Z., Chao, C.M., Chang, S.P., Lu, L.C. and Lai, C.C. (2022) Efficacy of melatonin in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials. J. Med. Virol. 94, 2102&#x2013;2107 10.1002/jmv.27595</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27595</ArticleId><ArticleId IdType="pmc">PMC9015545</ArticleId><ArticleId IdType="pubmed">35032042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramlall, V., Zucker, J. and Tatonetti, N. (2020) Melatonin is significantly associated with survival of intubated COVID-19 patients. medRxiv</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Kory, P., Meduri, G.U., Iglesias, J., Varon, J., Cadegiani, F.A. and Marik, P.E. (2022) "MATH+" multi-modal hospital treatment protocol for COVID-19 infection: clinical and scientific rationale. J. Clin. Med. Res. 14, 53&#x2013;79 10.14740/jocmr4658</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jocmr4658</ArticleId><ArticleId IdType="pmc">PMC8912998</ArticleId><ArticleId IdType="pubmed">35317360</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Y., Duan, W., Jin, Z., Yi, W., Yan, J., Zhang, S.et al. (2013) JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J. Pineal Res. 55, 275&#x2013;286 10.1111/jpi.12070</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jpi.12070</ArticleId><ArticleId IdType="pubmed">23796350</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss, E., Roux, O., Moyer, J.D., Paugam-Burtz, C., Boudaoud, L., Ajzenberg, N.et al. (2020) Fibrinolysis resistance: a potential mechanism underlying COVID-19 coagulopathy. Thromb. Haemost. 120, 1343&#x2013;1345 10.1055/s-0040-1713637</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1713637</ArticleId><ArticleId IdType="pubmed">32645725</ArticleId></ArticleIdList></Reference><Reference><Citation>Maier, C.L., Sarker, T., Szlam, F. and Sniecinski, R.M. (2021) COVID-19 patient plasma demonstrates resistance to tPA-induced fibrinolysis as measured by thromboelastography. J. Thromb. Thrombolysis. 52, 766&#x2013;771 10.1007/s11239-021-02438-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02438-y</ArticleId><ArticleId IdType="pmc">PMC8026096</ArticleId><ArticleId IdType="pubmed">33829396</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo, Y., Warnock, M., Harbaugh, A., Yalavarthi, S., Gockman, K., Zuo, M.et al. (2021) Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients. Sci. Rep. 11, 1580 10.1038/s41598-020-80010-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80010-z</ArticleId><ArticleId IdType="pmc">PMC7810990</ArticleId><ArticleId IdType="pubmed">33452298</ArticleId></ArticleIdList></Reference><Reference><Citation>Altaf, F., Wu, S.R. and Kasim, V. (2021) Role of fibrinolytic enzymes in anti-thrombosis therapy. Front. Mol. Biosci. 8, 680397 10.3389/fmolb.2021.680397</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.680397</ArticleId><ArticleId IdType="pmc">PMC8194080</ArticleId><ArticleId IdType="pubmed">34124160</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, S.S. and Sabu, A. (2019) Fibrinolytic enzymes for thrombolytic therapy. Adv. Exp. Med. Biol. 1148, 345&#x2013;381 10.1007/978-981-13-7709-9_15</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-981-13-7709-9_15</ArticleId><ArticleId IdType="pubmed">31482506</ArticleId></ArticleIdList></Reference><Reference><Citation>Ali, M., and Bavisetty, A.M. and B, S.C. (2020) Purification, physicochemical properties, and statistical optimization of fibrinolytic enzymes especially from fermented foods: a comprehensive review. Int. J. Biol. Macromol. 163, 1498&#x2013;1517 10.1016/j.ijbiomac.2020.07.303</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2020.07.303</ArticleId><ArticleId IdType="pubmed">32781120</ArticleId></ArticleIdList></Reference><Reference><Citation>Diwan, D., Usmani, Z., Sharma, M., Nelson, J.W., Thakur, V.K., Christie, G.et al. (2021) Thrombolytic enzymes of microbial origin: a review. Int. J. Mol. Sci 22, 10468 10.3390/ijms221910468</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910468</ArticleId><ArticleId IdType="pmc">PMC8508633</ArticleId><ArticleId IdType="pubmed">34638809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, X.Q., Liu, L.Z. and Zeng, X.R. (2021) Research progress on the utilisation of embedding technology and suitable delivery systems for improving the bioavailability of nattokinase: a review. Food Struct. 30, 100219 10.1016/j.foostr.2021.100219</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foostr.2021.100219</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita, M., Hong, K., Ito, Y., Fujii, R., Kariya, K. and Nishimuro, S. (1995) Thrombolytic effect of nattokinase on a chemically induced thrombosis model in rat. Biol. Pharm. Bull. 18, 1387&#x2013;1391 10.1248/bpb.18.1387</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.18.1387</ArticleId><ArticleId IdType="pubmed">8593442</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki, Y., Kondo, K., Matsumoto, Y., Zhao, B.Q., Otsuguro, K., Maeda, T.et al. (2003) Dietary supplementation of fermented soybean, natto, suppresses intimal thickening and modulates the lysis of mural thrombi after endothelial injury in rat femoral artery. Life Sci. 73, 1289&#x2013;1298 10.1016/S0024-3205(03)00426-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(03)00426-0</ArticleId><ArticleId IdType="pubmed">12850244</ArticleId></ArticleIdList></Reference><Reference><Citation>Tai, M.W. and Sweet, B.V. (2006) Nattokinase for prevention of thrombosis. Am. J. Health Syst. Pharm. 63, 1121&#x2013;1123 10.2146/ajhp050509</Citation><ArticleIdList><ArticleId IdType="doi">10.2146/ajhp050509</ArticleId><ArticleId IdType="pubmed">16754735</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu, R.L., Lee, K.T., Wang, J.H., Lee, L.Y. and Chen, R.P. (2009) Amyloid-degrading ability of nattokinase from Bacillus subtilis natto. J. Agric. Food Chem. 57, 503&#x2013;508 10.1021/jf803072r</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf803072r</ArticleId><ArticleId IdType="pubmed">19117402</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita, M., Hong, K., Ito, Y., Misawa, S., Takeuchi, N., Kariya, K.et al. (1995) Transport of nattokinase across the rat intestinal tract. Biol. Pharm. Bull. 18, 1194&#x2013;1196 10.1248/bpb.18.1194</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.18.1194</ArticleId><ArticleId IdType="pubmed">8845803</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi, H., Hamada, H., Nakanishi, K. and Hiratani, H. (1990) Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol. 84, 139&#x2013;143 10.1159/000205051</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000205051</ArticleId><ArticleId IdType="pubmed">2123064</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi, H., Yanagisawa, Y., Yatagai, C. and Saito, J. (2004) Natto bacillus as an oral fibrinolytic agent: nattokinase activity and the ingestion effect of Bacillus subtilis natto. Food Sci. Technol. Res. 10, 17&#x2013;20 10.3136/fstr.10.17</Citation><ArticleIdList><ArticleId IdType="doi">10.3136/fstr.10.17</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H., McGowan, E.M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F.et al. (2018) Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases. Biomark. Insights 13, 1177271918785130 10.1177/1177271918785130</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1177271918785130</ArticleId><ArticleId IdType="pmc">PMC6043915</ArticleId><ArticleId IdType="pubmed">30013308</ArticleId></ArticleIdList></Reference><Reference><Citation>Ero, M.P., Ng, C.M., Mihailovski, T., Harvey, N.R. and Lewis, B.H. (2013) A pilot study on the serum pharmacokinetics of nattokinase in humans following a single, oral, daily dose. Altern. Ther. Health Med. 19, 16&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pubmed">23709455</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabbagh, F., Negahdaripour, M., Berenjian, A., Behfar, A., Mohammadi, F., Zamani, M.et al. (2014) Nattokinase: production and application. Appl. Microbiol. Biotechnol. 98, 9199&#x2013;9206 10.1007/s00253-014-6135-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-014-6135-3</ArticleId><ArticleId IdType="pubmed">25348469</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapoor, R., Harde, H., Jain, S., Panda, A.K. and Panda, B.P. (2015) Downstream processing, formulation development and antithrombotic evaluation of microbial nattokinase. J. Biomed. Nanotechnol. 11, 1213&#x2013;1224 10.1166/jbn.2015.2071</Citation><ArticleIdList><ArticleId IdType="doi">10.1166/jbn.2015.2071</ArticleId><ArticleId IdType="pubmed">26307844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H., Wang, H., Xu, F., Chen, J., Duan, L. and Zhang, F. (2019) Acute toxicity and genotoxicity evaluations of Nattokinase, a promising agent for cardiovascular diseases prevention. Regul. Toxicol. Pharmacol. 103, 205&#x2013;209 10.1016/j.yrtph.2019.02.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yrtph.2019.02.006</ArticleId><ArticleId IdType="pubmed">30742876</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallelli, G., Di Mizio, G., Palleria, C., Siniscalchi, A., Rubino, P., Muraca, L.et al. (2021) Data recorded in real life support the safety of nattokinase in patients with vascular diseases. Nutrients 13, 2031 10.3390/nu13062031</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13062031</ArticleId><ArticleId IdType="pmc">PMC8231931</ArticleId><ArticleId IdType="pubmed">34199189</ArticleId></ArticleIdList></Reference><Reference><Citation>Metkar, S.K., Girigoswami, A., Murugesan, R. and Girigoswami, K. (2017) In vitro and in vivo insulin amyloid degradation mediated by serratiopeptidase. Mater. Sci. Eng. C Mater. Biol. Appl. 70, 728&#x2013;735 10.1016/j.msec.2016.09.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msec.2016.09.049</ArticleId><ArticleId IdType="pubmed">27770948</ArticleId></ArticleIdList></Reference><Reference><Citation>Sumi, H., Hamada, H., Tsushima, H., Mihara, H. and Muraki, H. (1987) A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese natto; a typical and popular soybean food in the Japanese diet. Experientia 43, 1110&#x2013;1111 10.1007/BF01956052</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01956052</ArticleId><ArticleId IdType="pubmed">3478223</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurosawa, Y., Nirengi, S., Homma, T., Esaki, K., Ohta, M., Clark, J.F.et al. (2015) A single-dose of oral nattokinase potentiates thrombolysis and anti-coagulation profiles. Sci. Rep. 5, 11601 10.1038/srep11601</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep11601</ArticleId><ArticleId IdType="pmc">PMC4479826</ArticleId><ArticleId IdType="pubmed">26109079</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvarajan, E. and Bhatnagar, N. (2017) Nattokinase: an updated critical review on challenges and perspectives. Cardiovasc. Hematol. Agents Med. Chem. 15, 126&#x2013;135 10.2174/1871525716666171207153332</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871525716666171207153332</ArticleId><ArticleId IdType="pubmed">29219060</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng, Y., Yao, J., Sparks, S. and Wang, K.Y. (2017) Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease. Int. J. Mol. Sci. 18, 523 10.3390/ijms18030523</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18030523</ArticleId><ArticleId IdType="pmc">PMC5372539</ArticleId><ArticleId IdType="pubmed">28264497</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagaki, S., Suzuki, M., Suzuki, E. and Hasumi, K. (2020) Unsaturated fatty acids enhance the fibrinolytic activity of subtilisin NAT (nattokinase). J. Food Biochem. 44, e13326 10.1111/jfbc.13326</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jfbc.13326</ArticleId><ArticleId IdType="pubmed">32572985</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba, M., Rongduo, W., Saito, A., Okabayashi, T., Yokota, T., Yasuoka, J.et al. (2021) Natto extract, a Japanese fermented soybean food, directly inhibits viral infections including SARS-CoV-2 in vitro. Biochem. Biophys. Res. Commun. 570, 21&#x2013;25 10.1016/j.bbrc.2021.07.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.07.034</ArticleId><ArticleId IdType="pmc">PMC8276596</ArticleId><ArticleId IdType="pubmed">34271432</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagisawa, Y., Chatake, T., Chiba-Kamoshida, K., Naito, S., Ohsugi, T., Sumi, H.et al. (2010) Purification, crystallization and preliminary X-ray diffraction experiment of nattokinase from Bacillus subtilis natto. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 66, 1670&#x2013;1673 10.1107/S1744309110043137</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S1744309110043137</ArticleId><ArticleId IdType="pmc">PMC2998380</ArticleId><ArticleId IdType="pubmed">21139221</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagisawa, Y., Chatake, T., Naito, S., Ohsugi, T., Yatagai, C., Sumi, H.et al. (2013) X-ray structure determination and deuteration of nattokinase. J. Synchrotron. Radiat. 20, 875&#x2013;879 10.1107/S0909049513020700</Citation><ArticleIdList><ArticleId IdType="doi">10.1107/S0909049513020700</ArticleId><ArticleId IdType="pmc">PMC3795547</ArticleId><ArticleId IdType="pubmed">24121331</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, P.T., Chiang, C.J. and Chao, Y.P. (2007) Medium optimization for the production of recombinant nattokinase by Bacillus subtilis using response surface methodology. Biotechnol. Prog. 23, 1327&#x2013;1332 10.1021/bp070109b</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bp070109b</ArticleId><ArticleId IdType="pubmed">17914859</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, P.T., Chiang, C.J. and Chao, Y.P. (2007) Strategy to approach stable production of recombinant nattokinase in Bacillus subtilis. Biotechnol. Prog. 23, 808&#x2013;813 10.1002/bp070108j</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bp070108j</ArticleId><ArticleId IdType="pubmed">17595111</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, D., Zhu, C. and Chen, S. (2017) Microbial production of nattokinase: current progress, challenge and prospect. World J. Microbiol. Biotechnol. 33, 84 10.1007/s11274-017-2253-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11274-017-2253-2</ArticleId><ArticleId IdType="pubmed">28378222</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Z., Zheng, W., Ge, C., Cui, W., Zhou, L. and Zhou, Z. (2019) High-level extracellular production of recombinant nattokinase in Bacillus subtilis WB800 by multiple tandem promoters. BMC Microbiol. 19, 89 10.1186/s12866-019-1461-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-019-1461-3</ArticleId><ArticleId IdType="pmc">PMC6505213</ArticleId><ArticleId IdType="pubmed">31064343</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, Z., Zhao, H., Han, L., Cui, W., Zhou, L. and Zhou, Z. (2019) Improvement of the acid resistance, catalytic efficiency, and thermostability of nattokinase by multisite-directed mutagenesis. Biotechnol. Bioeng. 116, 1833&#x2013;1843 10.1002/bit.26983</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bit.26983</ArticleId><ArticleId IdType="pubmed">30934114</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C., Du, Z., Qi, S., Zhang, X., Wang, M., Zhou, Y.et al. (2020) Food-grade expression of nattokinase in Lactobacillus delbrueckii subsp. bulgaricus and its thrombolytic activity in vitro. Biotechnol. Lett. 42, 2179&#x2013;2187 10.1007/s10529-020-02974-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10529-020-02974-2</ArticleId><ArticleId IdType="pubmed">32705453</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei, X., Zhou, Y., Chen, J., Cai, D., Wang, D., Qi, G.et al. (2015) Efficient expression of nattokinase in Bacillus licheniformis: host strain construction and signal peptide optimization. J. Ind. Microbiol. Biotechnol. 42, 287&#x2013;295 10.1007/s10295-014-1559-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10295-014-1559-4</ArticleId><ArticleId IdType="pubmed">25475755</ArticleId></ArticleIdList></Reference><Reference><Citation>Guangbo, Y., Min, S., Wei, S., Lixin, M., Chao, Z., Yaping, W.et al. (2021) Heterologous expression of nattokinase from B. subtilis natto using Pichia pastoris GS115 and assessment of its thrombolytic activity. BMC Biotechnol. 21, 49 10.1186/s12896-021-00708-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12896-021-00708-4</ArticleId><ArticleId IdType="pmc">PMC8353737</ArticleId><ArticleId IdType="pubmed">34372833</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang, J.Y., Kim, T.S., Cai, J., Kim, J., Kim, Y., Shin, K.et al. (2013) Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation. Lab. Anim. Res. 29, 221&#x2013;225 10.5625/lar.2013.29.4.221</Citation><ArticleIdList><ArticleId IdType="doi">10.5625/lar.2013.29.4.221</ArticleId><ArticleId IdType="pmc">PMC3879341</ArticleId><ArticleId IdType="pubmed">24396387</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, H., Wang, Y., Zhang, Y., Xu, F., Chen, J., Duan, L.et al. (2020) Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress. Redox Biol. 32, 101500 10.1016/j.redox.2020.101500</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2020.101500</ArticleId><ArticleId IdType="pmc">PMC7078552</ArticleId><ArticleId IdType="pubmed">32193146</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, J.Y., Gum, S.N., Paik, J.K., Lim, H.H., Kim, K.C., Ogasawara, K.et al. (2008) Effects of nattokinase on blood pressure: a randomized, controlled trial. Hypertens. Res. 31, 1583&#x2013;1588 10.1291/hypres.31.1583</Citation><ArticleIdList><ArticleId IdType="doi">10.1291/hypres.31.1583</ArticleId><ArticleId IdType="pubmed">18971533</ArticleId></ArticleIdList></Reference><Reference><Citation>Weichmann, F. and Rohdewald, P. (2020) Projected supportive effects of Pycnogenol() in patients suffering from multi-dimensional health impairments after a SARS-CoV2 infection. Int. J. Antimicrob. Agents 56, 106191 10.1016/j.ijantimicag.2020.106191</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2020.106191</ArticleId><ArticleId IdType="pmc">PMC7546273</ArticleId><ArticleId IdType="pubmed">33045354</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesarone, M.R., Belcaro, G., Nicolaides, A.N., Ricci, A., Geroulakos, G., Ippolito, E.et al. (2003) Prevention of venous thrombosis in long-haul flights with flite tabs: the LONFLIT-FLITE randomized, controlled trial. Angiology 54, 531&#x2013;539 10.1177/000331970305400502</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000331970305400502</ArticleId><ArticleId IdType="pubmed">14565628</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagat, S., Agarwal, M. and Roy, V. (2013) Serratiopeptidase: a systematic review of the existing evidence. Int. J. Surg. 11, 209&#x2013;217 10.1016/j.ijsu.2013.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijsu.2013.01.010</ArticleId><ArticleId IdType="pubmed">23380245</ArticleId></ArticleIdList></Reference><Reference><Citation>Jadhav, S.B., Shah, N., Rathi, A., Rathi, V. and Rathi, A. (2020) Serratiopeptidase: insights into the therapeutic applications. Biotechnol. Rep. (Amst.) 28, e00544 10.1016/j.btre.2020.e00544</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.btre.2020.e00544</ArticleId><ArticleId IdType="pmc">PMC7585045</ArticleId><ArticleId IdType="pubmed">33134103</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, C., Jha, N.K., Meeran, M.F.N., Patil, C.R., Goyal, S.N. and Ojha, S. (2021) Serratiopeptidase, a serine protease anti-inflammatory, fibrinolytic, and mucolytic drug, can be a useful adjuvant for management in COVID-19. Front. Pharmacol. 12, 603997 10.3389/fphar.2021.603997</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.603997</ArticleId><ArticleId IdType="pmc">PMC8265778</ArticleId><ArticleId IdType="pubmed">34248612</ArticleId></ArticleIdList></Reference><Reference><Citation>Vianney, Y.M., Tjoa, S.E.E., Aditama, R. and Putra, S.E.D. (2019) Designing a less immunogenic nattokinase from Bacillus subtilis subsp. natto: a computational mutagenesis. J. Mol. Model. 25, 337 10.1007/s00894-019-4225-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00894-019-4225-y</ArticleId><ArticleId IdType="pubmed">31705312</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, X.M., Kim, C.H., Lee, C.K., Shin, J.S., Cho, I.H. and Sohn, U.D. (2010) Intestinal absorption of fibrinolytic and proteolytic lumbrokinase extracted from earthworm, Eisenia andrei. Korean J. Physiol. Pharmacol. 14, 71&#x2013;75 10.4196/kjpp.2010.14.2.71</Citation><ArticleIdList><ArticleId IdType="doi">10.4196/kjpp.2010.14.2.71</ArticleId><ArticleId IdType="pmc">PMC2869457</ArticleId><ArticleId IdType="pubmed">20473377</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihara, H., Sumi, H., Yoneta, T., Mizumoto, H., Ikeda, R., Seiki, M.et al. (1991) A novel fibrinolytic enzyme extracted from the earthworm, Lumbricus rubellus. Jpn. J. Physiol. 41, 461&#x2013;472 10.2170/jjphysiol.41.461</Citation><ArticleIdList><ArticleId IdType="doi">10.2170/jjphysiol.41.461</ArticleId><ArticleId IdType="pubmed">1960890</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho, I.H., Choi, E.S. and Lee, H.H. (2004) Molecular cloning, sequencing, and expression of a fibrinolytic serine-protease gene from the earthworm Lumbricus rubellus. J. Biochem. Mol. Biol. 37, 574&#x2013;581 10.5483/bmbrep.2004.37.5.574</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/bmbrep.2004.37.5.574</ArticleId><ArticleId IdType="pubmed">15479621</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasim, M., Kiat, A.A., Rohman, M.S., Hanifah, Y. and Kiat, H. (2009) Improved myocardial perfusion in stable angina pectoris by oral lumbrokinase: a pilot study. J. Altern. Complement. Med. 15, 539&#x2013;544 10.1089/acm.2008.0506</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/acm.2008.0506</ArticleId><ArticleId IdType="pubmed">19416019</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y.H., Chen, K.M., Chiu, P.S., Lai, S.C., Su, H.H., Jan, M.S.et al. (2016) Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling. J. Mol. Cell. Cardiol. 99, 113&#x2013;122 10.1016/j.yjmcc.2016.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2016.08.004</ArticleId><ArticleId IdType="pubmed">27503317</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y.H., Li, S.A., Huang, C.H., Su, H.H., Chen, Y.H., Chang, J.T.et al. (2018) Sirt1 activation by post-ischemic treatment with lumbrokinase protects against myocardial ischemia-reperfusion injury. Front. Pharmacol. 9, 636 10.3389/fphar.2018.00636</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2018.00636</ArticleId><ArticleId IdType="pmc">PMC6013847</ArticleId><ArticleId IdType="pubmed">29962953</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickey, A., Wang, N., Cooper, E., Tull, L., Breedlove, D., Mason, H.et al. (2017) Transient expression of lumbrokinase (PI239) in tobacco (Nicotiana tabacum) using a geminivirus-based single replicon system dissolves fibrin and blood clots. Evid. Based Complement. Alternat. Med. 2017, 6093017 10.1155/2017/6093017</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6093017</ArticleId><ArticleId IdType="pmc">PMC5592424</ArticleId><ArticleId IdType="pubmed">28932252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, K.Y., Tull, L., Cooper, E., Wang, N. and Liu, D. (2013) Recombinant protein production of earthworm lumbrokinase for potential antithrombotic application. Evid. Based Complement. Alternat. Med. 2013, 783971 10.1155/2013/783971</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/783971</ArticleId><ArticleId IdType="pmc">PMC3876685</ArticleId><ArticleId IdType="pubmed">24416067</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi, A., Jadhav, S.B. and Shah, N. (2021) A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue. Medicines (Basel) 8, 47 10.3390/medicines8090047</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicines8090047</ArticleId><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao, Y.J., Zhang, X., Wang, W.H., Zhai, W.Q., Qian, J.F., Wang, J.S.et al. (2013) Oral fibrinogen-depleting agent lumbrokinase for secondary ischemic stroke prevention: results from a multicenter, randomized, parallel-group and controlled clinical trial. Chin. Med. J. (Engl.) 126, 4060&#x2013;4065 10.3760/cma.j.issn.0366-6999.20131332</Citation><ArticleIdList><ArticleId IdType="doi">10.3760/cma.j.issn.0366-6999.20131332</ArticleId><ArticleId IdType="pubmed">24229674</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y., Liu, Y., Zhang, J., Zhou, K., Zhang, X., Dai, H.et al. (2022) Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial. Trials 23, 285 10.1186/s13063-022-06200-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-022-06200-4</ArticleId><ArticleId IdType="pmc">PMC8996506</ArticleId><ArticleId IdType="pubmed">35410433</ArticleId></ArticleIdList></Reference><Reference><Citation>Novaes, d.L., Jozala, L.C., Lopes, A.F., de Carvalho Santos-Ebinuma, A.M., Mazzola, V., G, P.et al. (2016) Stability, purification, and applications of bromelain: a review. Biotechnol. Prog. 32, 5&#x2013;13 10.1002/btpr.2190</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/btpr.2190</ArticleId><ArticleId IdType="pubmed">26518672</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavan, R., Jain, S. and Shraddha and Kumar, A. (2012) Properties and therapeutic application of bromelain: a review. Biotechnol. Res. Int. 2012, 976203 10.1155/2012/976203</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/976203</ArticleId><ArticleId IdType="pmc">PMC3529416</ArticleId><ArticleId IdType="pubmed">23304525</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikisz, P. and Bernasinska-Slomczewska, J. (2021) Beneficial properties of bromelain. Nutrients 13, 4313 10.3390/nu13124313</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13124313</ArticleId><ArticleId IdType="pmc">PMC8709142</ArticleId><ArticleId IdType="pubmed">34959865</ArticleId></ArticleIdList></Reference><Reference><Citation>Varilla, C., Marcone, M., Paiva, L. and Baptista, J. (2021) Bromelain, a group of pineapple proteolytic complex enzymes (Ananas comosus) and their possible therapeutic and clinical effects. A summary. Foods 10, 2249 10.3390/foods10102249</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods10102249</ArticleId><ArticleId IdType="pmc">PMC8534447</ArticleId><ArticleId IdType="pubmed">34681298</ArticleId></ArticleIdList></Reference><Reference><Citation>Owoyele, B.V., Bakare, A.O. and Ologe, M.O. (2020) Bromelain: a review on its potential as a therapy for the management of COVID-19. Niger. J. Physiol. Sci. 35, 10&#x2013;19</Citation><ArticleIdList><ArticleId IdType="pubmed">33084621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar, S., Rathinavel, A.K., Lutz, W.E., Struble, L.R., Khurana, S., Schnaubelt, A.T.et al. (2021) Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein. Clin. Transl. Med. 11, e281 10.1002/ctm2.281</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.281</ArticleId><ArticleId IdType="pmc">PMC7811777</ArticleId><ArticleId IdType="pubmed">33635001</ArticleId></ArticleIdList></Reference><Reference><Citation>Say&#x131;ner, S., Velio&#x11f;lu-&#xd6;&#x11f;&#xfc;n&#xe7;, A. and &#x15e;ehirli, A&#xd6;. (2021) Bromelain: a potential therapeutic application in SARSCoV-2 infected patients. Ann. Antivir. Antriretrovir. 5, 015&#x2013;018 10.17352/aaa.000011</Citation><ArticleIdList><ArticleId IdType="doi">10.17352/aaa.000011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kritis, P., Karampela, I., Kokoris, S. and Dalamaga, M. (2020) The combination of bromelain and curcumin as an immune-boosting nutraceutical in the prevention of severe COVID-19. Metab. Open 8, 100066 10.1016/j.metop.2020.100066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metop.2020.100066</ArticleId><ArticleId IdType="pmc">PMC7661945</ArticleId><ArticleId IdType="pubmed">33205039</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson, D.P. and Lovegrove, J.A. (2020) Nutritional status of micronutrients as a possible and modifiable risk factor for COVID-19: a UK perspective. Br. J. Nutr. 125, 678&#x2013;684 10.1017/S000711452000330X</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S000711452000330X</ArticleId><ArticleId IdType="pmc">PMC7492581</ArticleId><ArticleId IdType="pubmed">32815493</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan, N. and Nair, D.T. (2020) Vitamin B12 may inhibit RNA-dependent-RNA polymerase activity of nsp12 from the SARS-CoV-2 virus. IUBMB Life 72, 2112&#x2013;2120 10.1002/iub.2359</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2359</ArticleId><ArticleId IdType="pmc">PMC7461454</ArticleId><ArticleId IdType="pubmed">32812340</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Guarde&#xf1;o, J.M., Ortega-Prieto, A.M., Moreno, B.M., Maguire, T.J.A., Richardson, A., Diaz-Hernandez, J.I.et al. (2021) Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12. bioRxiv 2021.2006.2025.449609</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9333455</ArticleId><ArticleId IdType="pubmed">35849631</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista, K.S., Cintra, V.M., Lucena, P.A.F., Manh&#xe3;es-de-Castro, R., Toscano, A.E., Costa, L.P.et al. (2022) The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the muscle-gut-brain axis and implications for SARS-CoV-2 infection. Nutr. Rev. 80, 561&#x2013;578 10.1093/nutrit/nuab092</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nutrit/nuab092</ArticleId><ArticleId IdType="pmc">PMC8689946</ArticleId><ArticleId IdType="pubmed">34791425</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll, H.A., Millar, E. and Deans, K.A. (2022) Vitamin B12 and D deficiency as cofactors of COVID-19 vaccine-induced chronic neurological adverse reactions: two cases and a hypothesis. Res. Sq. 10.3390/immuno1010003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/immuno1010003</ArticleId></ArticleIdList></Reference><Reference><Citation>Benskin, L.L. (2020) A basic review of the preliminary evidence that COVID-19 risk and severity is increased in vitamin D deficiency. Front. Public Health 8, 513 10.3389/fpubh.2020.00513</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2020.00513</ArticleId><ArticleId IdType="pmc">PMC7513835</ArticleId><ArticleId IdType="pubmed">33014983</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichniak, A., Kania, A., Sieminski, M. and Cubala, W.J. (2021) Melatonin as a potential adjuvant treatment for COVID-19 beyond sleep disorders. Int. J. Mol. Sci. 22, 8623 10.3390/ijms22168623</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22168623</ArticleId><ArticleId IdType="pmc">PMC8395320</ArticleId><ArticleId IdType="pubmed">34445329</ArticleId></ArticleIdList></Reference><Reference><Citation>Varikasuvu, S.R., Thangappazham, B., Vykunta, A., Duggina, P., Manne, M., Raj, H.et al. (2022) COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials. Expert. Rev. Anti Infect. Ther. 20, 907&#x2013;913 10.1080/14787210.2022.2035217</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14787210.2022.2035217</ArticleId><ArticleId IdType="pmc">PMC8862170</ArticleId><ArticleId IdType="pubmed">35086394</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasi, E., Ialongo, C., Labriola, R., Ferraguti, G., Lucarelli, M. and Angeloni, A. (2020) Vitamin K deficiency and COVID-19. Scand. J. Clin. Lab. Investig. 80, 525&#x2013;527 10.1080/00365513.2020.1805122</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365513.2020.1805122</ArticleId><ArticleId IdType="pubmed">32779537</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai, A.P., Dirajlal-Fargo, S., Durieux, J.C., Tribout, H., Labbato, D. and McComsey, G.A. (2021) Vitamin K &amp; D deficiencies are independently associated with COVID-19 disease severity. Open Forum. Infect. Dis. 8, ofab408 10.1093/ofid/ofab408</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab408</ArticleId><ArticleId IdType="pmc">PMC8344499</ArticleId><ArticleId IdType="pubmed">34642636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudelko, M., Yip, T.F., Law, G.C.H. and Lee, S.M.Y. (2021) Potential beneficial effects of vitamin K in SARS-CoV-2 induced vascular disease? Immunol. Lett. 1, 17&#x2013;29 10.3390/immuno1010003</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/immuno1010003</ArticleId></ArticleIdList></Reference><Reference><Citation>Linneberg, A., Kampmann, F.B., Israelsen, S.B., Andersen, L.R., J&#xf8;rgensen, H.L., Sandholt, H.et al. (2021) The association of low vitamin K status with mortality in a cohort of 138 hospitalized patients with COVID-19. Nutrients 13, 1985 10.3390/nu13061985</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13061985</ArticleId><ArticleId IdType="pmc">PMC8229962</ArticleId><ArticleId IdType="pubmed">34207745</ArticleId></ArticleIdList></Reference><Reference><Citation>Cara, K.C., Beauchesne, A.R., Li, R. and Chung, M. (2022) Cochrane review summary on "vitamin D supplementation for the treatment of COVID-19: a living systematic review". J. Diet. Suppl. 19, 143&#x2013;145 10.1080/19390211.2022.2008601</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19390211.2022.2008601</ArticleId><ArticleId IdType="pubmed">34842035</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, Y., Kung, J., Cave, A. and Banh, H.L. (2022) Effects of vitamin D serum level on morbidity and mortality in patients with COVID-19: a systematic review and meta-analysis. J. Pharm. Pharm. Sci. 25, 84&#x2013;92 10.18433/jpps32590</Citation><ArticleIdList><ArticleId IdType="doi">10.18433/jpps32590</ArticleId><ArticleId IdType="pubmed">35245430</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeri, H., Azimian, A., Ghasemzadeh-Moghaddam, H., Safdari, M., Haresabadi, M., Daneshmand, T.et al. (2022) Evaluation of the relationship between serum levels of zinc, vitamin B12, vitamin D, and clinical outcomes in patients with COVID-19. J. Med. Virol. 94, 141&#x2013;146 10.1002/jmv.27277</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27277</ArticleId><ArticleId IdType="pmc">PMC8426973</ArticleId><ArticleId IdType="pubmed">34406674</ArticleId></ArticleIdList></Reference><Reference><Citation>Abobaker, A., Alzwi, A. and Alraied, A.H.A. (2020) Overview of the possible role of vitamin C in management of COVID-19. Pharmacol. Rep. 72, 1517&#x2013;1528 10.1007/s43440-020-00176-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-020-00176-1</ArticleId><ArticleId IdType="pmc">PMC7592143</ArticleId><ArticleId IdType="pubmed">33113146</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak Kujund&#x17e;i&#x107;, R. (2022) COVID-19: are we facing secondary pellagra which cannot simply be cured by vitamin B3? Int. J. Mol. Sci. 23, 4309 10.3390/ijms23084309</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23084309</ArticleId><ArticleId IdType="pmc">PMC9032523</ArticleId><ArticleId IdType="pubmed">35457123</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, M., Schultz, M.B. and Sinclair, D.A. (2022) NAD+ in COVID-19 and viral infections. Trends Immunol. 43, 283&#x2013;295 10.1016/j.it.2022.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2022.02.001</ArticleId><ArticleId IdType="pmc">PMC8831132</ArticleId><ArticleId IdType="pubmed">35221228</ArticleId></ArticleIdList></Reference><Reference><Citation>Chudzik, M., Kapusta, J. and Burzy&#x144;ska, M. (2021) Use of 1-MNA to improve exercise tolerance and fatigue in patients after COVID-19. medRxiv 2021.2007.2014.21259081</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9331270</ArticleId><ArticleId IdType="pubmed">35893858</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosch, T. (1996) Lipid apheresis: from a heroic treatment to routine clinical practice. Artif. Organs 20, 414&#x2013;419 10.1111/j.1525-1594.1996.tb04525.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1525-1594.1996.tb04525.x</ArticleId><ArticleId IdType="pubmed">8725620</ArticleId></ArticleIdList></Reference><Reference><Citation>Bornstein, S.R., Voit-Bak, K., Donate, T., Rodionov, R.N., Gainetdinov, R.R., Tselmin, S.et al. (2022) Chronic post-COVID-19 syndrome and chronic fatigue syndrome: is there a role for extracorporeal apheresis? Mol. Psychiatry 27, 34&#x2013;37 10.1038/s41380-021-01148-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01148-4</ArticleId><ArticleId IdType="pmc">PMC8209771</ArticleId><ArticleId IdType="pubmed">34140635</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeger, B.R. and Seidel, D. (2001) [Hyperlipoproteinemia and LDL apheresis. Clinical experiences with the H.E.L.P. system]. Herz 26, 531&#x2013;544 10.1007/PL00002058</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/PL00002058</ArticleId><ArticleId IdType="pubmed">11820156</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaeger, B.R., Richter, Y., Nagel, D., Heigl, F., Vogt, A., Roeseler, E.et al. (2009) Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events. Nat. Clin. Pract. Cardiovasc. Med. 6, 229&#x2013;239 10.1038/ncpcardio1456</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpcardio1456</ArticleId><ArticleId IdType="pubmed">19234501</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattecka, S., Brunner, P., Hahnel, B., Kunze, R., Vogt, B. and Sheriff, A. (2019) Pentrasorb C-Reactive protein: characterization of the selective C-reactive protein adsorber resin. Ther. Apher. Dial. 23, 474&#x2013;481 10.1111/1744-9987.12796</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1744-9987.12796</ArticleId><ArticleId IdType="pubmed">30697961</ArticleId></ArticleIdList></Reference><Reference><Citation>Torzewski, J., Heigl, F., Zimmermann, O., Wagner, F., Schumann, C., Hettich, R.et al. (2020) First-in-man: case report of selective C-reactive protein apheresis in a patient with SARS-CoV-2 infection. Am. J. Case Rep. 21, e925020 10.12659/AJCR.925020</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/AJCR.925020</ArticleId><ArticleId IdType="pmc">PMC7377527</ArticleId><ArticleId IdType="pubmed">32661220</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maio, A. and Hightower, L.E. (2020) COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Cell Stress Chaperones 25, 717&#x2013;720 10.1007/s12192-020-01121-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12192-020-01121-0</ArticleId><ArticleId IdType="pmc">PMC7232923</ArticleId><ArticleId IdType="pubmed">32424591</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldmeier, J.J., Kirby, J.P., Buckey, J.C., Denham, D.W., Evangelista, J.S., Gelly, H.B.et al. (2021) Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen. Undersea Hyperb. Med. 48, 1&#x2013;12 10.22462/01.03.2021.1</Citation><ArticleIdList><ArticleId IdType="doi">10.22462/01.03.2021.1</ArticleId><ArticleId IdType="pubmed">33648028</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins, T., Gonevski, M., Clark, C., Baitule, S., Sharma, K., Magar, A.et al. (2021) Hyperbaric oxygen therapy for the treatment of long COVID: early evaluation of a highly promising intervention. Clin. Med. (Lond.) 21, e629&#x2013;e632 10.7861/clinmed.2021-0462</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega, M.A., Fraile-Martinez, O., Garcia-Montero, C., Callej&#xf3;n-Pel&#xe1;ez, E., S&#xe1;ez, M.A., &#xc1;lvarez-Mon, M.A.et al. (2021) A general overview on the hyperbaric oxygen therapy: applications, mechanisms and translational opportunities. Medicina (Kaunas) 57, 864 10.3390/medicina57090864</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57090864</ArticleId><ArticleId IdType="pmc">PMC8465921</ArticleId><ArticleId IdType="pubmed">34577787</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganini, M., Bosco, G., Perozzo, F.A.G., Kohlscheen, E., Sonda, R., Bassetto, F.et al. (2021) The role of hyperbaric oxygen treatment for COVID-19: a review. Adv. Exp. Med. Biol. 1289, 27&#x2013;35 10.1007/5584_2020_568</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2020_568</ArticleId><ArticleId IdType="pubmed">32696443</ArticleId></ArticleIdList></Reference><Reference><Citation>Harnanik, T., Soeroso, J., Suryokusumo, M.G. and Juliandhy, T. (2020) Effects of hyperbaric oxygen on T helper 17/regulatory T polarization in antigen and collagen-induced arthritis: hypoxia-inducible factor-1alpha as a target. Oman Med. J. 35, e90 10.5001/omj.2020.08</Citation><ArticleIdList><ArticleId IdType="doi">10.5001/omj.2020.08</ArticleId><ArticleId IdType="pmc">PMC6982795</ArticleId><ArticleId IdType="pubmed">31993228</ArticleId></ArticleIdList></Reference><Reference><Citation>Harnanik, T., Prihartono, S. and Juliandhy, T. (2020) Hyperbaric oxygen in animal model of rheumatoid arthritis: analysis Of HIF-1alpha, ACPA and IL-17a. Infect. Dis. Rep. 12, 8766 10.4081/idr.2020.8766</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/idr.2020.8766</ArticleId><ArticleId IdType="pmc">PMC7447948</ArticleId><ArticleId IdType="pubmed">32874480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sit, M.T., Schmidt, T.W., Edmonds, L.D., Kelly, J.A., Sky, K.M., Thornton, J.A.et al. (2021) The effects of hyperbaric oxygen on rheumatoid arthritis: a pilot study. J. Clin. Rheumatol. 27, e462&#x2013;e468 10.1097/RHU.0000000000001540</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000001540</ArticleId><ArticleId IdType="pubmed">32947434</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliaei, S., SeyedAlinaghi, S., Mehrtak, M., Karimi, A., Noori, T., Mirzapour, P.et al. (2021) The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review. Eur. J. Med. Res. 26, 96 10.1186/s40001-021-00570-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00570-2</ArticleId><ArticleId IdType="pmc">PMC8374420</ArticleId><ArticleId IdType="pubmed">34412709</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanagawa, Y. (2021) Current status of hyperbaric oxygen therapy for COVID-19. Acute Med. Surg. 8, e678 10.1002/ams2.678</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ams2.678</ArticleId><ArticleId IdType="pmc">PMC8264955</ArticleId><ArticleId IdType="pubmed">34262779</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaiyat, A.M., Sasson, E., Wang, Z., Khairy, S., Ginzarly, M., Qureshi, U.et al. (2022) Hyperbaric oxygen treatment for long coronavirus disease-19: a case report. J. Med. Case Rep. 16, 80 10.1186/s13256-022-03287-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03287-w</ArticleId><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="pubmed">35168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshari, R., Akhavan, O., Hamblin, M.R. and Varma, R.S. (2021) Review of oxygenation with nanobubbles: possible treatment for hypoxic COVID-19 patients. ACS Appl. Nano Mater. 4, 11386&#x2013;11412 10.1021/acsanm.1c01907</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsanm.1c01907</ArticleId><ArticleId IdType="pmc">PMC8565459</ArticleId><ArticleId IdType="pubmed">37556289</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>